10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________ 

FORM 10-Q

__________________________________ 

(Mark One)

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2017

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                     to                    

Commission File Number: 001-34452

__________________________________ 

Apollo Commercial Real Estate Finance, Inc.

(Exact name of registrant as specified in its charter)

__________________________________ 

Maryland	27-0467113
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

Apollo Commercial Real Estate Finance, Inc.

c/o Apollo Global Management, LLC

9 West 57th Street, 43rd Floor,

New York, New York 10019

(Address of registrant’s principal executive offices)

(212) 515–3200

(Registrant’s telephone number, including area code)

__________________________________ 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨
Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date.

As of October 31, 2017, there were 107,121,235 shares, par value $0.01, of the registrant’s common stock issued and outstanding.

Table of Contents

	Page
Part I — Financial Information
ITEM 1. Financial Statements	4
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk	43
ITEM 4. Controls and Procedures	44
Part II — Other Information
ITEM 1. Legal Proceedings	45
ITEM 1A. Risk Factors	45
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	45
ITEM 3. Defaults Upon Senior Securities	45
ITEM 4. Mine Safety Disclosures	45
ITEM 5. Other Information	45
ITEM 6. Exhibits	45

3

Part I — FINANCIAL INFORMATION

ITEM 1. Financial Statements

Apollo Commercial Real Estate Finance, Inc. and Consolidated Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands—except share and per share data)

	September 30, 2017			December 31, 2016
Assets:
Cash	$	140,229		$	200,996
Restricted cash	76			62,457
Securities, at estimated fair value	191,902			331,076
Securities, held-to-maturity	—			146,352
Commercial mortgage loans, held for investment, net	2,218,222			1,641,856
Subordinate loans, held for investment, net	1,340,378			1,051,236
Investment in unconsolidated joint venture	—			22,103
Derivative assets, net	—			5,906
Interest receivable	27,895			19,281
Other assets, net	14,240			1,714
Total Assets	$	3,932,942		$	3,482,977
Liabilities and Stockholders’ Equity
Liabilities:
Borrowings under repurchase agreements (net of deferred financing costs of $10,884 and $6,763 in 2017 and 2016, respectively)	$	1,278,631		$	1,139,803
Convertible senior notes, net	471,911			249,994
Participations sold	—			84,979
Derivative liabilities, net	11,746			—
Accounts payable, accrued expenses and other liabilities	8,852			17,681
Payable to related party	8,309			7,015
Dividends payable	55,916			51,278
Total Liabilities	1,835,365			1,550,750
Commitments and Contingencies (see Note 14)
Stockholders’ Equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized:
Series A preferred stock, 0 and 3,450,000 shares issued and outstanding ($0 and $86,250 aggregate liquidation preference) in 2017 and 2016, respectively	—			35
Series B preferred stock, 8,000,000 shares issued and outstanding ($200,000 aggregate liquidation preference) in 2017 and 2016	80			80
Series C preferred stock, 6,900,000 shares issued and outstanding ($172,500 aggregate liquidation preference) in 2017 and 2016	69			69
Common stock, $0.01 par value, 450,000,000 shares authorized, 105,451,235 and 91,422,676 shares issued and outstanding in 2017 and 2016, respectively	1,055			914
Additional paid-in-capital	2,163,539			1,983,010
Accumulated deficit	(67,166		)	(48,070		)
Accumulated other comprehensive loss	—			(3,811		)
Total Stockholders’ Equity	2,097,577			1,932,227
Total Liabilities and Stockholders’ Equity	$	3,932,942		$	3,482,977

See notes to unaudited condensed consolidated financial statements.

4

Apollo Commercial Real Estate Finance, Inc. and Consolidated Subsidiaries

Condensed Consolidated Statement of Operations (Unaudited)

(in thousands—except share and per share data)

	Three months ended   September 30,						Nine months ended   September 30,
	2017			2016			2017			2016
Net interest income:
Interest income from securities	$	2,625		$	8,029		$	9,247		$	23,685
Interest income from securities, held to maturity	—			2,875			4,132			8,597
Interest income from commercial mortgage loans	41,203			27,460			112,690			72,727
Interest income from subordinate loans	47,268			32,207			121,298			89,649
Interest expense	(19,855		)	(17,256		)	(56,089		)	(47,620		)
Net interest income	71,241			53,315			191,278			147,038
Operating expenses:
General and administrative expenses (includes $2,635 and $9,887 of equity based compensation in 2017 and $1,828 and $5,434 of equity compensation in 2016, respectively)	(4,629		)	(8,352		)	(15,587		)	(21,456		)
Management fees to related party	(8,309		)	(5,903		)	(23,484		)	(16,374		)
Total operating expenses	(12,938		)	(14,255		)	(39,071		)	(37,830		)
Income (loss) from unconsolidated joint venture	—			80			(2,847		)	207
Other income	359			309			710			334
Provision for loan losses and impairments	—			—			(5,000		)	(15,000		)
Realized loss on sale of assets	(4,076		)	(225		)	(5,118		)	(225		)
Unrealized gain (loss) on securities	13,488			(9,798		)	11,830			(36,601		)
Foreign currency gain (loss)	7,763			(4,369		)	17,848			(21,926		)
Bargain purchase gain	—			40,021			—			40,021
Gain (loss) on derivative instruments (includes unrealized gains (losses) of ($7,302) and ($17,626) in 2017 and ($10,297) and $1,731 in 2016, respectively)	(7,481		)	4,815			(17,916		)	22,831
Net income	68,356			69,893			151,714			98,849
Preferred dividends	$	(11,148	)	$	(9,310	)	$	(29,768	)	$	(20,985	)
Net income available to common stockholders	57,208			60,583			121,946			77,864
Basic and diluted net income per share of common stock	$	0.54		$	0.83		$	1.23		$	1.11
Basic weighted average shares of common stock outstanding	105,446,704			71,919,549			97,546,437			68,913,362
Diluted weighted average shares of common stock outstanding	106,812,721			72,861,611			98,919,689			69,865,603
Dividend declared per share of common stock	$	0.46		$	0.46		$	1.38		$	1.38

See notes to unaudited condensed consolidated financial statements.

5

Apollo Commercial Real Estate Finance, Inc. and Consolidated Subsidiaries

Condensed Consolidated Statement of Comprehensive Income (Unaudited)

(in thousands)

	Three months ended   September 30,				Nine months ended   September 30,
	2017		2016		2017		2016
Net income available to common stockholders	$	57,208	$	60,583	$	121,946	$	77,864
Foreign currency translation adjustment	—		73		3,811		499
Comprehensive income	$	57,208	$	60,656	$	125,757	$	78,363

See notes to unaudited condensed consolidated financial statements.

6

Apollo Commercial Real Estate Finance, Inc. and Consolidated Subsidiaries

Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited)

(in thousands—except share data)

	Preferred Stock					Common Stock			Additional Paid In Capital			Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Loss
	Shares		Par			Shares	Par											Total
Balance at January 1, 2017	18,350,000		$	184		91,422,676	$	914	$	1,983,010		$	(48,070	)	$	(3,811	)	$	1,932,227
Capital increase related to Equity Incentive Plan	—		—			200,859	3		7,551			—			—			7,554
Issuance of common stock	—		—			13,800,000	138		248,883			—			—			249,021
Redemption of preferred stock	(3,450,000	)	(35		)	—	—		(86,215		)	—			—			(86,250		)
Preferred stock redemption charge	—		—			—	—		3,016			—			—			3,016
Issuance of restricted common stock	—		—			27,700	—		—			—			—			—
Offering costs	—		—			—	—		(120		)	—			—			(120		)
Issuance of convertible senior notes	—		—			—	—		7,414			—			—			7,414
Net income	—		—			—	—		—			151,714			—			151,714
Change in other comprehensive loss	—		—			—	—		—			—			3,811			3,811
Dividends on common stock	—		—			—	—		—			(141,042		)	—			(141,042		)
Dividends on preferred stock	—		—			—	—		—			(29,768		)	—			(29,768		)
Balance at September 30, 2017	14,900,000		$	149		105,451,235	$	1,055	$	2,163,539		$	(67,166	)	$	—		$	2,097,577

See notes to unaudited condensed consolidated financial statements.

7

Apollo Commercial Real Estate Finance, Inc. and Consolidated Subsidiaries

Condensed Consolidated Statement of Cash Flows (Unaudited)

(in thousands)

	Nine months ended September 30, 2017			Nine months ended September 30, 2016
Cash flows provided by operating activities:
Net income	$	151,714		$	98,849
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of discount/premium and PIK interest	(15,491		)	(7,443		)
Amortization of deferred financing costs	4,464			3,199
Equity-based compensation	7,551			2,808
Unrealized (gain) loss on securities	(11,830		)	36,601
Provision for loan losses and impairment	5,000			15,000
Income (loss) from unconsolidated joint venture	2,259			(207		)
Foreign currency (gain) loss	(16,940		)	21,122
Realized (gain) loss on derivative instruments	289			(21,100		)
Unrealized (gain) loss on derivative instruments	17,564			(1,731		)
Realized loss on sale of securities	5,118			225
Bargain purchase gain	—			(40,021		)
Changes in operating assets and liabilities:
Accrued interest receivable, less purchased interest	(27,910		)	(17,638		)
Other assets	(983		)	(121		)
Accounts payable, accrued expenses and other liabilities	(8,623		)	(10,410		)
Payable to related party	1,295			606
Net cash provided by operating activities	113,477			79,739
Cash flows provided by (used in) investing activities:
Funding of commercial mortgage loans	(581,567		)	(548,171		)
Funding of subordinate loans	(475,503		)	(51,921		)
Payments received on commercial mortgage loans	17,062			118,120
Payments received on subordinate loans	221,478			81,524
Origination and exit fees received on commercial mortgage loans and subordinate loans	13,047			7,509
Funding of unconsolidated joint venture	(726		)	(362		)
Funding of other assets	(1,379		)	—
Proceeds (payments) on settlements of derivative instruments	(201		)	21,100
Decrease (Increase) in collateral held related to derivative contracts	(14,262		)	13,110
Proceeds from sale of securities	128,945			86,451
Proceeds from sale of investment in unconsolidated joint venture	24,498			—
Payments received on securities	13,306			22,424
Payments received on securities, held-to-maturity	146,530			5,970
Payments received on other assets	—			107
Proceeds from sale of AMTG assets, net	—			1,474,111
ARI Investment in AMTG, net of cash acquired	—			189,795
Net cash provided by (used in) investing activities	(508,772		)	1,419,767
Cash flows provided by (used in) financing activities:
Proceeds from issuance of common stock	249,021			—
Redemption of Series A preferred stock	(86,250		)	—
Payment of offering costs	(359		)	(45		)
Proceeds from repurchase agreement borrowings	866,548			448,177
Repayments of repurchase agreement borrowings	(727,691		)	(352,914		)
Repayments of AMTG repurchase agreement borrowings	—			(1,254,517		)
Proceeds from issuance of convertible senior notes	227,700			—
Repayments of participations sold	(85,081		)	(3,770		)
Payment of deferred financing costs	(8,585		)	(3,741		)
Dividends on common stock	(136,404		)	(94,625		)
Dividends on preferred stock	(26,752		)	(18,646		)
Net cash provided by (used in) financing activities	272,147			(1,280,081		)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(123,148		)	219,425
Cash, cash equivalents, and restricted cash, beginning of period	263,453			97,542
Cash, cash equivalents, and restricted cash, end of period	$	140,305		$	316,967
Supplemental disclosure of cash flow information:
Interest paid	$	44,303		$	47,093
Supplemental disclosure of non-cash investing and financing activities:
Dividend declared, not yet paid	$	55,916		$	46,028
Deferred financing costs, not yet paid	$	—		$	—
Offering costs payable	$	41		$	220
Fair value of assets acquired from AMTG	$	—		$	1,936
Fair value of liabilities assumed from AMTG	$	—		$	(1,285	)
Fair value of common stock issued to AMTG	$	—		$	218
Fair value of preferred stock issued to AMTG	$	—		$	173

See notes to unaudited condensed consolidated financial statements.

8

Apollo Commercial Real Estate Finance Inc. and Consolidated Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands—except share and per share data)

Note 1 – Organization

Apollo Commercial Real Estate Finance, Inc. (together with its consolidated subsidiaries, referred to throughout this report as the “Company,” “ARI,” “we,” “us” and “our”) is a corporation that has elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes and primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, commercial mortgage-backed securities (“CMBS”) and other commercial real estate-related debt investments in the United States. These asset classes are referred to as the Company’s target assets.

The Company, organized in Maryland on June 29, 2009, commenced operations on September 29, 2009 and is externally managed and advised by ACREFI Management, LLC (the “Manager”), an indirect subsidiary of Apollo Global Management, LLC (together with its subsidiaries, “Apollo”).

The Company elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2009. To maintain its tax qualification as a REIT, the Company is required to distribute at least 90% of its taxable income, excluding net capital gains, to stockholders and meet certain other asset, income, and ownership tests.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include the Company’s accounts and those of its consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company’s most significant estimates include the fair value of financial instruments, loan loss reserves and impairment. Actual results could differ from those estimates.

These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the Company’s financial position, results of operations and cash flows have been included. The Company's results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year or any other future period.

On August 31, 2016, the Company, pursuant to the terms and conditions of the Agreement and Plan of Merger, dated February 26, 2016 (as amended, the “AMTG Merger Agreement”) acquired Apollo Residential Mortgage, Inc. (“AMTG”). AMTG merged with and into the Company (the “AMTG Merger”) with the Company continuing as the surviving entity. As a result, all operations of AMTG and its former subsidiaries are consolidated with the operations of the Company. As of December 31, 2016 all assets acquired from AMTG were sold.

Under Financial Accounting Standards Board (the “FASB”) ASC Topic 805, “Business Combinations”, or ASC 805, the acquirer in a business combination must recognize, with certain exceptions, the fair values of assets acquired, liabilities assumed, and non-controlling interests when the acquisition constitutes a change in control of the acquired entity. We applied the provisions of ASC 805 in accounting for the Company's acquisition of AMTG. In doing so, we recorded provisional amounts for certain items as of the date of the acquisition, including the fair value of certain assets and liabilities. During the measurement period, a period which shall not exceed one year, the Company retrospectively adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of such date that, if known, would have affected the measurement of the amounts recognized. See further discussion in "Note 17 - Business Combination."

The Company currently operates in one business segment.

9

Recent Accounting Pronouncements

In May 2014, the FASB issued guidance which broadly amends the accounting guidance for revenue recognition. The guidance is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2017. The Company does not anticipate that the adoption of this guidance will have a material impact on the Company's condensed consolidated financial statements.

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” or ASU 2014-15. ASU 2014-15 introduces an explicit requirement for management to assess and provide certain disclosures if there is substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 is effective for the annual period ending after December 15, 2016. The Company adopted this guidance and determined that there was no material impact on the Company's condensed consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting (Topic 718),” or ASU 2016-09. ASU 2016-09 requires all income tax effects of share-based payment awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares for tax withholding purposes than is permitted under current guidance without triggering liability accounting. Finally, the guidance allows a policy election to account for employee forfeitures as they occur. The guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted this guidance and determined there was no material impact on the Company's condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments (Topic 326),” or ASU 2016-13. ASU 2016-13 significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income.  The guidance will replace the “incurred loss” approach under existing guidance with an “expected loss” model for instruments measured at amortized cost, and require entities to record allowances for available-for-sale debt securities rather than reduce the carrying amount, as they do today under the other-than-temporary impairment model. It also simplifies the accounting model for purchased credit-impaired debt securities and loans. The guidance is effective for fiscal years beginning after December 15, 2019 and is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company is currently assessing the impact, if any, the guidance will have on the Company's condensed consolidated financial statements when adopted.

In August 2016, the FASB issued ASU 2016-15 “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” or ASU 2016-15. ASU 2016-15 is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance addresses the classification of various transactions including debt prepayment or debt extinguishment costs, settlement of zero-coupon debt instruments, contingent consideration payments made after a business combination, distributions received from equity method investments, beneficial interests in securitization transactions, and others. The Company adopted this guidance in the third quarter of 2016 and determined that there was no material impact on the Company's condensed consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18 “Statement of Cash Flows (Topic 230): Restricted Cash,” or ASU 2016-18. ASU 2016-18 is intended to clarify how entities present restricted cash in the statement of cash flows. The guidance requires entities to show the changes in the total of cash and cash equivalents and restricted cash in the statement of cash flows. As a result, entities will no longer present transfers between cash and cash equivalents and restricted cash in the statement of cash flows. When cash and cash equivalents and restricted cash are presented in more than one line item on the balance sheet, the new guidance requires a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet. This reconciliation can be presented either on the face of the statement of cash flows or in the notes to the financial statements. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017 and is to be applied retrospectively. The Company early adopted ASU 2016-18 on June 30, 2017, which changed the Company's condensed consolidated statement of cash flows and related disclosures for all periods presented. The following is a reconciliation of the Company's cash, cash equivalents, and restricted cash to the total presented in the Company's condensed consolidated statement of cash flows for the nine months ended September 30, 2017 and September 30, 2016, respectively:

10

	Nine months ended September 30,
	2017		2016
Cash and cash equivalents	$	140,229	$	254,643
Restricted cash	76		62,324
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	140,305	$	316,967

In August 2017, the FASB issued ASU 2017-12 "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” or ASU 2017-12. The intention of ASU 2017-12 is to align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness previously recognized on existing cash flow and net investment hedges will be adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income (loss). The Company is currently assessing the impact, if any, the guidance will have on the Company's condensed consolidated financial statements when adopted. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018 and is applied retroactively.

Note 3 – Fair Value Disclosure

GAAP establishes a hierarchy of valuation techniques based on the observability of the inputs utilized in measuring financial instruments at fair values. Market based or observable inputs are the preferred source of values, followed by valuation models using management assumptions in the absence of market inputs. The three levels of the hierarchy as noted in ASC 820, Fair Value Measurements and Disclosures, are described below:

Level I — Quoted prices in active markets for identical assets or liabilities.

Level II — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

Level III — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

While the Company anticipates that its valuation methods will be appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company will use inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.

The estimated fair value of the Company's CMBS portfolio is determined by reference to market prices provided by certain dealers who make a market in these financial instruments. The Company believes that these dealers who are usually market makers in these securities utilize various valuation techniques and inputs including, but not limited to, observable trades, discounted cash flow, market yield and duration to price these securities. Broker quotes are only indicative of fair value and may not necessarily represent what the Company would receive in an actual trade for the applicable instrument. Management performs additional analysis on prices received based on broker quotes to validate the prices and adjustments are made as deemed necessary by management to capture current market information. As of December 31, 2016 the estimated fair values of the Company’s securities were based on observable inputs and were classified as Level II in the fair value hierarchy. In June 2017, the Manager determined that, based on illiquidity in the market for these securities, broker quotes lack observable inputs and thus a transfer into Level III in the fair value hierarchy was necessary. Based on this determination, as of June 30, 2017, we have applied Level III classification to these securities. In accordance with GAAP, the Company elects the fair value option for these securities at the date of purchase in order to allow the Company to measure these securities at fair value with the change in estimated fair value included as a component of earnings in order to reflect the performance of the investment in a timely manner.

The estimated fair values of the Company’s derivative instruments are determined using a discounted cash flow analysis on the expected cash flows of each derivative. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The fair values of interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts (or payments) that would occur if variable interest rates rise above the strike

11

rate of the caps. The variable interest rates used in the calculation of projected cash flows are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The fair values of foreign exchange forwards are determined by comparing the contracted forward exchange rate to the current market exchange rate.  The current market exchange rates are determined by using market spot rates, forward rates and interest rate curves for the underlying countries.  The Company’s derivative instruments are classified as Level II in the fair value hierarchy.

The following table summarizes the levels in the fair value hierarchy into which the Company’s financial instruments were categorized as of September 30, 2017 and December 31, 2016:

	Fair Value as of September 30, 2017										Fair Value as of December 31, 2016
	Level I		Level II			Level III		Total			Level I		Level II		Level III		Total
CMBS (Fair Value Option)	$	—	$	—		$	191,902	$	191,902		$	—	$	331,076	$	—	$	331,076
Derivative instruments, net	—		(11,746		)	—		(11,746		)	—		5,906		—		5,906
Total	$	—	$	(11,746	)	$	191,902	$	180,156		$	—	$	336,982	$	—	$	336,982

The following is a reconciliation of investments for which Level III inputs were used in determining fair value:

	CMBS
Fair value at December 31, 2016	$	—
Transfers into Level III (1)	254,484
Net realized loss on investments	(4,076		)
Net increase in unrealized gain on investments	13,488
Sales and repayments of investments	(71,073		)
Amortization of purchase discount, net	(921		)
Fair value at September 30, 2017	$	191,902

———————

(1) Transfers into Level III of the fair value hierarchy represent investments that experienced an insignificant level of market activity during the period and were thus valued in the absence of observable inputs. Transfers into Level III of the fair value hierarchy are recorded at the end of the reporting period. In June 2017, the Manager determined that, based on illiquidity in the market for these securities, broker quotes, which are the primary valuation technique used to mark these investments at fair value, lack observable inputs and thus a transfer into Level III was necessary. Based on this determination, as of June 30, 2017, we have applied Level III classification to these securities.

The following table summarizes information about significant unobservable inputs used in the fair value measurement of Level III investments as of September 30, 2017. There were no Level III investments as of December 31, 2016:

			Unobservable Input
Asset Category	Fair Value	Primary Valuation Technique	Input	Range
CMBS	191,902	Broker quotes	Price (1)	63 - 101

———————

(1) A significant increase (decrease) in the unobservable input in isolation would result in significantly higher (lower) fair value measurement.

Note 4 – Securities

At September 30, 2017, all of the Company's CMBS (Fair Value Option) were pledged to secure borrowings under the Company’s master repurchase agreement Deutsche Bank AG ("DB") (the "DB Facility"). The Company's master repurchase agreement with UBS AG, London Branch ("UBS") (the "UBS Facility") matured in September, 2017 and was fully repaid by the Company. See "Note 7 - Borrowings Under Repurchase Agreements" for further information regarding these facilities.

12

CMBS (Held-to-Maturity) represents a loan the Company closed during May 2014 that was subsequently contributed to a securitization during August 2014. During May 2014, the Company closed a $155,000 floating-rate whole loan secured by the first mortgage and equity interests in an entity that owns a resort hotel in Aruba. The property consists of 442 hotel rooms, 114 timeshare units, two casinos and approximately 131,500 square feet of retail space. During June 2014, the Company syndicated a $90,000 senior participation in the loan and retained a $65,000 junior participation. The Company evaluated this transaction and concluded that due to its continuing involvement, the transaction should not be accounted for as a sale. During August 2014, both the $90,000 senior participation and the Company's $65,000 junior participation were contributed to a CMBS securitization. In exchange for contributing its $65,000 junior participation, the Company received a CMBS secured solely by the $65,000 junior participation. During May 2017, the loan and associated CMBS (Held-to-Maturity) were fully repaid and the related Securities, held-to-maturity and participation sold line items were removed from the Company's condensed consolidated balance sheet.

The amortized cost and estimated fair value of the Company’s debt securities at September 30, 2017 are summarized as follows:

Security Description	Face Amount		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
CMBS (Fair Value Option)	$	222,522	$	217,242	$	247	$	(25,587	)	$	191,902

During the nine months ended September 30, 2017, the Company sold securities resulting in a net realized loss of $5,118.

The amortized cost and estimated fair value of the Company’s debt securities at December 31, 2016 are summarized as follows:

Security Description	Face Amount		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
CMBS (Fair Value Option)	$	375,861	$	368,247	$	292	$	(37,463	)	$	331,076
CMBS (Held-to-Maturity)	146,530		146,352		—		—			146,352
Total	$	522,391	$	514,599	$	292	$	(37,463	)	$	477,428

During August 2016, the Company sold CMBS with an amortized cost of $86,676 resulting in a net realized loss of $225, which was comprised of realized gains of $90 and realized losses of $315. The sale generated net proceeds of $16,222 after the repayment of $70,229 of borrowings under the DB Facility.

The overall statistics for the Company’s CMBS (Fair Value Option) calculated on a weighted average basis as of September 30, 2017 and December 31, 2016 are as follows:

	September 30, 2017		December 31, 2016
Credit Ratings *	BB-D		B+-NR
Coupon	5.9	%	5.9	%
Yield	4.2	%	6.0	%
Weighted Average Life	2.0 years		2.5 years

-————————

* Ratings per Fitch Ratings, Moody’s Investors Service or Standard & Poor's.

13

The percentage vintage, property type and location of the collateral securing the Company's CMBS (Fair Value Option) calculated on a weighted average basis as of September 30, 2017 and December 31, 2016 are as follows:

Vintage	September 30, 2017		December 31, 2016
2005	—	%	2.0	%
2006	21.2		12.1
2007	57.0		73.5
2008	21.8		12.4
Total	100.0	%	100.0	%

Property Type	September 30, 2017		December 31, 2016
Office	37.8	%	34.6	%
Retail	25.8		29.0
Multifamily	13.6		12.4
Other (1)	22.8		24.0
Total	100.0	%	100.0	%

———————

(1) No other individual category comprises more than 10% of the total.

Location	September 30, 2017		December 31, 2016
South Atlantic	28.3	%	23.8	%
Middle Atlantic	11.9		16.7
Pacific	5.8		15.3
East North Central	16.7		10.8
Other (1)	37.3		33.4
Total	100.0	%	100.0	%

———————

 (1) No other individual category comprises more than 10% of the total.

Note 5 – Loans, Held for Investment

The Company’s loans receivable are comprised of the following:

Loan Type	September 30, 2017		December 31, 2016
Commercial mortgage loans, held for investment, net	$	2,218,222	$	1,641,856
Subordinate loans, held for investment, net	1,340,378		1,051,236
Total loans, held for investment, net	$	3,558,600	$	2,693,092

Activity relating to our loans, held for investment portfolio was as follows:

	Principal Balance		Deferred Fees/Other Items (1)		Provision for Loan Loss (2)		Carrying Value
December 31, 2016	2,720,344		(12,252	)	(15,000	)	2,693,092
Loan fundings	1,057,070		—		—		1,057,070
Loan repayments	(238,541	)	—		—		(238,541	)
Unrealized gain on foreign currency translation	20,974		—		—		20,974
Provision for loan loss (2)	—		—		(1,981	)	(1,981	)
Deferred fees and other items (1)	—		(13,047	)	—		(13,047	)
PIK interest, amortization of fees and other items (1)	19,321		21,712		—		41,033
September 30, 2017	3,579,168		(3,587	)	(16,981	)	3,558,600

14

———————

(1) Other items primarily consist of purchase discounts or premiums, exit fees, and deferred origination expenses.

(2) In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 against a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet.

The following table details overall statistics for our loan portfolio:

	September 30, 2017			December 31, 2016
Number of loans	56			45
Principal balance	$	3,579,168		$	2,720,344
Carrying value	$	3,558,600		$	2,693,092
Unfunded loan commitments (1)	$	80,164		$	170,365
Weighted-average cash coupon (2)	8.5		%	8.88		%

———————

(1) Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2) For floating rate loans, assumes one-month LIBOR of 1.23%and 0.77%, as of September 30, 2017 and December 31, 2016, respectively.

The tables below detail the property type and geographic distribution of the properties securing the loans in our portfolio:

	September 30, 2017			December 31, 2016
Property Type	Carrying Value	% of Portfolio		Carrying Value	% of Portfolio
Residential - for sale	735,551	20.7	%	469,997	17.5	%
Hotel	652,745	18.3	%	408,428	15.2	%
Urban Retail Predevelopment	644,283	18.1	%	491,187	18.2	%
Mixed Use	352,094	9.9	%	134,797	5.0	%
Office	293,093	8.2	%	255,031	9.5	%
Residential Rental	278,117	7.8	%	309,243	11.5	%
Retail Center	197,120	5.5	%	209,401	7.8	%
Healthcare	174,244	4.9	%	170,549	6.3	%
Other	154,017	4.3	%	87,650	3.3	%
Industrial	77,336	2.3	%	156,809	5.7	%
	3,558,600	100.0	%	2,693,092	100.0	%

15

	September 30, 2017		December 31, 2016
Geographic Location	Carrying Value	% of Portfolio	Carrying Value	% of Portfolio
Manhattan, NY	$1,246,235	35.0%	$870,914	32.3%
Brooklyn, NY	244,501	6.9%	163,389	6.1%
Northeast	133,979	3.8%	137,770	5.1%
Southeast	530,881	14.9%	332,276	12.3%
Midwest	524,984	14.7%	405,992	15.1%
Mid Atlantic	248,786	7.0%	263,717	9.8%
West	205,274	5.8%	219,664	8.2%
Southwest	33,824	1.0%	54,614	2.0%
United Kingdom	312,159	8.7%	244,756	9.1%
Other International	77,977	2.2%	—	—%
Total	$3,558,600	100%	$2,693,092	100%

The Company evaluates its loans for possible impairment on a quarterly basis. The Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations are sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the property’s liquidation value. The Company also evaluates the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, the Company considers the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such loan loss analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants. An allowance for loan loss is established when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan.

During the second quarter of 2017, the Company recorded a loan loss provision of $1,981 on a commercial mortgage loan secured by fully-built, for-sale residential condominium units located in Bethesda, MD. In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 on a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet. The loan loss provision and impairment were based on the difference between fair value of the underlying collateral, and the carrying value of the loan (prior to the loan loss provision and related impairment). Fair value of the collateral was determined using a discounted cash flow analysis. The significant unobservable inputs used in determining the collateral value were sales price per square foot and discount rate which were an average of $678 dollars per square foot across properties and 15%, respectively. Effective April 1, 2017, the Company ceased accruing all interest associated with the loan and accounts for the loan on a cost-recovery basis (all proceeds are applied towards the loan balance).

During 2016, the Company recorded a loan loss provision of $10,000 on a multifamily commercial mortgage loan and $5,000 on a multifamily subordinate loan secured by a multifamily property located in Williston, ND. The loan loss provision was based on the difference between fair value of the underlying collateral, and the carrying value of the loan (prior to the loan loss provision). Fair value of the collateral was determined using a discounted cash flow analysis. The significant unobservable inputs used in determining the collateral value were terminal capitalization rate and discount rate which were 11% and 10%, respectively. The Company ceased accruing payment in kind ("PIK") interest associated with the loan and recognizing interest income upon receipt of cash.

As of September 30, 2017, the aggregate loan loss provision was $11,981 and $5,000 for commercial mortgage loans and subordinate loans, respectively. As of December 31, 2016, the aggregate loan loss provision was $10,000 and $5,000 for commercial mortgage loans and subordinate loans, respectively.

16

For the three and nine months ended September 30, 2017, the Company received pre-payment penalties of $3,590 and $3,998, respectively. For the three and nine months ended September 30, 2016, the Company received pre-payment penalties of $4,000 and $5,225, respectively. The Company records pre-payment penalty income under interest income.

For the three and nine months ended September 30, 2017, the Company recognized PIK interest of $5,309 and $19,323, respectively. For the three and nine months ended September 30, 2016, the Company recognized PIK interest of $5,808 and $15,902, respectively.

Note 6 – Unconsolidated Joint Venture

In September 2014, the Company, through a wholly owned subsidiary, acquired a 59% ownership interest in Champ L.P. (“Champ LP”) following which a wholly-owned subsidiary of Champ LP then acquired a 35% ownership interest in Bremer Kreditbank AG ("BKB"). The Company acquired its ownership interest in Champ LP for an initial purchase price paid at closing of approximately €30,724 (or $39,477). The Company committed to invest up to approximately €38,000 (or $50,000). Champ LP together with certain unaffiliated third party investors, in aggregate, own 100% of BKB.

BKB specializes in corporate banking and financial services for medium-sized German companies. It also provides professional real estate financing, acquisition finance, institutional asset management and private wealth management services for German high-net-worth individuals.

The Company evaluated Champ LP to determine if it met the definition of a variable interest entity ("VIE") in accordance with ASC 810, Consolidation. The Company determined that Champ LP met the definition of a VIE, however, the Company was not the primary beneficiary; therefore, the Company was not required to consolidate the assets and liabilities of the partnership in accordance with the authoritative guidance. Additionally, Champ LP is an Investment Company under GAAP, and is therefore reflected at fair value. The Company's investment in Champ LP was accounted for as an equity method investment and therefore the Company recorded its proportionate share of the net asset value in accordance with ASC 323, Investments - Equity Method and Joint Ventures.

In January 2015, the Company funded an additional investment of €3,331 (or $3,929) related to its investment in Champ LP. In February 2015, the Company sold approximately 48% of its ownership interest in Champ LP at cost to an investment fund managed by Apollo for €16,314 (or $20,794) (of which $2,614 related to foreign exchange losses which were previously included in accumulated other comprehensive loss). In June 2016, the Company transferred €427 of its unfunded commitment to Apollo, reducing its unfunded commitment to Champ LP to €2,802 (or $2,985).

In May 2017, the Company sold its remaining ownership interest in Champ LP to unaffiliated third parties for €21,792 or $24,498, resulting in a loss of $3,305. As of September 30, 2017, the Company had no interest in Champ LP.

Note 7 – Borrowings Under Repurchase Agreements

At September 30, 2017 and December 31, 2016, the Company’s borrowings had the following outstanding balances, maturities and weighted average interest rates:

17

	September 30, 2017								December 31, 2016
Lender	Maximum Amount of Borrowings		Borrowings Outstanding			Maturity (1)	Weighted Average Rate (2)		Maximum Amount of Borrowings		Borrowings Outstanding			Maturity (1)	Weighted Average Rate (2)
JPMorgan Facility (3)	$	1,118,000	$	840,360		March 2020	L+2.27%		$	943,000	$	657,452		January 2019	L+2.25%
DB Repurchase Facility (4)	565,491		265,658			March 2020	L+2.35%		300,000		137,355			September 2019	L+2.66%
Goldman Loan	34,180		34,180			April 2019	L+3.50%		N/A		40,657			April 2019	L+3.50%
Sub-total	1,717,671		1,140,198				L+2.32%				835,464				L+2.38%
UBS Facility	N/A		N/A			N/A	N/A		N/A		133,899			September 2018	2.79	%
DB Facility (5)	300,000		149,317			April 2018	3.48	%	N/A		177,203			April 2018	3.63	%
Sub-total	300,000		149,317				3.48	%			311,102				3.27	%
Less: deferred financing costs	N/A		(10,884		)		N/A		N/A		(6,763		)		N/A
Total / Weighted Average	$	2,017,671	$	1,278,631			3.55	%			$	1,139,803			3.18	%

———————

(1) Maturity date assumes all extensions are exercised.

(2) Assumes one-month LIBOR was 1.23% and 0.77% as of September 30, 2017 and December 31, 2016, respectively.

(3) As of September 30, 2017, the Company's master repurchase agreement with JPMorgan Chase Bank, National Association

(the "JPMorgan Facility") provided for maximum total borrowings comprised of the $975,000 repurchase facility and a $143,000 asset specific financing.

(4) As of September 30, 2017, the Company's master repurchase agreement with Deutsche Bank AG, Cayman Islands Branch (the "DB Repurchase Facility") provided for maximum total borrowings comprised of the $450,000 and £45,000 repurchase facility and a $55,200 asset specific financing.

(5) Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 2.09% to 2.39% based on the rating of the collateral pledged.

At September 30, 2017, the Company’s borrowings had the following remaining maturities:

	Less than 1 year (1)		1 to 3 years (1)		3 to 5 years		More than 5 years		Total
JPMorgan Facility	$	166,273	$	674,087	$	—	$	—	$	840,360
DB Repurchase Facility	—		265,658		—		—		265,658
Goldman Loan	—		34,180		—		—		34,180
DB Facility	149,317		—		—		—		149,317
Total	$	315,590	$	973,925	$	—	$	—	$	1,289,515

———————

(1) Assumes underlying assets are financed through the fully extended maturity date of the facility.

At September 30, 2017, the Company’s collateralized financings were comprised of borrowings outstanding under the JPMorgan Facility, the DB Repurchase Facility, the Company's repurchase agreement with Goldman Sachs Bank USA (the "Goldman Loan") and the DB Facility. The table below summarizes the outstanding balances at September 30, 2017, as well as the maximum and average month-end balances for the nine months ended September 30, 2017 for the Company's borrowings under repurchase agreements.

			For the nine months ended September 30, 2017
	Balance at September 30, 2017		Maximum Month-End Balance		Average Month-End Balance
JPMorgan Facility borrowings	$	840,360	$	986,611	$	849,355
DB Repurchase Facility borrowings	265,658		367,010		286,326
Goldman Loan borrowings	34,180		39,590		37,554
DB Facility borrowings	149,317		177,203		136,930
Total	$	1,289,515

18

JPMorgan Facility

On March 31, 2017, the Company, through two indirect wholly owned subsidiaries, amended and restated the JPMorgan Facility, which currently provides for maximum total borrowings of $1,118,000, comprised of the $975,000 repurchase facility and a $143,000 asset specific financing, and a term expiring in March 2019 plus a one-year extension option available at the Company's option, subject to certain conditions. Amounts borrowed under the JPMorgan Facility bear interest at spreads ranging from 2.25% to 3.50% over one-month LIBOR. Margin calls may occur any time the aggregate repurchase price exceeds the agreed upon advance rate multiplied by the market value of the assets by more than $250. The Company has agreed to provide a limited guarantee of the obligations of its indirect wholly-owned subsidiaries under the JPMorgan Facility.

As of September 30, 2017, the Company had $840,360 of borrowings outstanding under the JPMorgan Facility secured by certain of the Company's commercial mortgage and subordinate loans.

DB Repurchase Facility

On September 29, 2016, the Company, through indirect wholly-owned subsidiaries, entered into the DB Repurchase Facility which provides for maximum total borrowings of $565,491 comprised of the $450,000 and £45,000 repurchase facility as well as a $55,200 asset specific financing in connection with financing first mortgage loans secured by real estate. The DB Repurchase Facility matures in March 2018 with twoone-year extension options available at the Company's option, subject to certain conditions. Amounts borrowed under the DB Repurchase Facility bear interest at spreads ranging from 2.10% to 3.00% over one-month LIBOR. Margin calls may occur any time at specified aggregate margin deficit thresholds. The Company has agreed to provide a guarantee of the obligations of its indirect wholly-owned subsidiaries under this facility.

As of September 30, 2017, the Company had $265,658 (inclusive of £45,000) borrowings outstanding under the DB Repurchase Facility secured by certain of the Company's commercial mortgage loans.

Goldman Loan

On January 26, 2015, the Company, through an indirect wholly-owned subsidiary, entered into the Goldman Loan. The Goldman Loan provides for a purchase price of $34,180 (as of September 30, 2017) and a repurchase date of the earliest of: (1) April 30, 2019, (2) an early repurchase date as a result of repayment or sale of the purchased loan, or (3) an accelerated repurchase date as a result of certain events of default. Subject to the terms and conditions thereof, the Goldman Loan provides for the purchase and sale of certain participation interests in a mortgage loan secured by single-family and condominium properties. Amounts borrowed under the Goldman Loan bear interest at a spread of 3.5% plus one-month LIBOR. In addition, the Goldman Loan provides that margin calls may occur during the continuance of certain credit events if the market value of the mortgaged properties drop below an agreed upon percentage. The Goldman Loan contains affirmative and negative covenants and provisions regarding events of default that are normal and customary for similar repurchase agreements.

As of September 30, 2017, the Company had $34,180 of borrowings outstanding under the Goldman Loan secured by one commercial mortgage loan held by the Company.

UBS Facility

In September 2013, the Company, through an indirect wholly-owned subsidiary, entered into the UBS Facility, which provided that the Company may borrow up to $133,899 in order to finance the acquisition of CMBS. The UBS Facility matured in September 2017 and the Company repaid the outstanding borrowings in full.

DB Facility

In April 2014, the Company, through an indirect wholly-owned subsidiary, entered into the DB Facility, which currently provides that the Company may borrow up to $300,000 in order to finance the acquisition of CMBS. The DB Facility matures in April 2018. Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 2.09% to 2.39% based on the rating of the collateral pledged.

The Company posts margin in cash based on the fair value of the underlying collateral. The margin posted is classified as restricted cash on the Company's condensed consolidated balance sheets.

Additionally, the undrawn amount is subject to a 1.8% non-use fee. The DB Facility contains customary terms and conditions for facilities of this type and financial covenants to be met by the Company, including minimum shareholder's equity of 50% of the gross capital proceeds of its initial public offering and any subsequent public or private offerings.

As of September 30, 2017, the Company had $149,317 of borrowings outstanding under the DB Facility secured by CMBS held by the Company.

19

The Company was in compliance with the financial covenants under each of its borrowing agreements at September 30, 2017 and December 31, 2016.

Note 8 – Convertible Senior Notes

On March 17, 2014, the Company issued $143,750 aggregate principal amount of 5.50% Convertible Senior Notes due 2019 (the "March 2019 Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company, of approximately $139,037. At September 30, 2017, the March 2019 Notes had a carrying value of $142,251 and an unamortized discount of $1,499.

On August 18, 2014, the Company issued an additional $111,000 aggregate principal amount of 5.50% Convertible Senior Notes due 2019 (the "August 2019 Notes" and together with the March 2019 Notes, the "2019 Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company, of approximately $109,615. At September 30, 2017, the August 2019 Notes had a carrying value of $109,187 and an unamortized discount of $1,813.

On August 21, 2017, the Company issued $230,000 aggregate principal amount of 4.75% Convertible Senior Notes due 2022 (the "August 2022 Notes" and together with the 2019 Notes, the "Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company, of approximately $224,825. At September 30, 2017, the August 2022 Notes had a carrying value of $220,473 and an unamortized discount of $9,527.

The following table summarizes the terms of the Notes.

	Principal Amount	Coupon Rate	Effective Rate (1)	Conversion Rate (2)	Maturity Date	Remaining Period of Amortization
March 2019 Notes	$143,750	5.50%	6.25%	57.3034	3/15/2019	1.46 years
August 2019 Notes	$111,000	5.50%	6.50%	57.3034	3/15/2019	1.46 years
August 2022 Notes	$230,000	4.75%	5.72%	50.2260	8/23/2022	4.90 years

———————

(1) Effective rate includes the effect of the adjustment for the conversion option (see footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.

(2) The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof.  The conversion rate represents the number of shares of common stock issuable per $1,000 principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by the Company to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.

The Company may not redeem the Notes prior to maturity. The closing price of the Company's common stock on September 29, 2017 of $18.11 was greater than the per share conversion price of the 2019 Notes and less than the per share conversion price of the August 2022 Notes. The Company has the intent and ability to settle the Notes in cash and, as a result, the Notes did not have any impact on the Company's diluted earnings per share.

In accordance with ASC 470 the liability and equity components of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) is to be separately accounted for in a manner that reflects the issuer’s nonconvertible debt borrowing rate. GAAP requires that the initial proceeds from the sale of the Notes be allocated between a liability component and an equity component in a manner that reflects interest expense at the interest rate of similar nonconvertible debt that could have been issued by the Company at such time. The Company measured the fair value of the debt components of the Notes as of their issuance date based on effective interest rates.  As a result, the Company attributed approximately $18,859 of the proceeds to the equity component of the Notes ($11,445 to the 2019 Notes and $7,414 to the August 2022 Notes), which represents the excess proceeds received over the fair value of the liability component of the Notes at the date of issuance. The equity component of the Notes has been reflected within additional paid-in capital in the condensed consolidated balance sheet as of September 30, 2017. The resulting debt discount is being amortized over the period during which the Notes are expected to be outstanding (the maturity date) as additional non-cash interest expense. The additional non-cash interest expense attributable to each of the Notes will increase in subsequent reporting periods through the maturity date as the Notes accrete to their par value over the same period.

The aggregate contractual interest expense was approximately $4,717 and $11,722 for the three and nine months ended September 30, 2017, respectively. The aggregate contractual interest expense was approximately $3,503 and $10,508 for the three and nine months ended September 30, 2016, respectively. With respect to the amortization of the discount on the liability component of the Notes as well as the amortization of deferred financing costs, the Company reported additional non-cash interest expense of approximately $1,213 and $3,025 for the three and nine months ended September 30, 2017, respectively. With respect to the

20

amortization of the discount on the liability component of the Notes as well as the amortization of deferred financing costs, the Company reported additional non-cash interest expense of approximately $895 and $2,654 for the three and nine months ended September 30, 2016, respectively.

Note 9 – Participations Sold

Participations sold represent the interests in loans the Company originated and subsequently partially sold. The Company presents the participations sold as both assets and non-recourse liabilities because the participation does not qualify as a sale according to ASC 860, Transfers and Servicing. The income earned on the participation sold is recorded as interest income and an identical amount is recorded as interest expense on the Company's condensed consolidated statements of operations.

During January 2015, the Company closed a £34,519 (or $51,996) floating-rate mezzanine loan secured by a portfolio of 44 senior housing facilities located throughout the United Kingdom. During February 2015, the Company closed an additional £20,000 (or $30,672) and participated that balance to an investment fund affiliated with Apollo. During December 2016, the Company qualified for sale accounting with respect to the previous participation sold that was converted to a discrete financial instrument, and therefore deconsolidated the participation sold.

During May 2014, the Company closed a $155,000 floating-rate whole loan secured by the first mortgage and equity interests in an entity that owns a resort hotel in Aruba. During June 2014, the Company syndicated a $90,000 senior participation in the loan and retained a $65,000 junior participation in the loan. During August 2014, both the $90,000 senior participation and the Company's $65,000 junior participation were contributed to a CMBS securitization. In exchange for contributing its $65,000 junior participation, the Company received a CMBS secured solely by the $65,000 junior participation and classified it as CMBS (Held-to-Maturity) on its condensed consolidated financial statements. During May 2017, the loan and associated CMBS (Held-to-Maturity) were fully repaid and the related Securities, held-to-maturity and participation sold line items were removed from the Company's condensed consolidated balance sheet.

Note 10 – Derivative Instruments

The Company uses forward currency contracts to economically hedge interest and principal payments due under its loans denominated in currencies other than U.S. dollars.

The Company has entered into a series of forward contracts to sell an amount of foreign currency (British pound ("GBP")) for an agreed upon amount of U.S. dollars at various dates through April 2018. These forward contracts were executed to economically fix the U.S. dollar amounts of foreign denominated cash flows expected to be received by the Company related to foreign denominated loan investments.

The following table summarizes the Company's non-designated foreign exchange (“Fx”) forwards as of September 30, 2017:

Type of Derivative	September 30, 2017
	Number of Contracts	Aggregate Notional Amount	Notional Currency	Maturity
Fx Contracts - GBP	13	197,401	GBP	October 2017- April 2018

The following table summarizes the Company's non-designated Fx forwards as of December 31, 2016:

Type of Derivative	December 31, 2016
	Number of Contracts	Aggregate Notional Amount	Notional Currency	Maturity
Fx Contracts - GBP	11	148,310	GBP	January 2017- December 2017

The Company has not designated any of its derivative instruments as hedges as defined in ASC 815, Derivatives and Hedging and, therefore, changes in the fair value of the Company's derivative instruments are recorded directly in earnings. The following table summarizes the amounts recognized on the condensed consolidated statements of operations related to the Company’s derivative instruments for the three and nine months ended September 30, 2017 and 2016.

21

		Three months ended September 30,						Nine months ended September 30,
	Location of Loss Recognized in Income	2017			2016			2017			2016
Forward currency contract	Gain (loss) on derivative instruments - unrealized	$	(7,308	)	$	(10,304	)	$	(17,629	)	$	1,812
Forward currency contract	Gain (loss) on derivative instruments - realized	(179		)	15,112			(290		)	21,100
Interest rate caps (1)	Gain (loss) on derivative instruments - unrealized	6			7			3			(81		)
Sub-total		$	(7,481	)	$	4,815		$	(17,916	)	$	22,831
Forward currency contract	Income (loss) from unconsolidated joint venture	—			—			(587		)	—
Total		$	(7,481	)	$	4,815		$	(18,503	)	$	22,831

———————

(1) With a notional amount of $41,507 and $46,798 at September 30, 2017 and 2016, respectively.

The following table summarizes the gross asset and liability amounts related to the Company's derivative instruments at September 30, 2017 and December 31, 2016.

	September 30, 2017								December 31, 2016
	Gross Amount of Recognized Liabilities			Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet			Gross Amount of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheet		Net Amounts of Assets Presented in the Consolidated Balance Sheet
Interest rate caps	$	—		$	1	$	1		$	23	$	—	$	23
Forward currency contract	(11,747		)	—		(11,747		)	5,883		—		5,883
Total derivative instruments	$	(11,747	)	$	1	$	(11,746	)	$	5,906	$	—	$	5,906

Note 11 – Related Party Transactions

AMTG Merger

As fully described in "Note 17- Business Combination", in August 2016, the Company acquired AMTG, an entity managed by an affiliate of Apollo.

Management Agreement

In connection with the Company’s initial public offering in September 2009, the Company entered into a management agreement (the “Management Agreement”) with the Manager, which describes the services to be provided by the Manager and its compensation for those services. The Manager is responsible for managing the Company’s day-to-day operations, subject to the direction and oversight of the Company’s board of directors.

Pursuant to the terms of the Management Agreement, the Manager is paid a base management fee equal to 1.5% per annum of the Company’s stockholders’ equity (as defined in the Management Agreement), calculated and payable (in cash) quarterly in arrears.

The current term of the Management Agreement expires on September 29, 2018 and is automatically renewed for successive one-year terms on each anniversary thereafter. The Management Agreement may be terminated upon expiration of the one-year extension term only upon the affirmative vote of at least two-thirds of the Company’s independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to the Company or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of the Company’s independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Following a meeting by the Company’s independent

22

directors in February 2017, which included a discussion of the Manager’s performance and the level of the management fees thereunder, the Company determined not to seek termination of the Management Agreement.

For the three and nine months ended September 30, 2017, the Company incurred approximately $8,309 and $23,484, respectively, in base management fees under the Management Agreement. For the three and nine months ended September 30, 2016, the Company incurred approximately $5,903 and $16,374, respectively, in base management fees under the Management Agreement. In addition to the base management fee, the Company is also responsible for reimbursing the Manager for certain expenses paid by the Manager on behalf of the Company or for certain services provided by the Manager to the Company. For the three and nine months ended September 30, 2017, the Company paid expenses totaling $37 and $231 respectively, related to reimbursements for certain expenses paid by the Manager on behalf of the Company under the Management Agreement. For the three and nine months ended September 30, 2016, the Company paid expenses totaling $517 and $1,359, respectively, related to reimbursements for certain expenses paid by the Manager on behalf of the Company under the Management Agreement. Expenses incurred by the Manager and reimbursed by the Company are reflected in the respective condensed consolidated statement of operations expense category or the condensed consolidated balance sheet based on the nature of the item.

Included in payable to related party on the condensed consolidated balance sheet at September 30, 2017 and December 31, 2016 are approximately $8,309 and $7,015, respectively, for base management fees incurred but not yet paid under the Management Agreement.

Unconsolidated Joint Venture

In September 2014, the Company, through a wholly owned subsidiary, acquired a 59% ownership interest in Champ LP following which a wholly-owned subsidiary of Champ LP then acquired a 35% ownership interest in BKB. The Company acquired its ownership interest in Champ LP for an initial purchase price paid at closing of approximately €30,724 (or $39,477). The Company committed to invest up to approximately €38,000 (or $50,000).

In January 2015, the Company funded an additional investment of €3,331 (or $3,929) related to its investment in Champ LP. In February 2015, the Company sold approximately 48% of its ownership interest in Champ LP at cost to an account managed by Apollo for approximately €16,314 (or $20,794). In June 2016, the Company transferred €427 of its unfunded commitment to Apollo, reducing its unfunded commitment to Champ LP to €2,802 (or $2,985). 

In May 2017, the Company sold its remaining ownership interest in Champ LP, to unaffiliated third parties for €21,792 or $24,498, resulting in a loss of $3,305. As of September 30, 2017, the Company had no interest in Champ LP.

Loans receivable

In June, 2017, the Company increased its outstanding loan commitment through the acquisition of an additional $25,000 of interests in an existing pre-development mezzanine loan from a fund managed by an affiliate of the Manager, increasing the Company's total outstanding loan commitment to $100,000. Furthermore, in September 2017 the Company funded an additional $25,000 to acquire a portion of the same pre-development mezzanine loan from a fund managed by an affiliate of the Manager, increasing the Company's total outstanding loan commitment to $125,000. The pre-development mezzanine loan is for the construction of a residential condominium building in New York, New York and is part of a $300,000 mezzanine loan.

23

Note 12 – Share-Based Payments

On September 23, 2009, the Company’s board of directors approved the Apollo Commercial Real Estate Finance, Inc., 2009 Equity Incentive Plan (as amended from time to time, the “LTIP”). The LTIP provides for grants of restricted common stock, restricted stock units ("RSUs") and other equity-based awards up to an aggregate of 7.5% of the issued and outstanding shares of the Company’s common stock (on a fully diluted basis). The LTIP is administered by the compensation committee of the Company’s board of directors (the “Compensation Committee”) and all grants under the LTIP must be approved by the Compensation Committee.

The Company recognized stock-based compensation expense of $2,635 and $9,887, respectively, for the three and nine months ended September 30, 2017, related to restricted stock and RSU vesting. The Company recognized stock-based compensation expense of $1,828 and $5,434, respectively, for the three and nine months ended September 30, 2016, related to restricted common stock and RSU vesting. The following table summarizes the activity related to restricted common stock and RSUs during the nine months ended September 30, 2017:

	Type	Date	Restricted Stock		RSUs		Estimated Fair Value on Grant Date		Initial Vesting	Final Vesting
Outstanding at December 31, 2016			150,110		1,703,775
	Canceled upon delivery	January 2017	—		(332,349	)	n/a		n/a	n/a
	Vested	January 2017	(5,161	)	—		n/a		n/a	n/a
	Forfeiture	March 2017	—		(1,971	)	n/a		n/a	n/a
	Vested	April 2017	(5,164	)			n/a		n/a	n/a
	Grant	April 2017	14,674		—		$	275	April 2018	April 2020
	Canceled upon delivery	May 2017	—		(1,971	)	n/a		n/a	n/a
	Vested	July 2017	(4,004	)			n/a		n/a	n/a
	Canceled upon delivery	July 2017			(544	)	n/a		n/a	n/a
	Grant	August 2017	13,026				$	233	August 2018	August 2018
	Grant	August 2017			790		$	14	August 2018	August 2021
	Forfeiture	September 2017			(8,273	)	n/a		n/a	n/a
Outstanding at September 30, 2017			163,481		1,359,457

24

Below is a summary of restricted stock and RSU vesting dates as of September 30, 2017.

Vesting Date	Restricted Stock Vesting	RSU Vesting	Total Awards
October 2017	3,997	—	3,997
December 2017	53,923	603,677	657,600
January 2018	2,749	—	2,749
April 2018	7,645	—	7,645
June 2018	—	544	544
July 2018	1,420	—	1,420
October 2018	1,424	—	1,424
December 2018	41,670	477,173	518,843
January 2019	1,419	—	1,419
April 2019	6,314	—	6,314
December 2019	25,000	277,273	302,273
April 2020	4,894	—	4,894
August 2020	—	264	264
Total	163,481	1,359,457	1,522,939

At September 30, 2017, the Company had unrecognized compensation expense of approximately $1,932 and $16,629, respectively, related to the vesting of restricted stock awards and RSUs noted in the table above.

RSU Deliveries

During the nine months ended September 30, 2017, the Company delivered 200,859 shares of common stock for 334,864 vested RSUs. The Company allows RSU participants to settle their tax liabilities with a reduction of their share delivery from the originally granted and vested RSUs. The amount, when agreed to by the participant, results in a cash payment to the Manager related to this tax liability and a corresponding adjustment to additional paid-in-capital on the condensed consolidated statement of changes in stockholders' equity. The adjustment was $2,336 for the nine months ended September 30, 2017, and is included as a reduction of capital increase related to the Company's equity incentive plan in the condensed consolidated statement of changes in stockholders’ equity.

Note 13 – Stockholders’ Equity

The Company's authorized capital stock consists of 450,000,000 shares of common stock, $0.01 par value per share and 50,000,000 shares of preferred stock, $0.01 par value per share. As of September 30, 2017, 105,451,235 shares of common stock were issued and outstanding and there were 8,000,000 shares of 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") issued and outstanding and 6,900,000 shares of 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock ("Series C Preferred Stock") issued and

outstanding.

On August 2, 2017, the Company redeemed all 3,450,000 shares of 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") at $25.00 plus accumulated but unpaid dividends of $0.1079 per share.

Dividends. During 2017, the Company declared the following dividends on its common stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.4600
June 15, 2017	June 30, 2017	July 17, 2017	$0.4600
September 14, 2017	September 29, 2017	October 16, 2017	$0.4600

During 2017, the Company declared the following dividends on its Series A Preferred Stock:

25

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.5391
June 15, 2017	June 30, 2017	July 17, 2017	$0.5391
July 3, 2017	August 2, 2017	August 2, 2017	$0.1079

During 2017, the Company declared the following dividends on its Series B Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.5000
June 15, 2017	June 30, 2017	July 17, 2017	$0.5000
September 14, 2017	September 29, 2017	October 16, 2017	$0.5000

During 2017, the Company declared the following dividends on its Series C Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 28, 2017	$0.5000
June 15, 2017	June 30, 2017	July 31, 2017	$0.5000
September 14, 2017	September 29, 2017	October 31, 2017	$0.5000

Common Stock Offerings. During the second quarter of 2017, the Company completed a follow-on public offering of 13,800,000 shares of its common stock, at a price of $18.05 per share. The aggregate net proceeds from the offering, including proceeds from the sale of the additional shares, were approximately $248,900 after deducting estimated offering expenses.

During the fourth quarter of 2016, the Company completed a follow-on public offering of 10,500,000 shares of its common stock, at a price of $16.97 per share. The aggregate net proceeds from the offering, including proceeds from the sale of the additional shares, were approximately $177,796 after deducting estimated offering expenses.

AMTG Merger. In addition, in 2016 the Company issued common and preferred equity in connection with the AMTG Merger as described in "Note 17 - Business Combination."

Note 14 – Commitments and Contingencies

Legal Proceedings. From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of business.

After the announcement of the execution of the AMTG Merger Agreement, two putative class action lawsuits challenging the proposed First Merger (as defined in the AMTG Merger Agreement), captioned Aivasian v. Apollo Residential Mortgage, Inc., et al., No. 24-C-16-001532 and Wiener v. Apollo Residential Mortgage, Inc., et al., No. 24-C-16-001837, were filed in the Circuit Court for Baltimore City, (the “Court”). A putative class and derivative lawsuit was later filed in the Court captioned Crago v. Apollo Residential Mortgage, Inc., No. 24-C-16-002610. Following a hearing on May 6, 2016, the Court entered orders among other things, consolidating the three actions under the caption In Re Apollo Residential Mortgage, Inc. Shareholder Litigation, Case No.: 24-C-16-002610. The plaintiffs have designated the Crago complaint as the operative complaint. The operative complaint includes both direct and derivative claims, names as defendants AMTG, the board of directors of AMTG (the “AMTG Board”), ARI, Arrow Merger Sub Inc., Apollo and Athene Holding Ltd. and alleges, among other things, that the members of the AMTG Board breached their fiduciary duties to the AMTG stockholders and that the other corporate defendants aided and abetted such fiduciary breaches. The operative complaint further alleges, among other things, that the proposed First Merger involves inadequate consideration, was the result of an inadequate and conflicted sales process, and includes unreasonable deal protection devices that purportedly preclude competing offers. It also alleges that the transactions with Athene Holding Ltd. are unfair and that the registration statement on Form S-4 filed with the SEC on April 6, 2016 contains materially misleading disclosures and omits certain material information. The operative complaint seeks, among other things, certification of the proposed class, declaratory relief, preliminary and permanent injunctive relief, including enjoining or rescinding the First Merger, unspecified damages, and an award of other unspecified attorneys’ and other fees and costs. On May 6, 2016, counsel for the plaintiffs filed with the Court a stipulation seeking the appointment of interim co-lead counsel, which stipulation was approved by the Court on June 9, 2016. Defendants’ motions to dismiss have been fully briefed,

26

and oral argument was held on December 8, 2016. On August 14, 2017, the Court issued an opinion dismissing the operative complaint in its entirety with prejudice. The time to appeal the order dismissing the lawsuit has expired, and no appeals have been filed.

On January 4, 2017, the United States Department of Justice served a Request for Information and Documents (the “Request”) on the Company, in connection with a preliminary investigation into certain aspects of the Company's former residential real estate portfolio, which the Company acquired in connection with the AMTG Merger and subsequently sold in 2016. The Request seeks a range of information in connection with the residential real estate portfolio, including, among other things, information concerning policies, procedures, and practices related to advertising, marketing, identifying, or acquiring residential properties for sale or rent, and various data for all rental and sales contracts executed since January 1, 2012. The Company is cooperating with the Department of Justice and fully complying with the Request.

Loan Commitments. As described in "Note 5 - Loans, Held for Investment", at September 30, 2017, the Company had $80,164 of unfunded commitments related to its commercial mortgage loan portfolio and subordinate loan portfolio.

Note 15 – Fair Value of Financial Instruments

The following table presents the carrying value and estimated fair value of the Company’s financial instruments not carried at fair value on the condensed consolidated balance sheet at September 30, 2017 and December 31, 2016:

	September 30, 2017						December 31, 2016
	Carrying Value			Estimated Fair Value			Carrying Value			Estimated Fair Value
Cash and cash equivalents	$	140,229		$	140,229		$	200,996		$	200,996
Restricted cash	76			76			62,457			62,457
Securities, held-to-maturity	—			—			146,352			146,352
Commercial mortgage loans	2,218,222			2,235,084			1,641,856			1,648,896
Subordinate loans	1,340,378			1,323,249			1,051,236			1,060,882
Borrowings under repurchase agreements	(1,289,515		)	(1,288,982		)	(1,146,566		)	(1,146,807		)
2019 Notes	(251,438		)	(277,041		)	(249,994		)	(268,124		)
August 2022 Notes	(220,473		)	(234,025		)	—			—
Participations sold	—			—			(84,979		)	(85,072		)

To determine estimated fair values of the financial instruments listed above, market rates of interest, which include credit assumptions, are used to discount contractual cash flows. The estimated fair values are not necessarily indicative of the amount the Company could realize on disposition of the financial instruments. The use of different market assumptions or estimation methodologies could have a material effect on the estimated fair value amounts. Estimates of fair value for cash and cash equivalents, restricted cash and convertible senior notes, net are measured using observable Level I inputs as defined in "Note 3 - Fair Value Disclosure." Estimates of fair value for all other financial instruments in the table above are measured using significant estimates, or unobservable Level III inputs as defined in "Note 3 - Fair Value Disclosure."

Note 16 – Net Income per Share

ASC 260, Earnings per share, requires the use of the two-class method of computing earnings per share for all periods presented for each class of common stock and participating security as if all earnings for the period had been distributed. Under the two-class method, during periods of net income, the net income is first reduced for dividends declared on all classes of securities to arrive at undistributed earnings. During periods of net losses, the net loss is reduced for dividends declared on participating securities only if the security has the right to participate in the earnings of the entity and an objectively determinable contractual obligation to share in net losses of the entity.

The remaining earnings are allocated to common stockholders and participating securities to the extent that each security shares in earnings as if all of the earnings for the period had been distributed. Each total is then divided by the applicable number of shares to arrive at basic earnings per share. For the diluted earnings, the denominator includes all outstanding shares of common stock and all potential shares of common stock assumed issued if they are dilutive. The numerator is adjusted for any changes in income or loss that would result from the assumed conversion of these potential shares of common stock.

27

The table below presents basic and diluted net (loss) income per share of common stock using the two-class method for the three and nine months ended September 30, 2017 and September 30, 2016:

	For the three     months ended   September 30,						For the nine   months ended   September 30,
	2017			2016			2017			2016
Numerator:
Net income	$	68,356		$	69,893		$	151,714		$	98,849
Preferred dividends	(11,148		)	(9,310		)	(29,768		)	(20,985		)
Net income available to common stockholders	57,208			60,583			121,946			77,864
Dividends declared on common stock	(48,507		)	(37,180		)	(139,155		)	(99,182		)
Dividends on participating securities	(625		)	(413		)	(1,884		)	(1,298		)
Net income (loss) attributable to common stockholders	$	8,076		$	22,990		$	(19,093	)	$	(22,616	)
Denominator:
Basic weighted average shares of common stock outstanding	105,446,704			71,919,549			97,546,437			68,913,362
Diluted weighted average shares of common stock outstanding	106,812,721			72,861,611			98,919,689			69,865,603
Basic and diluted net income per weighted average share of common stock
Distributable Earnings	$	0.46		$	0.52		$	1.43		$	1.44
Undistributed income (loss)	$	0.08		$	0.31		$	(0.20	)	$	(0.33	)
Basic and diluted net income per share of common stock	$	0.54		$	0.83		$	1.23		$	1.11

For the three and nine months ended September 30, 2017, 1,366,016 and 1,373,252 unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. For the three and nine months ended September 30, 2016, 942,062 and 952,241 unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive.

Note 17 – Business Combination

On August 31, 2016, the Company, pursuant to the terms and conditions of the AMTG Merger Agreement, acquired AMTG for consideration of common stock and preferred stock, as applicable and cash. AMTG merged with and into the Company with the Company continuing as the surviving entity. As a result, all operations of AMTG and its former subsidiaries are consolidated with the operations of the Company. In connection with financing the AMTG Merger, on August 31, 2016, the Company entered into a Loan Agreement (the “Athene Loan Agreement”) with Athene USA Corporation, a subsidiary of Athene Holding Ltd., as lender (“Athene USA”), pursuant to which the Company borrowed $175,000 in order to fund a portion of the Company’s obligations under the AMTG Merger Agreement. The Athene Loan Agreement was repaid in full and terminated on September 1, 2016. On August 31, 2016, pursuant to an Asset Purchase and Sale Agreement, dated February 26, 2016 (as amended, the “Asset Purchase Agreement”) by and among Athene Annuity & Life Assurance Company and Athene Annuity and Life Company (collectively, “Athene Annuity”) and the Company, the Company sold primarily non-agency residential mortgage backed securities previously held by AMTG to Athene Annuity for cash consideration of approximately $1,100,000. Proceeds from the sale were used to repay approximately $804,000 in associated financing, $175,000 to satisfy the Athene Loan Agreement and for general corporate purposes. All of the assets acquired from AMTG were sold during 2016.

The AMTG Merger was accounted for as a business combination in accordance with ASC 805, Business Combinations.  The transactions pursuant to the Athene Loan Agreement and the Asset Purchase Agreement were contemporaneous with and contingent on the AMTG Merger, therefore the Company recorded the transaction net. The Company was designated as the accounting acquirer. The total purchase price has been allocated based upon management’s estimates of fair value. The difference between the fair value of net assets of AMTG and the consideration was recorded as a bargain purchase gain.

The bargain purchase gain was computed as follows:

28

Consideration Paid:		$ (in thousands)
	Cash	$	220,159
	Common stock issued	218,397
	Preferred stock assumed	172,500
	Total consideration paid	$	611,056
Assets acquired:
	Cash and cash equivalents	399,402
	Restricted cash	10,552
	Investments	1,491,484
	Other assets	34,822
Liabilities assumed:
	Borrowings under repurchase agreements	(1,254,518		)
	Other liabilities	(30,665		)
	Net assets acquired	651,077
	Bargain purchase gain	$	40,021

The Company incurred $11,350 of transaction-related expenses related to the AMTG Merger during 2016. Transaction-related expenses are comprised primarily of transaction fees and AMTG Merger costs, including legal, finance, consulting, professional fees and other third-party costs.

The following table provides the pro forma consolidated operational data as if the AMTG Merger had occurred on January 1, 2016:

	Three Months Ended		Nine Months Ended
(in thousands, except per share data)	September 30, 2016		September 30, 2016
Total revenue	$	89,665	$	280,230
Net income attributable to common shareholders	15,615		40,161
Common shares outstanding at September 30, 2016	80,826,566		80,826,566
Net income per common share, basic and diluted	$	0.19	$	0.50

The pro forma consolidated operational data is based on assumptions and estimates considered appropriate by our management; however, these pro forma results are not necessarily indicative of the results of operations that would have been obtained had the AMTG Merger occurred at the beginning of the period presented, nor do they purport to represent the consolidated results of operations for future periods. The pro forma consolidated operational data does not include the impact of any synergies that may be achieved from the AMTG Merger or any strategies that management may consider in order to continue to efficiently manage operations.

Note 18 – Subsequent Events

In October 2017, the Company received approximately $48,357 in proceeds from sales and principal pay downs from four CMBS.

Subsequent to the end of the third quarter, the Company committed capital to $294,134 of first mortgage loans, all of which were funded.

The Company funded approximately $2,475 of previously closed loans.

29

The Company received approximately $166,240 from loan repayments, including $35,530 of first mortgage loans and $130,710 from subordinate loans.

In October 2017, the Company concurrently entered into a common stock purchase agreement and a preferred stock repurchase agreement with QH RE Asset Company, LLC (“QHREAC”). Pursuant to the agreements, (i) QHREAC purchased 1,670,000 shares of the Company’s common stock, par value $0.01 per share, for cash at an aggregate purchase price of $30,795 ($18.44 per share), and (ii) the Company repurchased from QHREAC 1,229,607 shares of the Company’s Series B Preferred Stock, par value $0.01 per share, for an aggregate purchase price of $30,795 ( approximately $25.04 per share, made up of $25 liquidation value per share, plus $0.04 per share of accumulated and unpaid dividends through, but not including, the closing date of the transaction).

In October 2017, the Company upsized its JPMorgan Facility increasing the maximum borrowing capacity amount to $1,393,000, comprised of a $1,250,000 repurchase facility and a $143,000 asset specific financing.

30

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

(in thousands—except share and per share data)

FORWARD-LOOKING INFORMATION

The Company makes forward-looking statements herein and will make forward-looking statements in future filings with the SEC, press releases or other written or oral communications within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For these statements, the Company claims the protections of the safe harbor for forward-looking statements contained in such Sections. Forward-looking statements are subject to substantial risks and uncertainties, many of which are difficult to predict and are generally beyond the Company’s control. These forward-looking statements include information about possible or assumed future results of the Company’s business, financial condition, liquidity, results of operations, plans and objectives. When the Company uses the words “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “may” or similar expressions, it intends to identify forward-looking statements. Statements regarding the following subjects, among others, may be forward-looking: market trends in the Company’s industry, interest rates, real estate values, the debt securities markets or the general economy or the demand for commercial real estate loans; the Company’s business and investment strategy; the Company’s operating results; actions and initiatives of the U.S. government and governments outside of the United States and changes to government policies and the execution and impact of these actions, initiatives and policies; the state of the economy generally or in specific geographic regions; economic trends and economic recoveries; the Company’s ability to obtain and maintain financing arrangements, including repurchase agreement financing and securitizations; the availability of debt financing from traditional lenders; the volume of short-term loan extensions; the demand for new capital to replace maturing loans; expected leverage; general volatility of the securities markets in which the Company participates; changes in the value of the Company’s assets; the scope of the Company’s target assets; interest rate mismatches between the Company’s target assets and any borrowings used to fund such assets; changes in interest rates and the market value of the Company’s target assets; changes in prepayment rates on the Company’s target assets; effects of hedging instruments on the Company’s target assets; rates of default or decreased recovery rates on the Company’s target assets; the degree to which hedging strategies may or may not protect the Company from interest rate volatility; impact of and changes in governmental regulations, tax law and rates, accounting, legal or regulatory issues or guidance and similar matters; the Company’s continued maintenance of its qualification as a REIT for U.S. federal income tax purposes; the Company’s continued exclusion from registration under the Investment Company Act of 1940, as amended; the availability of opportunities to acquire commercial mortgage-related, real estate-related and other securities; the availability of qualified personnel; estimates relating to the Company’s ability to make distributions to its stockholders in the future; and the Company’s present and potential future competition.

The forward-looking statements are based on the Company’s beliefs, assumptions and expectations of its future performance, taking into account all information currently available to it. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to the Company. See “Item 1A - Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that the Company files with the SEC, could cause its actual results to differ materially from those included in any forward-looking statements the Company makes. All forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us. Except as required by law, the Company is not obligated to, and does not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Overview

The Company is a Maryland corporation that has elected to be taxed as a REIT for U.S. federal income tax purposes. The Company primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, CMBS and other commercial real estate-related debt investments. These asset classes are referred to as the Company’s target assets.

The Company is externally managed and advised by the Manager, an indirect subsidiary of Apollo, a leading global alternative investment manager with a contrarian and value oriented investment approach in private equity, credit and real estate with assets under management of approximately $242 billion as of September 30, 2017.

The Manager is led by an experienced team of senior real estate professionals who have significant expertise in underwriting and structuring commercial real estate financing transactions. The Company benefits from Apollo’s global infrastructure and operating platform, through which the Company is able to source, evaluate and manage potential investments in the Company’s target assets.

31

Market Overview

Based on the current market dynamics, including significant upcoming commercial real estate debt maturities, we believe there remain compelling opportunities for the Company to invest capital in its target assets at attractive risk adjusted returns. The Company will continue to focus on underlying real estate value, and transactions that benefit from the Company’s ability to execute complex and sophisticated transactions.

Although the Company does not participate in the conduit lending market, the Company believes that an active CMBS market can be viewed as an indicator of the active commercial real estate lending markets. New-issue CMBS issuance continued in 2017 with total issuance in the United States of approximately $67 billion. During the nine months ended September 30, 2017, despite the robust issuance, current volumes of CMBS issuance are still moderate relative to the peak of the market, which saw more than $229 billion in CMBS issuance in 2007, creating significant opportunities for non-CMBS lenders such as the Company.

On February 3, 2017, President Trump signed an executive order for a broad review of federal regulation of the U.S. financial system by the Secretary of the Treasury, in consultation with the heads of the member agencies of the Financial Stability Oversight Council, a panel comprising top U.S. financial regulators, to be reported within 120 days of the day of the order. While the outcome is uncertain, there have been several indications that the new administration will seek to deregulate the U.S. financial industry, including by altering the Dodd-Frank Act, which may, among other things, decrease the restrictions on banks and other financial institutions and allow them to compete with us for investment opportunities that were previously not available to them.

The Company believes the challenges faced by conduit lenders and the general uncertainty around value and pricing could create attractive risk adjusted investment opportunities for the Company. As a result, the Company expects to continue to see opportunities to originate mezzanine and first mortgage financings in transactions which benefit from the Company’s ability to source, structure and execute complex transactions.

Critical Accounting Policies

A summary of the Company’s accounting policies is set forth in its Annual Report on Form 10-K for the year ended December 31, 2016 under “Item 7 – Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Use of Estimates.” There have been no material changes to the Company's critical accounting policies described in the Company's Annual Report on Form 10-K filed with the SEC on February 28, 2017.

Financial Condition and Results of Operations

All non-U.S. dollar denominated assets and liabilities are translated to U.S. dollars at the exchange rate prevailing at the reporting date and income, expenses, gains, and losses are translated at the prevailing exchange rate on the dates that they were recorded.

Investments

The following table sets forth certain information regarding the Company’s investments at September 30, 2017:

Description	Amortized Cost		Weighted Average Coupon (1)		Weighted Average All-in Yield (1) (2)		Debt		Cost of Funds		Equity at cost
First mortgages	$	2,218,222	6.5	%	7.3	%	$	1,140,198	3.6	%	$	1,078,024
Subordinate loans	1,340,378		11.8		13.1		—		—		1,340,378
Total/Weighted Average	$	3,558,600	8.5	%	9.5	%	$	1,140,198	3.6	%	$	2,418,402

-————————

(1) Weighted-Average Coupon and Weighted Average All-in-Yield reflects one-month LIBOR at September 30, 2017, which was 1.23%.

(2) Weighted-Average All-in-Yield includes the amortization of deferred origination fees, loan origination costs and accrual of both extension and exit fees.

32

The Company's average asset and debt balances for the nine months ended September 30, 2017, were:

	Average month-end balances for the nine months ended September 30, 2017
Description	Assets		Related debt
First mortgages	$	2,027,620	$	1,173,235
Subordinate loans (1)	1,209,787		—
CMBS	305,470		233,884

———————

(1) Subordinate loans also include CMBS (Held-to-Maturity).

Investment Activity

During the nine-months ended September 30, 2017, the Company committed $910,566 of capital to loans ($866,300 of which was funded at closing). In addition, during the nine-months ended September 30, 2017 the Company funded approximately $190,737 for previously closed loans and received $238,541 in repayments from loans.

Net Income Available to Common Stockholders

For the three months ended September 30, 2017 and September 30, 2016, respectively, the Company’s net income available to common stockholders was $57,208, or $0.54 per share, and $60,583, or $0.83 per share. For the nine months ended September 30, 2017 and September 30, 2016, respectively, the Company’s net income available to common stockholders was $121,946, or $1.23 per share, and $77,864, or $1.11 per share.

Operating Results

The following table sets forth information regarding our consolidated results of operations and certain key operating metrics:

	Three months ended September 30,						2017 vs. 2016			Nine months ended September 30,						2017 vs. 2016
	2017			2016			$			2017			2016			$
Net interest income:
Interest income from securities	$	2,625		$	8,029		$	(5,404	)	$	9,247		$	23,685		$	(14,438	)
Interest income from securities, held to maturity	—			2,875			(2,875		)	4,132			8,597			(4,465		)
Interest income from commercial mortgage loans	41,203			27,460			13,743			112,690			72,727			39,963
Interest income from subordinate loans	47,268			32,207			15,061			121,298			89,649			31,649
Interest expense	(19,855		)	(17,256		)	(2,599		)	(56,089		)	(47,620		)	(8,469		)
Net interest income	71,241			53,315			17,926			191,278			147,038			44,240
Operating expenses:
General and administrative expenses	(4,629		)	(8,352		)	3,723			(15,587		)	(21,456		)	5,869
Management fees to related party	(8,309		)	(5,903		)	(2,406		)	(23,484		)	(16,374		)	(7,110		)
Total operating expenses	(12,938		)	(14,255		)	1,317			(39,071		)	(37,830		)	(1,241		)
Income (loss) from unconsolidated joint venture	—			80			(80		)	(2,847		)	207			(3,054		)
Other income	359			309			50			710			334			376
Provision for loan losses and impairments	—			—			—			(5,000		)	(15,000		)	10,000
Realized loss on sale of assets	(4,076		)	(225		)	(3,851		)	(5,118		)	(225		)	(4,893		)
Unrealized gain (loss) on securities	13,488			(9,798		)	23,286			11,830			(36,601		)	48,431
Foreign currency gain (loss)	7,763			(4,369		)	12,132			17,848			(21,926		)	39,774
Bargain purchase gain	—			40,021			(40,021		)	—			40,021			(40,021		)
Gain (loss) on derivative instruments	(7,481		)	4,815			(12,296		)	(17,916		)	22,831			(40,747		)
Net income	$	68,356		$	69,893		$	(1,537	)	$	151,714		$	98,849		$	52,865

33

Net interest income

Net interest income increased by $17,926 and $44,240during the three and nine months ended September 30, 2017, respectively as compared to the same periods in 2016. The increase was primarily due to an increase in the principal balance of the Company's loan portfolio, by $1,222,797 as of September 30, 2017 compared to September 30, 2016 and an increase in one-month LIBOR of 0.70% from 0.53% as of September 30, 2016 to 1.23% as of September 30, 2017 partially offset by (i) an increase in interest expense due to an increase in the Company's debt balance of $490,861 as of September 30, 2017 compared to September 30, 2016 and (ii) a decrease in the principal balance of the Company's securities by $327,150 as of September 30, 2017 compared to September 30, 2016.

For the three and nine months ended September 30, 2017, the Company received pre-payment penalties of $3,590 and $3,998, respectively. For the three and nine months ended September 30, 2016, the Company received pre-payment penalties of $4,000 and $5,225, respectively. The Company records pre-payment penalty income under interest income.

For the three and nine months ended September 30, 2017, the Company recognized PIK interest of $5,309 and $19,323, respectively. For the three and nine months ended September 30, 2016, the Company recognized PIK interest of $5,808 and $15,902, respectively.

General and administrative expenses

Excluding $4,925 in expenses related to the AMTG merger, general and administrative expenses increased by $1,202 for the three months ended September 30, 2017 compared to the same period in 2016. The increase was primarily driven by an increase of $807 of non-cash restricted stock and RSU amortization related to shares awarded under the Company's long-term incentive plans and a $395 increase in general operating expenses.

Excluding $11,350 in expenses related to the AMTG merger, general and administrative expenses increased by $5,481 for the nine months ended September 30, 2017 compared to the same period in 2016. The increase was primarily driven by $4,453 of non-cash restricted stock and RSU amortization related to shares awarded under the Company's long-term incentive plans and a $1,028 increase in general operating expenses.

Management fees to related party

Management fee expense increased by $2,406 and $7,110 during the three and nine months ended September 30, 2017, respectively as compared to the same periods in 2016. The increase is primarily attributable to an increase in the Company’s stockholders’ equity (as defined in the Management Agreement) as a result of the Company’s issuance of common and preferred equity in connection with the AMTG Merger in 2016, and the Company’s follow-on common equity offerings in December 2016 and June 2017. Management fees and the relationship between the Company and the Manager under the Management Agreement are discussed further in the accompanying condensed consolidated financial statements, in “Note 11—Related Party Transactions.”

Income (loss) from unconsolidated joint venture

Income (loss) from unconsolidated joint ventures consists of activity related to our ownership interest in Champ LP, as described in Note 6 to the unaudited condensed consolidated financial statements - Unconsolidated Joint Ventures. In May 2017, the Company sold its remaining ownership interest in Champ LP, to unaffiliated third parties, resulting in a loss of $3,305, which is the primary driver for the increase in the loss from unconsolidated joint ventures during the nine months ended September 2017 compared to the same period in 2016. The realized loss included currency translation losses, which were previously included in accumulated other comprehensive loss on the Company's condensed consolidated statement of changes in stockholders' equity.

Provision for loan losses and impairments

During the three and nine months ended September 30, 2017, the Company recorded $0 and $5,000 for provision for loan losses and impairment, respectively. The $5,000, recognized in the second quarter of 2017, related to an investment in a fully-built, for-sale residential condominium units located in Bethesda, MD. During the three and nine months September 30, 2016, the Company recorded a loan loss provision of $10,000 on a multifamily commercial mortgage loan and $5,000 on a multifamily subordinate loan secured by a multifamily property located in Williston, ND.

34

Realized loss on sale of assets

Realized losses on the sale of assets relate to the sale of CMBS. These losses were $4,076 and $5,118 for the three and nine months ended September 30, 2017, respectively and there was $225 in losses for the three and nine months ended September 30, 2016.

Unrealized gain (loss) on securities

Unrealized losses on securities relate to the change in fair value of the CMBS portfolio where the Company has elected the fair value option and were $13,488 and $11,830 for the three and nine months ended September 30, 2017, respectively and ($9,798) and ($36,601) for the three and nine months ended September 30, 2016, respectively.

Foreign currency gain (loss) and gain (loss) on derivative instruments

The Company uses forward currency contracts to economically hedge interest and principal payments due under its loans denominated in currencies other than U.S. dollars. The Company has in the past used and may in the future use interest rate swaps and caps to manage exposure to variable cash flows on portions of its borrowings under repurchase agreements. Interest rate swap and cap agreements allow the Company to receive a variable rate cash flow based on LIBOR and pay a fixed rate cash flow, mitigating the impact of this exposure. As a result of mitigating the impact of this exposure, when foreign currency gains (losses) and gain (losses) on derivative instruments are looked at on a combined basis the net impact for the three and nine months ended September 30, 2017 was $282 and ($68), respectively and the net impact for the three and nine months ended September 30, 2016 was $446 and $905, respectively.

Dividends

Dividends.For the nine months ended September 30, 2017, the Company declared the following dividends on its common stock:

Declaration Date	Record Date	Payment Date	Amount
March 14, 2017	March 31, 2017	April 17, 2017	$0.4600
June 15, 2017	June 30, 2017	July 17, 2017	$0.4600
September 14, 2017	September 29, 2017	October 16, 2017	$0.4600

For the nine months ended September 30, 2017, the Company declared the following dividends on its Series A Preferred Stock:

Declaration Date	Record Date	Payment Date	Amount
March 14, 2017	March 31, 2017	April 17, 2017	$0.5391
June 15, 2017	June 30, 2017	July 17, 2017	$0.5391
September 14, 2017	August 2, 2017	August 2, 2017	$0.1079

For the nine months ended September 30, 2017, the Company declared the following dividends on its Series B Preferred Stock:

Declaration Date	Record Date	Payment Date	Amount
March 14, 2017	March 31, 2017	April 17, 2017	$0.5000
June 15, 2017	June 30, 2017	July 17, 2017	$0.5000
September 14, 2017	September 29, 2017	October 16, 2017	$0.5000

35

For the nine months ended September 30, 2017, the Company declared the following dividends on its Series C Preferred Stock:

Declaration Date	Record Date	Payment Date	Amount
March 14, 2017	March 31, 2017	April 28, 2017	$0.5000
June 15, 2017	June 30, 2017	July 31, 2017	$0.5000
September 14, 2017	September 29, 2017	October 31, 2017	$0.5000

Subsequent Events

Refer to "Note 18 - Subsequent Events" to the unaudited condensed consolidated financial statements for disclosure regarding significant transactions that occurred subsequent to September 30, 2017.

Liquidity and Capital Resources

Liquidity is a measure of the Company’s ability to meet potential cash requirements, including ongoing commitments to repay borrowings, fund and maintain its assets and operations, make distributions to its stockholders and other general business needs. The Company’s cash is used to purchase or originate target assets, repay principal and interest on borrowings, make distributions to stockholders and fund operations. The Company’s liquidity position is closely monitored and the Company believes it has sufficient current liquidity and access to additional liquidity to meet financial obligations for at least the next 12 months. The Company’s primary sources of liquidity are as follows:

Cash Generated from Operations

Cash from operations is generally comprised of interest income from the Company’s investments, net of any associated financing expense, principal repayments from the Company’s investments, net of associated financing repayments, proceeds from the sale of investments and changes in working capital balances. See “—Financial Condition and Results of Operations—Investments” above for a summary of interest rates and weighted average lives related to the Company’s investment portfolio at September 30, 2017. While there are no contractual paydowns related to the Company’s CMBS, periodic paydowns do occur. Repayments on the debt secured by the Company’s CMBS occur in conjunction with the paydowns on the collateral pledged.

Borrowings Under Various Financing Arrangements

JPMorgan Facility

On March 31, 2017, the Company, through two indirect wholly owned subsidiaries, amended and restated the JPMorgan Facility, which currently provides for maximum total borrowings of $1,118,000, comprised of the $975,000 repurchase facility and a $143,000 asset specific financing, and a term expiring in March 2019 plus a one-year extension option available at the Company's option, subject to certain conditions. Amounts borrowed under the JPMorgan Facility bear interest at spreads ranging from 2.25% to 3.50% over one-month LIBOR. Margin calls may occur any time the aggregate repurchase price exceeds the agreed upon advance rate multiplied by the market value of the assets by more than $250. The Company has agreed to provide a limited guarantee of the obligations of its indirect wholly-owned subsidiaries under the JPMorgan Facility.

As of September 30, 2017, the Company had $840,360 of borrowings outstanding under the JPMorgan Facility secured by certain of the Company's commercial mortgage and subordinate loans.

DB Repurchase Facility

On September 29, 2016, the Company, through indirect wholly-owned subsidiaries, entered into the DB Repurchase Facility which provides for maximum total borrowings of $565,491 comprised of the $450,000 and £45,000 repurchase facility as well as a $55,200 asset specific financing in connection with financing first mortgage loans secured by real estate. The DB Repurchase Facility matures in March 2018 with twoone-year extension options available at the Company's option, subject to certain conditions. Amounts borrowed under the DB Repurchase Facility bear interest at spreads ranging from 2.10% to 3.00% over one-month LIBOR. Margin calls may occur any time at specified aggregate margin deficit thresholds. The Company has agreed to provide a guarantee of the obligations of its indirect wholly-owned subsidiaries under this facility.

36

As of September 30, 2017, the Company had $265,658 (inclusive of £45,000) borrowings outstanding under the DB Repurchase Facility secured by certain of the Company's commercial mortgage loans.

Goldman Loan

On January 26, 2015, the Company, through an indirect wholly-owned subsidiary, entered into the Goldman Loan. The Goldman Loan provides for a purchase price of $34,180 (as of September 30, 2017) and a repurchase date of the earliest of: (1) April 30, 2019, (2) an early repurchase date as a result of repayment or sale of the purchased loan, or (3) an accelerated repurchase date as a result of certain events of default. Subject to the terms and conditions thereof, the Goldman Loan provides for the purchase and sale of certain participation interests in a mortgage loan secured by single-family and condominium properties. Prior to an event of default, amounts borrowed under the Goldman Loan bear interest at a spread of 3.5% plus one-month LIBOR. In addition, the Goldman Loan provides that margin calls may occur during the continuance of certain credit events if the market value of the mortgaged properties drop below an agreed upon percentage. The Goldman Loan contains affirmative and negative covenants and provisions regarding events of default that are normal and customary for similar repurchase agreements.

As of September 30, 2017, the Company had $34,180 of borrowings outstanding under the Goldman Loan secured by one commercial mortgage loan held by the Company.

UBS Facility

In September 2013, the Company, through an indirect wholly-owned subsidiary, entered into the UBS Facility, which provided that the Company may borrow up to $133,899 in order to finance the acquisition of CMBS. The UBS Facility matured in September 2017 and the Company repaid the outstanding borrowings in full.

DB Facility

In April 2014, the Company, through an indirect wholly-owned subsidiary, entered into the DB Facility, which currently provides that the Company may borrow up to $300,000 in order to finance the acquisition of CMBS. The DB Facility matures in April 2018. Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 2.09% to 2.39% based on the rating of the collateral pledged.

The Company posts margin in cash based on the fair value of the underlying collateral. The margin posted is classified as restricted cash on the Company's condensed consolidated balance sheets.

Additionally, the undrawn amount is subject to a 1.8% non-use fee. The DB Facility contains customary terms and conditions for facilities of this type and financial covenants to be met by the Company, including minimum shareholder's equity of 50% of the gross capital proceeds of its initial public offering and any subsequent public or private offerings.

As of September 30, 2017, the Company had $149,317 of borrowings outstanding under the DB Facility secured by CMBS held by the Company.

The Company was in compliance with the financial covenants under each of its borrowing agreements at September 30, 2017 and December 31, 2016.

Convertible Senior Notes

In 2014, the Company issued, in two offerings with an aggregate principal amount of $254,750, 5.50% Convertible Senior Notes due 2019, for which the Company received aggregate net proceeds, after deducting the underwriting discount and estimated offering expenses payable by the Company, of approximately $248,652.

On August 21, 2017, the Company issued $230,000 aggregate principal amount of 4.75% Convertible Senior Notes due 2022, for which the Company received aggregate net proceeds, after deducting the underwriting discount and estimated offering expenses payable by the Company, of approximately $224,825.

Cash Generated from Offerings

37

During the second quarter of 2017, the Company completed a follow-on public offering of 13,800,000 shares of its common stock, at a price of $18.05 per share. The aggregate net proceeds from the offering, including proceeds from the sale of the additional shares, were approximately $248,900 after deducting estimated offering expenses.

During the fourth quarter of 2016, the Company completed a follow-on public offering of 10,500,000 shares of its common stock, at a price of $16.97 per share. The net proceeds from the offering were approximately $177,796 after deducting estimated offering expenses payable by the Company.

During the third quarter of 2016, the Company consummated the AMTG Merger and issued 13,398,586 shares of its common stock and 6,900,000 shares of Series C Preferred Stock. As of December 31, 2016, the Company had liquidated all of the assets of AMTG and realized proceeds of approximately $421,000 (net of expenses).

Other Potential Sources of Financing

The Company’s primary sources of cash currently consist of cash available, which was $140,229 as of September 30, 2017, principal and interest payments the Company receives on its portfolio of assets, and available borrowings under its repurchase agreements. The Company expects its other sources of cash to consist of cash generated from operations and prepayments of principal received on the Company’s portfolio of assets. Such prepayments are difficult to estimate in advance. Depending on market conditions, the Company may utilize additional borrowings as a source of cash, which may also include additional repurchase agreements as well as other borrowings such as credit facilities, or conduct additional public and private debt and equity offerings.

The Company maintains policies relating to its borrowings and use of leverage. See “—Leverage Policies” below. In the future, the Company may seek to raise further equity or debt capital or engage in other forms of borrowings in order to fund future investments or to refinance expiring indebtedness.

The Company generally intends to hold its target assets as long-term investments, although it may sell certain of its investments in order to manage its interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions.

To maintain its qualification as a REIT under the Internal Revenue Code of 1986, as amended, the Company must distribute annually at least 90% of its taxable income. These distribution requirements limit the Company’s ability to retain earnings and thereby replenish or increase capital for operations.

Leverage Policies

The Company uses leverage for the sole purpose of financing its portfolio and not for the purpose of speculating on changes in interest rates. In addition to its repurchase agreements, in the future the Company may access additional sources of borrowings. The Company’s charter and bylaws do not limit the amount of indebtedness the Company can incur; however, the Company is limited by certain financial covenants under its repurchase agreements. Consistent with the Company’s strategy of keeping leverage within a conservative range, the Company expects that its total borrowings on loans will be in an amount that is approximately 35% of the value of its total loan portfolio.

Investment Guidelines

The Company's current investment guidelines, approved by the Company's board of directors, are comprised of the following:

• no investment will be made that would cause the Company to fail to qualify as a REIT for U.S. federal income tax purposes;

• no investment will be made that would cause the Company to register as an investment company under the Investment Company Act of 1940;

• investments will be predominantly in the Company’s target assets;

• no more than 20% of the Company’s cash equity (on a consolidated basis) will be invested in any single investment at the time of the investment;

• until appropriate investments can be identified, the Manager may invest the proceeds of any offering in interest bearing, short-term investments, including money market accounts and/or funds, that are consistent with the Company’s intention to qualify as a REIT.

The board of directors must approve any change in these investment guidelines.

38

Contractual Obligations and Commitments

The Company’s contractual obligations including expected interest payments as of September 30, 2017 are summarized as follows:

	Less than 1 year (3)		1 to 3 years (3)		3 to 5 years (3)		More than 5 years		Total
JPMorgan Facility (1)	$	194,500	$	700,426	$	—	$	—	$	894,926
DB Repurchase Facility (1)	10,174		214,400		—		—		224,574
Goldman Loan (1)	6,291		30,123		—		—		36,414
DB Facility	151,946		—		—		—		151,946
Convertible Senior Notes	22,858		285,100		250,727		—		558,685
Unfunded loan commitments (2)	75,164		5,000		—		—		80,164
Total	$	460,933	$	1,235,049	$	250,727	$	—	$	1,946,709

-————————

(1) Assumes current LIBOR of 1.23% for interest payments due under the JPMorgan Facility, the DB Repurchase Facility and the Goldman Loan.

(2) Based on the Company's expected funding schedule, which is based upon the Manager’s estimates based upon the best information available to the Manager at the time. There is no assurance that the payments will occur in accordance with these estimates or at all, which could affect the Company’s operating results.

(3) Assumes underlying assets are financed through the fully extended maturity date of the facility.

Loan Commitments. At September 30, 2017, the Company had $80,164 of unfunded commitments related to its commercial mortgage loan portfolio and subordinate loan portfolio.

Management Agreement. On September 23, 2009, the Company entered into the Management Agreement with the Manager pursuant to which the Manager is entitled to receive a management fee and the reimbursement of certain expenses. The table above does not include amounts due under the Management Agreement as those obligations do not have fixed and determinable payments. Pursuant to the Management Agreement, the Manager is entitled to a base management fee calculated and payable quarterly in arrears in an amount equal to 1.5% of the Company’s stockholders’ equity (as defined in the Management Agreement), per annum. The Manager will use the proceeds from its management fee in part to pay compensation to its officers and personnel. The Company does not reimburse its Manager or its affiliates for the salaries and other compensation of their personnel, except for the allocable share of the compensation of (1) the Company’s Chief Financial Officer based on the percentage of time spent on the Company’s affairs and (2) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of the Manager or its affiliates who spend all or a portion of their time managing the Company’s affairs based on the percentage of time devoted by such personnel to the Company’s affairs. The Company is also required to reimburse its Manager for operating expenses related to the Company incurred by its Manager, including expenses relating to legal, accounting, due diligence and other services. Expense reimbursements to the Manager are made in cash on a monthly basis following the end of each month. The Company’s reimbursement obligation is not subject to any dollar limitation.

The current term of the Management Agreement currently runs through September 29, 2018. Absent certain action by the independent directors of the Company’s board of directors, as described below, the Management Agreement will automatically renew on each anniversary for a one year term. The Management Agreement may be terminated upon expiration of the one-year term only upon the affirmative vote of at least two-thirds of the Company’s independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to the Company or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of the Company’s independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Amounts payable under the Company’s Management Agreement are not fixed and determinable. Following a meeting by the Company’s independent directors in February 2017, which included a discussion of the Manager’s performance and the level of the management fees thereunder, the Company determined not to terminate the Management Agreement.

39

Off-balance Sheet Arrangements

As disclosed in "Note 6 - Unconsolidated Joint Venture," the Company does not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured investment vehicles, or special purpose or variable interest entities, established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes. Further, the Company has not guaranteed any obligations of unconsolidated entities or entered into any commitment to provide additional funding to any such entities.

Dividends

The Company intends to continue to make regular quarterly distributions to holders of its common stock. U.S. federal income tax law generally requires that a REIT distribute annually at least 90% of its REIT taxable income, without regard to the deduction for dividends paid and excluding net capital gains, and that it pay tax at regular corporate rates to the extent that it annually distributes less than 100% of its net taxable income. The Company generally intends over time to pay dividends to its stockholders in an amount equal to its net taxable income, if and to the extent authorized by its board of directors. Any distributions the Company makes will be at the discretion of its board of directors and will depend upon, among other things, its actual results of operations. These results and the Company’s ability to pay distributions will be affected by various factors, including the net interest and other income from its portfolio, its operating expenses and any other expenditures. If the Company’s cash available for distribution is less than its net taxable income, the Company could be required to sell assets or borrow funds to make cash distributions or the Company may make a portion of the required distribution in the form of a taxable stock distribution or distribution of debt securities.

Prior to August 2, 2017, the Company had 3,450,000 shares of Series A Preferred Stock outstanding, which entitled holders to receive dividends at the rate of 8.625% per annum of the $25.00 per share liquidation preference equivalent to $2.16 per annum, per share. The dividends on the Series A Preferred Stock were cumulative and payable quarterly in arrears.

On August 2, 2017, the Company redeemed all 3,450,000 shares of 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock"). The Series A Preferred Stockholders received the redemption price of $25.00 plus accumulated but unpaid dividends to the redemption date of $0.1079 per share.

At September 30, 2017, the Company had 8,000,000 shares of Series B Preferred Stock outstanding, which entitles holders to receive dividends that are payable quarterly in arrears. The Series B Preferred Stock pay cumulative cash dividends: (i) from, and including, the original date of issuance of the Series B Preferred Stock to, but excluding, September 20, 2020, at an initial rate of 8.00% per annum of the $25.00 per share liquidation preference; and (ii) from, and including, September 20, 2020, at the rate per annum equal to the greater of (a) 8.00% and (b) a floating rate equal to the 3-month LIBOR rate as calculated on each applicable date of determination plus 6.46% of the $25.00 liquidation preference. Except under certain limited circumstances, the Series B Preferred Stock is generally not convertible into or exchangeable for any other property or any other securities of the Company at the election of the holders. On or after September 21, 2020, the Company may, at its option, redeem the shares at a redemption price of $25.00, plus any accrued unpaid distribution through the date of the redemption.

The Company has 6,900,000 shares of Series C Preferred Stock outstanding, which entitles holders to receive dividends that are payable quarterly in arrears. The Series C Preferred Stock pay cumulative cash dividends at the rate of 8.00% per annum of the $25.00 per share liquidation preference (equivalent to $2.00 per annum per share) from, and including July 29, 2016 (the “Series C Initial Dividend Date”) and shall be payable (i) for the period from the Series C Initial Dividend Date to, but excluding, October 31, 2016, on October 31, 2016, and (ii) for each subsequent quarterly dividend period commencing on the last day of each of January, April, July and October and ending on, and including, the day before the first day of the next succeeding dividend period, quarterly in equal amounts in arrears on the last day of each April, July, October and January, commencing on January 31, 2017 at the then applicable annual rate. Except under certain limited circumstances, the Series C Preferred Stock is generally not convertible into or exchangeable for any other property or any other securities of the Company at the election of the holders. On or after September 20, 2017, the Company may, at its option, redeem the shares at a redemption price of $25.00, plus any accrued unpaid distribution through the date of the redemption.

40

Non-GAAP Financial Measures

Operating Earnings

For the three and nine months ended September 30, 2017, the Company’s Operating Earnings were $49,771, or $0.47 per share, and $132,988, or $1.34 per share, respectively. For the three and nine months ended September 30, 2016, the Company’s Operating Earnings were $32,744, or $0.45 per share, and $96,002, or $1.38 per share, respectively. Operating Earnings is a non-GAAP financial measure that is defined by the Company as net income available to common stockholders, computed in accordance with GAAP, adjusted for (i) equity-based compensation expense (a portion of which may become cash-based upon final vesting and settlement of awards should the holder elect net share settlement to satisfy income tax withholding), (ii) any unrealized gains or losses or other non-cash items included in net income available to common stockholders, (iii) unrealized income from unconsolidated joint ventures, (iv) foreign currency gains (losses) other than realized gains/(losses) related to interest income, (v) the non-cash amortization expense related to the reclassification of a portion of the convertible senior notes to stockholders’ equity in accordance with GAAP, and (vi) provision for loan losses and impairments. Operating Earnings may also be adjusted to exclude certain other non-cash items, as determined by the Manager and approved by a majority of the Company's independent directors.

In order to evaluate the effective yield of the portfolio, the Company uses Operating Earnings to reflect the net investment income of the Company’s portfolio as adjusted to include the net interest expense related to the Company’s derivative instruments. Operating Earnings allows the Company to isolate the net interest expense associated with the Company’s swaps in order to monitor and project the Company’s full cost of borrowings. The Company also believes that its investors use Operating Earnings, or a comparable supplemental performance measure, to evaluate and compare the performance of the Company and its peers and, as such, the Company believes that the disclosure of Operating Earnings is useful to its investors.

A significant limitation associated with Operating Earnings as a measure of the Company’s financial performance over any period is that it excludes unrealized gains (losses) from investments. In addition, the Company’s presentation of Operating Earnings may not be comparable to similarly-titled measures of other companies, who may use different calculations. As a result, Operating Earnings should not be considered as a substitute for the Company’s GAAP net income as a measure of its financial performance or any measure of its liquidity under GAAP.

Beginning with the quarter ended September 30, 2016, the Company slightly modified its definition of Operating Earnings to include realized gains/(losses) on currency swaps related to interest income on investments denominated in a currency other than U.S. dollars.  The Company believes that including the effects of realized gains/(losses) on currency swaps related to interest income more accurately reflects the Company's investment income for a particular period and will allow investors to more easily compare its operating results over various periods. The effects of such unrealized gains/(losses) in prior periods were not material to the Company's financial results. 

The table below summarizes the reconciliation from net income available to common stockholders to Operating Earnings:

41

	For the three months ended   September 30,						For the nine   months ended   September 30,
	2017			2016			2017			2016
Net income available to common stockholders	$	57,208		$	60,583		$	121,946		$	77,864
Adjustments:
Equity-based compensation expense	2,635			1,828			9,887			5,434
Unrealized (gain) loss on securities	(13,488		)	9,798			(11,830		)	36,601
Unrealized (gain) loss on derivative instruments	7,481			(4,815		)	17,916			(22,831		)
Foreign Currency (gain) loss, net	(7,850		)	4,861			(18,135		)	22,417
Amortization of the Notes related to equity reclassification	769			590			1,995			1,745
Income (loss) from unconsolidated joint venture	—			(80		)	2,847			(207		)
Provision for loan losses and impairments	—			—			5,000			15,000
Series A preferred stock redemption charge	3,016			—			3,016			—
Bargain Purchase Gain	—			(40,021		)	—			(40,021		)
Realized gain from unconsolidated joint venture	—						346			—
Total adjustments:	(7,437		)	(27,839		)	11,042			18,138
Operating Earnings	$	49,771		$	32,744		$	132,988		$	96,002
Basic and diluted Operating Earnings per share of common stock	$	0.47		$	0.45		$	1.34		$	1.38
Basic weighted average shares of common stock outstanding	105,446,704			71,919,549			97,546,437			68,913,362
Diluted weighted average shares of common stock outstanding	106,812,721			72,861,611			98,919,689			69,865,603

42

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

The Company seeks to manage its risks related to the credit quality of its assets, interest rates, liquidity, prepayment speeds and market value, while, at the same time, seeking to provide an opportunity to stockholders to realize attractive risk-adjusted returns through ownership of its capital stock. While risks are inherent in any business enterprise, the Company seeks to quantify and justify risks in light of available returns and to maintain capital levels consistent with the risks the Company undertakes.

Credit Risk

One of the Company’s strategic focuses is acquiring assets that it believes to be of high credit quality. The Company believes this strategy will generally keep its credit losses and financing costs low. However, the Company is subject to varying degrees of credit risk in connection with its other target assets. The Company seeks to mitigate this risk by seeking to acquire high quality assets, at appropriate prices given anticipated and unanticipated losses, and by deploying a value-driven approach to underwriting and diligence, consistent with the Manager’s historical investment strategy, with a focus on current cash flows and potential risks to cash flow. The Manager seeks to enhance its due diligence and underwriting efforts by accessing the Manager’s knowledge base and industry contacts. Nevertheless, unanticipated credit losses could occur, which could adversely impact the Company’s operating results.

Interest Rate Risk

Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political considerations, as well as other factors beyond the Company’s control. The Company is subject to interest rate risk in connection with its target assets and its related financing obligations.

To the extent consistent with maintaining the Company’s REIT qualification, the Company seeks to manage risk exposure to protect its portfolio of financial assets against the effects of major interest rate changes. The Company generally seeks to manage this risk by:

• attempting to structure its financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;

• using hedging instruments, interest rate swaps and interest rate caps; and

• to the extent available, using securitization financing to better match the maturity of the Company’s financing with the duration of its assets.

At September 30, 2017, all of the Company’s borrowings outstanding under the Goldman Loan, the JPM Facility and the DB Repurchase Facility were floating-rate borrowings. At September 30, 2017, the Company also had floating rate assets with a face amount of $3,168,843 resulting in net variable rate exposure of $2,028,645. A 100 basis point increase in LIBOR would increase the quarterly net interest income related to this variable rate exposure by approximately $20,242 or $0.19 per share. Any such hypothetical impact on interest rates on the Company’s variable rate borrowings does not consider the effect of any change in overall economic activity that could occur in a rising interest rate environment. Further, in the event of a change in interest rates of that magnitude, the Company may take actions to further mitigate the Company’s exposure to such a change.  However, due to the uncertainty of the specific actions that would be taken and their possible effects, this analysis assumes no changes in the Company’s financial structure.

Prepayment Risk

Prepayment risk is the risk that principal will be repaid at a different rate than anticipated, causing the return on an asset to be less than expected. The Company does not anticipate facing prepayment risk on most of its portfolio of assets since most of the commercial loans held directly by the Company or securing the Company’s CMBS assets contain provisions preventing prepayment or imposing prepayment penalties in the event of loan prepayments.

Market Risk

Market value risk. The Company’s available-for-sale securities and securities at estimated fair value are reflected at their estimated fair value. The change in estimated fair value of securities available-for-sale is reflected in accumulated other comprehensive income while the change in estimated fair value of securities at estimated fair value is reflected as a component of net income. The estimated fair value of these securities fluctuates primarily due to changes in interest rates and other factors. Generally, in a rising interest rate environment, the estimated fair value of these securities would be expected to decrease;

43

conversely, in a decreasing interest rate environment, the estimated fair value of these securities would be expected to increase. As market volatility increases or liquidity decreases, the fair value of the Company’s assets may be adversely impacted.

Real estate risk. Commercial mortgage assets are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional and local economic conditions (which may be adversely affected by industry slowdowns and other factors); local real estate conditions; changes or continued weakness in specific industry segments; construction quality, age and design; demographic factors; and retroactive changes to building or similar codes. In addition, decreases in property values reduce the value of the collateral and the potential proceeds available to a borrower to repay the underlying loans or loans, as the case may be, which could also cause the Company to suffer losses.

Inflation

Virtually all of the Company’s assets and liabilities are interest rate sensitive in nature. As a result, interest rates and other factors influence the Company’s performance far more so than does inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. The Company’s financial statements are prepared in accordance with GAAP and distributions are determined by the Company's board of directors consistent with the Company's obligation to distribute to its stockholders at least 90% of its REIT taxable income, excluding net capital gains and determined without regard to the dividends paid deduction, on an annual basis in order to maintain the Company’s REIT qualification. In each case, the Company’s activities and balance sheet are measured with reference to historical cost and/or fair market value without considering inflation.

ITEM 4. Controls and Procedures

The Company’s Chief Executive Officer and Chief Financial Officer, based on their evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) required by paragraph (b) of Rule 13a-15 or Rule 15d-15, have concluded that as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective to give reasonable assurances to the timely collection, evaluation and disclosure of information relating to the Company that would potentially be subject to disclosure under the Exchange Act, and the rules and regulations promulgated thereunder.

During the period ended September 30, 2017, there was no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Notwithstanding the foregoing, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports.

44

PART II — OTHER INFORMATION

ITEM 1. Legal Proceedings

From time to time, the Company may be involved in various claims and legal actions in the ordinary course of business. After the announcement of the execution of the AMTG Merger Agreement, two putative class action lawsuits challenging the proposed First Merger (as defined in the AMTG Merger Agreement), captioned Aivasian v. Apollo Residential Mortgage, Inc., et al., No. 24-C-16-001532 and Wiener v. Apollo Residential Mortgage, Inc., et al., No. 24-C-16-001837, were filed in the Circuit Court for Baltimore City. A putative class and derivative lawsuit was later filed in the Court captioned Crago v. Apollo Residential Mortgage, Inc., No. 24-C-16-002610. Following a hearing on May 6, 2016, the Court entered orders among other things, consolidating the three actions under the caption In Re Apollo Residential Mortgage, Inc. Shareholder Litigation, Case No.: 24-C-16-002610. The plaintiffs have designated the Crago complaint as the operative complaint. The operative complaint includes both direct and derivative claims, names as defendants AMTG, the board of directors of AMTG, ARI, Arrow Merger Sub Inc., Apollo and Athene Holding Ltd. and alleges, among other things, that the members of the AMTG Board breached their fiduciary duties to the AMTG stockholders and that the other corporate defendants aided and abetted such fiduciary breaches. The operative complaint further alleges, among other things, that the proposed First Merger involves inadequate consideration, was the result of an inadequate and conflicted sales process, and includes unreasonable deal protection devices that purportedly preclude competing offers. It also alleges that the transactions with Athene Holding Ltd. are unfair and that the registration statement on Form S-4 filed with the SEC on April 6, 2016 contains materially misleading disclosures and omits certain material information. The operative complaint seeks, among other things, certification of the proposed class, declaratory relief, preliminary and permanent injunctive relief, including enjoining or rescinding the First Merger, unspecified damages, and an award of other unspecified attorneys’ and other fees and costs. On May 6, 2016, counsel for the plaintiffs filed with the Court a stipulation seeking the appointment of interim co-lead counsel, which stipulation was approved by the Court on June 9, 2016. Defendants’ motions to dismiss have been fully briefed, and oral argument was held on December 8, 2016. On August 14, 2017, the Court issued an opinion dismissing the operative complaint in its entirety with prejudice. The time to appeal the order dismissing the lawsuit has expired, and no appeals have been filed.

On January 4, 2017, the United States Department of Justice served a Request for Information and Documents on the Company, in connection with a preliminary investigation into certain aspects of the Company's former residential real estate portfolio, which the Company acquired in connection with the AMTG Merger and subsequently sold in 2016. The Request seeks a range of information in connection with the residential real estate portfolio, including, among other things, information concerning policies, procedures, and practices related to advertising, marketing, identifying, or acquiring residential properties for sale or rent, and various data for all rental and sales contracts executed since January 1, 2012. The Company is cooperating with the Department of Justice and fully complying with the Request.

ITEM 1A. Risk Factors

See the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. There have been no material changes to the Company’s risk factors during the three and nine months ended September 30, 2017.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

ITEM 3. Defaults Upon Senior Securities

None.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None.

ITEM 6. Exhibits

45

Exhibit No.	Description
3.1	Articles of Amendment and Restatement of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
3.2	Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K filed on September 23, 2015 (File No.: 001-34452).
3.3	Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K filed on September 1, 2016 (File No.: 001-34452).
3.4	By-laws of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.2 of the Registrant’s Form S-4 (Registration No. 333-210632).
4.1	Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 4.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
4.2	Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc.’s 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed on September 23, 2015.
4.3	Form of stock certificate evidencing the 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-A filed on August 26, 2016 (File No.: 001-34452).
4.4	Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-K filed on March 21, 2014(File No.: 001-34452).
4.5	First Supplemental Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee (including the form of 5.50% Convertible Senior Note due 2019), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on March 21, 2014 (File No.: 001-34452).
4.6	Second Supplemental Indenture, dated as of August 21, 2017, between the Company and Wells Fargo Bank, National Association, as Trustee (including the form of 4.75% Convertible Senior Note due 2022), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on August 21, 2017 (File No.: 001-34452).
31.1*	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.

46

101.INS *	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase
101.DEF*	XBRL Taxonomy Extension Definition Linkbase
101.LAB*	XBRL Taxonomy Extension Label Linkbase
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith.

47

EXHIBIT INDEX

Exhibit No.	Description
3.1	Articles of Amendment and Restatement of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
3.2	Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K filed on September 23, 2015 (File No.: 001-34452).
3.3	Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K filed on September 1, 2016 (File No.: 001-34452).
3.4	By-laws of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.2 of the Registrant’s Form S-4 (Registration No. 333-210632).
4.1	Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 4.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
4.2	Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc.’s 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed on September 23, 2015.
4.3	Form of stock certificate evidencing the 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-A filed on August 26, 2016 (File No.: 001-34452).
4.4	Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-K filed on March 21, 2014 (File No.: 001-34452).
4.5	First Supplemental Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee (including the form of 5.50% Convertible Senior Note due 2019), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on March 21, 2014 (File No.: 001-34452).
4.6	Second Supplemental Indenture, dated as of August 21, 2017, between the Company and Wells Fargo Bank, National Association, as Trustee (including the form of 4.75% Convertible Senior Note due 2022), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on March 21, 2014 (File No.: 001-34452).
31.1*	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase
101.DEF*	XBRL Taxonomy Extension Definition Linkbase
101.LAB*	XBRL Taxonomy Extension Label Linkbase
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

48

		APOLLO COMMERCIAL REAL ESTATE FINANCE, INC.
November 1, 2017
	By:	/s/ Stuart A. Rothstein
		Stuart A. Rothstein
		President and Chief Executive Officer
		(Principal Executive Officer)
	By:	/s/ Jai Agarwal
		Jai Agarwal
		Chief Financial Officer, Treasurer and Secretary
		(Principal Financial Officer and Principal Accounting Officer)

49

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Stuart A. Rothstein, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Apollo Commercial Real Estate Finance, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial
reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 1, 2017	By:	/s/ Stuart A. Rothstein
	Name:	Stuart A. Rothstein
	Title:	President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Jai Agarwal, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Apollo Commercial Real Estate Finance, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial
reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 1, 2017	By:	/s/ Jai Agarwal
	Name:	Jai Agarwal
	Title:	Chief Financial Officer, Treasurer and Secretary

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S. C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the President and Chief Executive Officer of Apollo Commercial Real Estate Finance, Inc. (the “Company”), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the period ended September 30, 2017 (the “Form 10-Q”), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2017	By:	/s/ Stuart A. Rothstein
	Name:	Stuart A. Rothstein
	Title:	President and Chief Executive Officer

The undersigned, the Chief Financial Officer, Treasurer and Secretary of Apollo Commercial Real Estate Finance, Inc. (the “Company”), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the period ended September 30, 2017 (the “Form 10-Q”), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2017	By:	/s/ Jai Agarwal
	Name:	Jai Agarwal
	Title:	Chief Financial Officer, Treasurer and Secretary

Pursuant to the Securities and Exchange Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 31, 2017
Document Document And Entity Information [Abstract]
Entity Registrant Name	Apollo Commercial Real Estate Finance, Inc.
Trading Symbol	ARI
Entity Central Index Key	0001467760
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		107,121,235

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Assets:
Cash	$ 140,229	$ 200,996
Restricted cash	76	62,457
Securities, at estimated fair value	191,902	331,076
Securities, held-to-maturity	0	146,352
Total loans, held for investment, net	3,558,600	2,693,092
Investment in unconsolidated joint venture	0	22,103
Derivative assets, net	0	5,906
Interest receivable	27,895	19,281
Other assets, net	14,240	1,714
Total Assets	3,932,942	3,482,977
Liabilities:
Borrowings under repurchase agreements (net of deferred financing costs of $10,884 and $6,763 in 2017 and 2016, respectively)	1,278,631	1,139,803
Convertible senior notes, net	471,911	249,994
Participations sold	0	84,979
Derivative liabilities, net	11,746	0
Accounts payable, accrued expenses and other liabilities	8,852	17,681
Payable to related party	8,309	7,015
Dividends payable	55,916	51,278
Total Liabilities	1,835,365	1,550,750
Commitments and Contingencies (see Note 14)
Stockholders’ Equity:
Common stock, $0.01 par value, 450,000,000 shares authorized, 105,451,235 and 91,422,676 shares issued and outstanding in 2017 and 2016, respectively	1,055	914
Additional paid-in-capital	2,163,539	1,983,010
Accumulated deficit	(67,166)	(48,070)
Accumulated other comprehensive loss	0	(3,811)
Total Stockholders’ Equity	2,097,577	1,932,227
Total Liabilities and Stockholders’ Equity	3,932,942	3,482,977
Commercial Mortgage Portfolio Segment [Member]
Assets:
Total loans, held for investment, net	2,218,222	1,641,856
Subordinate Mortgage Portfolio Segment [Member]
Assets:
Total loans, held for investment, net	1,340,378	1,051,236
Series A Preferred stock [Member]
Stockholders’ Equity:
Preferred stock	0	35
Series B Preferred stock [Member]
Stockholders’ Equity:
Preferred stock	80	80
Series C Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock	$ 69	$ 69

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Deferred financing costs	$ 10,884	$ 6,763
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	450,000,000	450,000,000
Common stock, shares issued (in shares)	105,451,235	91,422,676
Common stock, shares outstanding (in shares)	105,451,235	91,422,676
Series A Preferred stock [Member]
Preferred stock, shares issued (in shares)	0	3,450,000
Preferred stock, shares outstanding (in shares)	0	3,450,000
Preferred stock, aggregate liquidation preference, value	$ 0	$ 86,250
Series B Preferred stock [Member]
Preferred stock, shares issued (in shares)	8,000,000	8,000,000
Preferred stock, shares outstanding (in shares)	8,000,000	8,000,000
Preferred stock, aggregate liquidation preference, value	$ 200,000	$ 200,000
Series C Preferred Stock [Member]
Preferred stock, shares issued (in shares)	6,900,000	6,900,000
Preferred stock, shares outstanding (in shares)	6,900,000	6,900,000
Preferred stock, aggregate liquidation preference, value	$ 172,500	$ 172,500

XML

Condensed Consolidated Statement of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net interest income:
Interest income from securities	$ 2,625	$ 8,029	$ 9,247	$ 23,685
Interest income from securities, held to maturity	0	2,875	4,132	8,597
Interest income from commercial mortgage loans	41,203	27,460	112,690	72,727
Interest income from subordinate loans	47,268	32,207	121,298	89,649
Interest expense	(19,855)	(17,256)	(56,089)	(47,620)
Net interest income	71,241	53,315	191,278	147,038
Operating expenses:
General and administrative expenses (includes $2,635 and $9,887 of equity based compensation in 2017 and $1,828 and $5,434 of equity compensation in 2016, respectively)	(4,629)	(8,352)	(15,587)	(21,456)
Management fees to related party	(8,309)	(5,903)	(23,484)	(16,374)
Total operating expenses	(12,938)	(14,255)	(39,071)	(37,830)
Income (loss) from unconsolidated joint venture	0	80	(2,847)	207
Other income	359	309	710	334
Provision for loan losses and impairments	0	0	(5,000)	(15,000)
Realized loss on sale of assets	(4,076)	(225)	(5,118)	(225)
Unrealized gain (loss) on securities	13,488	(9,798)	11,830	(36,601)
Foreign currency gain (loss)	7,763	(4,369)	17,848	(21,926)
Bargain purchase gain	0	40,021	0	40,021
Gain (loss) on derivative instruments (includes unrealized gains (losses) of ($7,302) and ($17,626) in 2017 and ($10,297) and $1,731 in 2016, respectively)	(7,481)	4,815	(17,916)	22,831
Net income	68,356	69,893	151,714	98,849
Preferred dividends	(11,148)	(9,310)	(29,768)	(20,985)
Net income available to common stockholders	$ 57,208	$ 60,583	$ 121,946	$ 77,864
Basic and diluted net income per share of common stock (in dollars per share)	$ 0.54	$ 0.83	$ 1.23	$ 1.11
Basic weighted average shares of common stock outstanding (shares)	105,446,704	71,919,549	97,546,437	68,913,362
Diluted weighted average shares of common stock outstanding (shares)	106,812,721	72,861,611	98,919,689	69,865,603
Dividend declared per share of common stock (in dollars per share)	$ 0.46	$ 0.46	$ 1.38	$ 1.38

XML

Condensed Consolidated Statement of Operations (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
General and administrative expenses, equity-based compensation	$ 2,635	$ 1,828	$ 9,887	$ 5,434
Unrealized gains (losses) on derivative instruments	$ (7,302)	$ (10,297)	$ (17,626)	$ 1,731

XML

Condensed Consolidated Statement of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income available to common stockholders	$ 57,208	$ 60,583	$ 121,946	$ 77,864
Foreign currency translation adjustment	0	73	3,811	499
Comprehensive income	$ 57,208	$ 60,656	$ 125,757	$ 78,363

XML

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($) $ in Thousands	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid In Capital [Member]	Returned Earnings/ (Accumulated Deficit) [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance (shares) at Dec. 31, 2016		18,350,000	91,422,676
Beginning balance at Dec. 31, 2016	$ 1,932,227	$ 184	$ 914	$ 1,983,010	$ (48,070)	$ (3,811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase related to Equity Incentive Plan (shares)			200,859
Capital increase related to Equity Incentive Plan	7,554		$ 3	7,551
Issuance of common stock (shares)			13,800,000
Issuance of common stock	249,021		$ 138	248,883
Redemption of preferred stock (shares)		(3,450,000)
Redemption of preferred stock	(86,250)	$ (35)		(86,215)
Preferred stock redemption charge	3,016			3,016
Issuance of restricted common stock (shares)			27,700
Issuance of restricted common stock	0
Offering costs	(120)			(120)
Issuance of convertible senior notes	7,414			7,414
Net income	151,714				151,714
Change in other comprehensive loss	3,811					3,811
Dividends on common stock	(141,042)				(141,042)
Dividends on preferred stock	(29,768)				(29,768)
Ending balance (shares) at Sep. 30, 2017		14,900,000	105,451,235
Ending balance at Sep. 30, 2017	$ 2,097,577	$ 149	$ 1,055	$ 2,163,539	$ (67,166)	$ 0

XML

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows provided by operating activities:
Net income	$ 151,714	$ 98,849
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of discount/premium and PIK interest	(15,491)	(7,443)
Amortization of deferred financing costs	4,464	3,199
Equity-based compensation	7,551	2,808
Unrealized (gain) loss on securities	(11,830)	36,601
Provision for loan losses and impairment	5,000	15,000
Income (loss) from unconsolidated joint venture	2,259	(207)
Foreign currency (gain) loss	(16,940)	21,122
Realized (gain) loss on derivative instruments	289	(21,100)
Unrealized (gain) loss on derivative instruments	17,564	(1,731)
Realized loss on sale of securities	5,118	225
Bargain purchase gain	0	(40,021)
Changes in operating assets and liabilities:
Accrued interest receivable, less purchased interest	(27,910)	(17,638)
Other assets	(983)	(121)
Accounts payable, accrued expenses and other liabilities	(8,623)	(10,410)
Payable to related party	1,295	606
Net cash provided by operating activities	113,477	79,739
Cash flows provided by (used in) investing activities:
Funding of commercial mortgage loans	(581,567)	(548,171)
Funding of subordinate loans	(475,503)	(51,921)
Payments received on commercial mortgage loans	17,062	118,120
Payments received on subordinate loans	221,478	81,524
Origination and exit fees received on commercial mortgage loans and subordinate loans	13,047	7,509
Funding of unconsolidated joint venture	(726)	(362)
Funding of other assets	(1,379)	0
Proceeds (payments) on settlements of derivative instruments	(201)	21,100
Decrease (Increase) in collateral held related to derivative contracts	(14,262)	13,110
Proceeds from sale of securities	128,945	86,451
Proceeds from sale of investment in unconsolidated joint venture	24,498	0
Payments received on securities	13,306	22,424
Payments received on securities, held-to-maturity	146,530	5,970
Payments received on other assets	0	107
Net cash provided by (used in) investing activities	(508,772)	1,419,767
Cash flows provided by (used in) financing activities:
Proceeds from issuance of common stock	249,021	0
Redemption of Series A preferred stock	(86,250)	0
Payment of offering costs	(359)	(45)
Proceeds from repurchase agreement borrowings	866,548	448,177
Repayments of repurchase agreement borrowings	(727,691)	(352,914)
Proceeds from issuance of convertible senior notes	227,700	0
Repayments of participations sold	(85,081)	(3,770)
Payment of deferred financing costs	(8,585)	(3,741)
Dividends on common stock	(136,404)	(94,625)
Dividends on preferred stock	(26,752)	(18,646)
Net cash provided by (used in) financing activities	272,147	(1,280,081)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(123,148)	219,425
Cash, cash equivalents, and restricted cash, beginning of period	263,453	97,542
Cash, cash equivalents, and restricted cash, end of period	140,305	316,967
Supplemental disclosure of cash flow information:
Interest paid	44,303	47,093
Supplemental disclosure of non-cash investing and financing activities:
Dividend declared, not yet paid	55,916	46,028
Deferred financing costs, not yet paid	0	0
Offering costs payable	41	220
Apollo Residential Mortgage, Inc. [Member]
Cash flows provided by (used in) investing activities:
Proceeds from sale of AMTG assets, net	0	1,474,111
Proceeds from sale of AMTG assets, net	0	189,795
Cash flows provided by (used in) financing activities:
Repayments of repurchase agreement borrowings	0	(1,254,517)
Supplemental disclosure of non-cash investing and financing activities:
Fair value of assets acquired from AMTG	0	1,936
Fair value of liabilities assumed from AMTG	0	(1,285)
Fair value of common stock issued to AMTG	0	218
Fair value of preferred stock issued to AMTG	$ 0	$ 173

XML

Organization

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

Apollo Commercial Real Estate Finance, Inc. (together with its consolidated subsidiaries, referred to throughout this report as the “Company,” “ARI,” “we,” “us” and “our”) is a corporation that has elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes and primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, commercial mortgage-backed securities (“CMBS”) and other commercial real estate-related debt investments in the United States. These asset classes are referred to as the Company’s target assets.

The Company, organized in Maryland on June 29, 2009, commenced operations on September 29, 2009 and is externally managed and advised by ACREFI Management, LLC (the “Manager”), an indirect subsidiary of Apollo Global Management, LLC (together with its subsidiaries, “Apollo”).

The Company elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2009. To maintain its tax qualification as a REIT, the Company is required to distribute at least 90% of its taxable income, excluding net capital gains, to stockholders and meet certain other asset, income, and ownership tests.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include the Company’s accounts and those of its consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company’s most significant estimates include the fair value of financial instruments, loan loss reserves and impairment. Actual results could differ from those estimates.

These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the Company’s financial position, results of operations and cash flows have been included. The Company's results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year or any other future period.

On August 31, 2016, the Company, pursuant to the terms and conditions of the Agreement and Plan of Merger, dated February 26, 2016 (as amended, the “AMTG Merger Agreement”) acquired Apollo Residential Mortgage, Inc. (“AMTG”). AMTG merged with and into the Company (the “AMTG Merger”) with the Company continuing as the surviving entity. As a result, all operations of AMTG and its former subsidiaries are consolidated with the operations of the Company. As of December 31, 2016 all assets acquired from AMTG were sold.

Under Financial Accounting Standards Board (the “FASB”) ASC Topic 805, “Business Combinations”, or ASC 805, the acquirer in a business combination must recognize, with certain exceptions, the fair values of assets acquired, liabilities assumed, and non-controlling interests when the acquisition constitutes a change in control of the acquired entity. We applied the provisions of ASC 805 in accounting for the Company's acquisition of AMTG. In doing so, we recorded provisional amounts for certain items as of the date of the acquisition, including the fair value of certain assets and liabilities. During the measurement period, a period which shall not exceed one year, the Company retrospectively adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of such date that, if known, would have affected the measurement of the amounts recognized. See further discussion in "Note 17 - Business Combination."

The Company currently operates in one business segment.

Recent Accounting Pronouncements

In May 2014, the FASB issued guidance which broadly amends the accounting guidance for revenue recognition. The guidance is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2017. The Company does not anticipate that the adoption of this guidance will have a material impact on the Company's condensed consolidated financial statements.

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” or ASU 2014-15. ASU 2014-15 introduces an explicit requirement for management to assess and provide certain disclosures if there is substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 is effective for the annual period ending after December 15, 2016. The Company adopted this guidance and determined that there was no material impact on the Company's condensed consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting (Topic 718),” or ASU 2016-09. ASU 2016-09 requires all income tax effects of share-based payment awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares for tax withholding purposes than is permitted under current guidance without triggering liability accounting. Finally, the guidance allows a policy election to account for employee forfeitures as they occur. The guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted this guidance and determined there was no material impact on the Company's condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments (Topic 326),” or ASU 2016-13. ASU 2016-13 significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income.  The guidance will replace the “incurred loss” approach under existing guidance with an “expected loss” model for instruments measured at amortized cost, and require entities to record allowances for available-for-sale debt securities rather than reduce the carrying amount, as they do today under the other-than-temporary impairment model. It also simplifies the accounting model for purchased credit-impaired debt securities and loans. The guidance is effective for fiscal years beginning after December 15, 2019 and is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company is currently assessing the impact, if any, the guidance will have on the Company's condensed consolidated financial statements when adopted.

In August 2016, the FASB issued ASU 2016-15 “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” or ASU 2016-15. ASU 2016-15 is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance addresses the classification of various transactions including debt prepayment or debt extinguishment costs, settlement of zero-coupon debt instruments, contingent consideration payments made after a business combination, distributions received from equity method investments, beneficial interests in securitization transactions, and others. The Company adopted this guidance in the third quarter of 2016 and determined that there was no material impact on the Company's condensed consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18 “Statement of Cash Flows (Topic 230): Restricted Cash,” or ASU 2016-18. ASU 2016-18 is intended to clarify how entities present restricted cash in the statement of cash flows. The guidance requires entities to show the changes in the total of cash and cash equivalents and restricted cash in the statement of cash flows. As a result, entities will no longer present transfers between cash and cash equivalents and restricted cash in the statement of cash flows. When cash and cash equivalents and restricted cash are presented in more than one line item on the balance sheet, the new guidance requires a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet. This reconciliation can be presented either on the face of the statement of cash flows or in the notes to the financial statements. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017 and is to be applied retrospectively. The Company early adopted ASU 2016-18 on June 30, 2017, which changed the Company's condensed consolidated statement of cash flows and related disclosures for all periods presented. The following is a reconciliation of the Company's cash, cash equivalents, and restricted cash to the total presented in the Company's condensed consolidated statement of cash flows for the nine months ended September 30, 2017 and September 30, 2016, respectively:

	Nine months ended September 30,
	2017		2016
Cash and cash equivalents	$	140,229	$	254,643
Restricted cash	76		62,324
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	140,305	$	316,967

In August 2017, the FASB issued ASU 2017-12 "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” or ASU 2017-12. The intention of ASU 2017-12 is to align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness previously recognized on existing cash flow and net investment hedges will be adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income (loss). The Company is currently assessing the impact, if any, the guidance will have on the Company's condensed consolidated financial statements when adopted. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018 and is applied retroactively.

XML

Fair Value Disclosure

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Disclosure

Fair Value Disclosure

GAAP establishes a hierarchy of valuation techniques based on the observability of the inputs utilized in measuring financial instruments at fair values. Market based or observable inputs are the preferred source of values, followed by valuation models using management assumptions in the absence of market inputs. The three levels of the hierarchy as noted in ASC 820, Fair Value Measurements and Disclosures, are described below:

Level I — Quoted prices in active markets for identical assets or liabilities.

Level II — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

Level III — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

While the Company anticipates that its valuation methods will be appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company will use inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.

The estimated fair value of the Company's CMBS portfolio is determined by reference to market prices provided by certain dealers who make a market in these financial instruments. The Company believes that these dealers who are usually market makers in these securities utilize various valuation techniques and inputs including, but not limited to, observable trades, discounted cash flow, market yield and duration to price these securities. Broker quotes are only indicative of fair value and may not necessarily represent what the Company would receive in an actual trade for the applicable instrument. Management performs additional analysis on prices received based on broker quotes to validate the prices and adjustments are made as deemed necessary by management to capture current market information. As of December 31, 2016 the estimated fair values of the Company’s securities were based on observable inputs and were classified as Level II in the fair value hierarchy. In June 2017, the Manager determined that, based on illiquidity in the market for these securities, broker quotes lack observable inputs and thus a transfer into Level III in the fair value hierarchy was necessary. Based on this determination, as of June 30, 2017, we have applied Level III classification to these securities. In accordance with GAAP, the Company elects the fair value option for these securities at the date of purchase in order to allow the Company to measure these securities at fair value with the change in estimated fair value included as a component of earnings in order to reflect the performance of the investment in a timely manner.

The estimated fair values of the Company’s derivative instruments are determined using a discounted cash flow analysis on the expected cash flows of each derivative. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The fair values of interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts (or payments) that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected cash flows are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The fair values of foreign exchange forwards are determined by comparing the contracted forward exchange rate to the current market exchange rate.  The current market exchange rates are determined by using market spot rates, forward rates and interest rate curves for the underlying countries.  The Company’s derivative instruments are classified as Level II in the fair value hierarchy.

The following table summarizes the levels in the fair value hierarchy into which the Company’s financial instruments were categorized as of September 30, 2017 and December 31, 2016:

	Fair Value as of September 30, 2017										Fair Value as of December 31, 2016
	Level I		Level II			Level III		Total			Level I		Level II		Level III		Total
CMBS (Fair Value Option)	$	—	$	—		$	191,902	$	191,902		$	—	$	331,076	$	—	$	331,076
Derivative instruments, net	—		(11,746		)	—		(11,746		)	—		5,906		—		5,906
Total	$	—	$	(11,746	)	$	191,902	$	180,156		$	—	$	336,982	$	—	$	336,982

The following is a reconciliation of investments for which Level III inputs were used in determining fair value:

	CMBS
Fair value at December 31, 2016	$	—
Transfers into Level III (1)	254,484
Net realized loss on investments	(4,076		)
Net increase in unrealized gain on investments	13,488
Sales and repayments of investments	(71,073		)
Amortization of purchase discount, net	(921		)
Fair value at September 30, 2017	$	191,902

———————

(1) Transfers into Level III of the fair value hierarchy represent investments that experienced an insignificant level of market activity during the period and were thus valued in the absence of observable inputs. Transfers into Level III of the fair value hierarchy are recorded at the end of the reporting period. In June 2017, the Manager determined that, based on illiquidity in the market for these securities, broker quotes, which are the primary valuation technique used to mark these investments at fair value, lack observable inputs and thus a transfer into Level III was necessary. Based on this determination, as of June 30, 2017, we have applied Level III classification to these securities.

The following table summarizes information about significant unobservable inputs used in the fair value measurement of Level III investments as of September 30, 2017. There were no Level III investments as of December 31, 2016:

			Unobservable Input
Asset Category	Fair Value	Primary Valuation Technique	Input	Range
CMBS	191,902	Broker quotes	Price (1)	63 - 101

———————

(1) A significant increase (decrease) in the unobservable input in isolation would result in significantly higher (lower) fair value measurement.

XML

Securities

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Securities

Securities

At September 30, 2017, all of the Company's CMBS (Fair Value Option) were pledged to secure borrowings under the Company’s master repurchase agreement Deutsche Bank AG ("DB") (the "DB Facility"). The Company's master repurchase agreement with UBS AG, London Branch ("UBS") (the "UBS Facility") matured in September, 2017 and was fully repaid by the Company. See "Note 7 - Borrowings Under Repurchase Agreements" for further information regarding these facilities.

CMBS (Held-to-Maturity) represents a loan the Company closed during May 2014 that was subsequently contributed to a securitization during August 2014. During May 2014, the Company closed a $155,000 floating-rate whole loan secured by the first mortgage and equity interests in an entity that owns a resort hotel in Aruba. The property consists of 442 hotel rooms, 114 timeshare units, two casinos and approximately 131,500 square feet of retail space. During June 2014, the Company syndicated a $90,000 senior participation in the loan and retained a $65,000 junior participation. The Company evaluated this transaction and concluded that due to its continuing involvement, the transaction should not be accounted for as a sale. During August 2014, both the $90,000 senior participation and the Company's $65,000 junior participation were contributed to a CMBS securitization. In exchange for contributing its $65,000 junior participation, the Company received a CMBS secured solely by the $65,000 junior participation. During May 2017, the loan and associated CMBS (Held-to-Maturity) were fully repaid and the related Securities, held-to-maturity and participation sold line items were removed from the Company's condensed consolidated balance sheet.

The amortized cost and estimated fair value of the Company’s debt securities at September 30, 2017 are summarized as follows:

Security Description	Face Amount		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
CMBS (Fair Value Option)	$	222,522	$	217,242	$	247	$	(25,587	)	$	191,902

During the nine months ended September 30, 2017, the Company sold securities resulting in a net realized loss of $5,118.

The amortized cost and estimated fair value of the Company’s debt securities at December 31, 2016 are summarized as follows:

Security Description	Face Amount		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
CMBS (Fair Value Option)	$	375,861	$	368,247	$	292	$	(37,463	)	$	331,076
CMBS (Held-to-Maturity)	146,530		146,352		—		—			146,352
Total	$	522,391	$	514,599	$	292	$	(37,463	)	$	477,428

During August 2016, the Company sold CMBS with an amortized cost of $86,676 resulting in a net realized loss of $225, which was comprised of realized gains of $90 and realized losses of $315. The sale generated net proceeds of $16,222 after the repayment of $70,229 of borrowings under the DB Facility.

The overall statistics for the Company’s CMBS (Fair Value Option) calculated on a weighted average basis as of September 30, 2017 and December 31, 2016 are as follows:

	September 30, 2017		December 31, 2016
Credit Ratings *	BB-D		B+-NR
Coupon	5.9	%	5.9	%
Yield	4.2	%	6.0	%
Weighted Average Life	2.0 years		2.5 years

-————————

* Ratings per Fitch Ratings, Moody’s Investors Service or Standard & Poor's.

The percentage vintage, property type and location of the collateral securing the Company's CMBS (Fair Value Option) calculated on a weighted average basis as of September 30, 2017 and December 31, 2016 are as follows:

Vintage	September 30, 2017		December 31, 2016
2005	—	%	2.0	%
2006	21.2		12.1
2007	57.0		73.5
2008	21.8		12.4
Total	100.0	%	100.0	%

Property Type	September 30, 2017		December 31, 2016
Office	37.8	%	34.6	%
Retail	25.8		29.0
Multifamily	13.6		12.4
Other (1)	22.8		24.0
Total	100.0	%	100.0	%

———————

(1) No other individual category comprises more than 10% of the total.

Location	September 30, 2017		December 31, 2016
South Atlantic	28.3	%	23.8	%
Middle Atlantic	11.9		16.7
Pacific	5.8		15.3
East North Central	16.7		10.8
Other (1)	37.3		33.4
Total	100.0	%	100.0	%

———————

 (1) No other individual category comprises more than 10% of the total.

XML

Loans, Held for Investment

9 Months Ended

Sep. 30, 2017

Mortgage Loans on Real Estate [Abstract]

Loans, Held for Investment

Loans, Held for Investment

The Company’s loans receivable are comprised of the following:

Loan Type	September 30, 2017		December 31, 2016
Commercial mortgage loans, held for investment, net	$	2,218,222	$	1,641,856
Subordinate loans, held for investment, net	1,340,378		1,051,236
Total loans, held for investment, net	$	3,558,600	$	2,693,092

Activity relating to our loans, held for investment portfolio was as follows:

	Principal Balance		Deferred Fees/Other Items (1)		Provision for Loan Loss (2)		Carrying Value
December 31, 2016	2,720,344		(12,252	)	(15,000	)	2,693,092
Loan fundings	1,057,070		—		—		1,057,070
Loan repayments	(238,541	)	—		—		(238,541	)
Unrealized gain on foreign currency translation	20,974		—		—		20,974
Provision for loan loss (2)	—		—		(1,981	)	(1,981	)
Deferred fees and other items (1)	—		(13,047	)	—		(13,047	)
PIK interest, amortization of fees and other items (1)	19,321		21,712		—		41,033
September 30, 2017	3,579,168		(3,587	)	(16,981	)	3,558,600

———————

(1) Other items primarily consist of purchase discounts or premiums, exit fees, and deferred origination expenses.

(2) In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 against a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet.

The following table details overall statistics for our loan portfolio:

	September 30, 2017			December 31, 2016
Number of loans	56			45
Principal balance	$	3,579,168		$	2,720,344
Carrying value	$	3,558,600		$	2,693,092
Unfunded loan commitments (1)	$	80,164		$	170,365
Weighted-average cash coupon (2)	8.5		%	8.88		%

———————

(1) Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2) For floating rate loans, assumes one-month LIBOR of 1.23%and 0.77%, as of September 30, 2017 and December 31, 2016, respectively.

The tables below detail the property type and geographic distribution of the properties securing the loans in our portfolio:

	September 30, 2017			December 31, 2016
Property Type	Carrying Value	% of Portfolio		Carrying Value	% of Portfolio
Residential - for sale	735,551	20.7	%	469,997	17.5	%
Hotel	652,745	18.3	%	408,428	15.2	%
Urban Retail Predevelopment	644,283	18.1	%	491,187	18.2	%
Mixed Use	352,094	9.9	%	134,797	5.0	%
Office	293,093	8.2	%	255,031	9.5	%
Residential Rental	278,117	7.8	%	309,243	11.5	%
Retail Center	197,120	5.5	%	209,401	7.8	%
Healthcare	174,244	4.9	%	170,549	6.3	%
Other	154,017	4.3	%	87,650	3.3	%
Industrial	77,336	2.3	%	156,809	5.7	%
	3,558,600	100.0	%	2,693,092	100.0	%

	September 30, 2017		December 31, 2016
Geographic Location	Carrying Value	% of Portfolio	Carrying Value	% of Portfolio
Manhattan, NY	$1,246,235	35.0%	$870,914	32.3%
Brooklyn, NY	244,501	6.9%	163,389	6.1%
Northeast	133,979	3.8%	137,770	5.1%
Southeast	530,881	14.9%	332,276	12.3%
Midwest	524,984	14.7%	405,992	15.1%
Mid Atlantic	248,786	7.0%	263,717	9.8%
West	205,274	5.8%	219,664	8.2%
Southwest	33,824	1.0%	54,614	2.0%
United Kingdom	312,159	8.7%	244,756	9.1%
Other International	77,977	2.2%	—	—%
Total	$3,558,600	100%	$2,693,092	100%

The Company evaluates its loans for possible impairment on a quarterly basis. The Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations are sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the property’s liquidation value. The Company also evaluates the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, the Company considers the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such loan loss analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants. An allowance for loan loss is established when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan.

During the second quarter of 2017, the Company recorded a loan loss provision of $1,981 on a commercial mortgage loan secured by fully-built, for-sale residential condominium units located in Bethesda, MD. In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 on a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet. The loan loss provision and impairment were based on the difference between fair value of the underlying collateral, and the carrying value of the loan (prior to the loan loss provision and related impairment). Fair value of the collateral was determined using a discounted cash flow analysis. The significant unobservable inputs used in determining the collateral value were sales price per square foot and discount rate which were an average of $678 dollars per square foot across properties and 15%, respectively. Effective April 1, 2017, the Company ceased accruing all interest associated with the loan and accounts for the loan on a cost-recovery basis (all proceeds are applied towards the loan balance).

During 2016, the Company recorded a loan loss provision of $10,000 on a multifamily commercial mortgage loan and $5,000 on a multifamily subordinate loan secured by a multifamily property located in Williston, ND. The loan loss provision was based on the difference between fair value of the underlying collateral, and the carrying value of the loan (prior to the loan loss provision). Fair value of the collateral was determined using a discounted cash flow analysis. The significant unobservable inputs used in determining the collateral value were terminal capitalization rate and discount rate which were 11% and 10%, respectively. The Company ceased accruing payment in kind ("PIK") interest associated with the loan and recognizing interest income upon receipt of cash.

As of September 30, 2017, the aggregate loan loss provision was $11,981 and $5,000 for commercial mortgage loans and subordinate loans, respectively. As of December 31, 2016, the aggregate loan loss provision was $10,000 and $5,000 for commercial mortgage loans and subordinate loans, respectively.

For the three and nine months ended September 30, 2017, the Company received pre-payment penalties of $3,590 and $3,998, respectively. For the three and nine months ended September 30, 2016, the Company received pre-payment penalties of $4,000 and $5,225, respectively. The Company records pre-payment penalty income under interest income.

For the three and nine months ended September 30, 2017, the Company recognized PIK interest of $5,309 and $19,323, respectively. For the three and nine months ended September 30, 2016, the Company recognized PIK interest of $5,808 and $15,902, respectively.

XML

Unconsolidated Joint Venture

9 Months Ended

Sep. 30, 2017

Equity Method Investments and Joint Ventures [Abstract]

Unconsolidated Joint Venture

Unconsolidated Joint Venture

In September 2014, the Company, through a wholly owned subsidiary, acquired a 59% ownership interest in Champ L.P. (“Champ LP”) following which a wholly-owned subsidiary of Champ LP then acquired a 35% ownership interest in Bremer Kreditbank AG ("BKB"). The Company acquired its ownership interest in Champ LP for an initial purchase price paid at closing of approximately €30,724 (or $39,477). The Company committed to invest up to approximately €38,000 (or $50,000). Champ LP together with certain unaffiliated third party investors, in aggregate, own 100% of BKB.

BKB specializes in corporate banking and financial services for medium-sized German companies. It also provides professional real estate financing, acquisition finance, institutional asset management and private wealth management services for German high-net-worth individuals.

The Company evaluated Champ LP to determine if it met the definition of a variable interest entity ("VIE") in accordance with ASC 810, Consolidation. The Company determined that Champ LP met the definition of a VIE, however, the Company was not the primary beneficiary; therefore, the Company was not required to consolidate the assets and liabilities of the partnership in accordance with the authoritative guidance. Additionally, Champ LP is an Investment Company under GAAP, and is therefore reflected at fair value. The Company's investment in Champ LP was accounted for as an equity method investment and therefore the Company recorded its proportionate share of the net asset value in accordance with ASC 323, Investments - Equity Method and Joint Ventures.

In January 2015, the Company funded an additional investment of €3,331 (or $3,929) related to its investment in Champ LP. In February 2015, the Company sold approximately 48% of its ownership interest in Champ LP at cost to an investment fund managed by Apollo for €16,314 (or $20,794) (of which $2,614 related to foreign exchange losses which were previously included in accumulated other comprehensive loss). In June 2016, the Company transferred €427 of its unfunded commitment to Apollo, reducing its unfunded commitment to Champ LP to €2,802 (or $2,985).

In May 2017, the Company sold its remaining ownership interest in Champ LP to unaffiliated third parties for €21,792 or $24,498, resulting in a loss of $3,305. As of September 30, 2017, the Company had no interest in Champ LP.

XML

Borrowings Under Repurchase Agreements

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Borrowings Under Repurchase Agreements

Borrowings Under Repurchase Agreements

At September 30, 2017 and December 31, 2016, the Company’s borrowings had the following outstanding balances, maturities and weighted average interest rates:

	September 30, 2017								December 31, 2016
Lender	Maximum Amount of Borrowings		Borrowings Outstanding			Maturity (1)	Weighted Average Rate (2)		Maximum Amount of Borrowings		Borrowings Outstanding			Maturity (1)	Weighted Average Rate (2)
JPMorgan Facility (3)	$	1,118,000	$	840,360		March 2020	L+2.27%		$	943,000	$	657,452		January 2019	L+2.25%
DB Repurchase Facility (4)	565,491		265,658			March 2020	L+2.35%		300,000		137,355			September 2019	L+2.66%
Goldman Loan	34,180		34,180			April 2019	L+3.50%		N/A		40,657			April 2019	L+3.50%
Sub-total	1,717,671		1,140,198				L+2.32%				835,464				L+2.38%
UBS Facility	N/A		N/A			N/A	N/A		N/A		133,899			September 2018	2.79	%
DB Facility (5)	300,000		149,317			April 2018	3.48	%	N/A		177,203			April 2018	3.63	%
Sub-total	300,000		149,317				3.48	%			311,102				3.27	%
Less: deferred financing costs	N/A		(10,884		)		N/A		N/A		(6,763		)		N/A
Total / Weighted Average	$	2,017,671	$	1,278,631			3.55	%			$	1,139,803			3.18	%

———————

(1) Maturity date assumes all extensions are exercised.

(2) Assumes one-month LIBOR was 1.23% and 0.77% as of September 30, 2017 and December 31, 2016, respectively.

(3) As of September 30, 2017, the Company's master repurchase agreement with JPMorgan Chase Bank, National Association

(the "JPMorgan Facility") provided for maximum total borrowings comprised of the $975,000 repurchase facility and a $143,000 asset specific financing.

(4) As of September 30, 2017, the Company's master repurchase agreement with Deutsche Bank AG, Cayman Islands Branch (the "DB Repurchase Facility") provided for maximum total borrowings comprised of the $450,000 and £45,000 repurchase facility and a $55,200 asset specific financing.

(5) Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 2.09% to 2.39% based on the rating of the collateral pledged.

At September 30, 2017, the Company’s borrowings had the following remaining maturities:

	Less than 1 year (1)		1 to 3 years (1)		3 to 5 years		More than 5 years		Total
JPMorgan Facility	$	166,273	$	674,087	$	—	$	—	$	840,360
DB Repurchase Facility	—		265,658		—		—		265,658
Goldman Loan	—		34,180		—		—		34,180
DB Facility	149,317		—		—		—		149,317
Total	$	315,590	$	973,925	$	—	$	—	$	1,289,515

———————

(1) Assumes underlying assets are financed through the fully extended maturity date of the facility.

At September 30, 2017, the Company’s collateralized financings were comprised of borrowings outstanding under the JPMorgan Facility, the DB Repurchase Facility, the Company's repurchase agreement with Goldman Sachs Bank USA (the "Goldman Loan") and the DB Facility. The table below summarizes the outstanding balances at September 30, 2017, as well as the maximum and average month-end balances for the nine months ended September 30, 2017 for the Company's borrowings under repurchase agreements.

			For the nine months ended September 30, 2017
	Balance at September 30, 2017		Maximum Month-End Balance		Average Month-End Balance
JPMorgan Facility borrowings	$	840,360	$	986,611	$	849,355
DB Repurchase Facility borrowings	265,658		367,010		286,326
Goldman Loan borrowings	34,180		39,590		37,554
DB Facility borrowings	149,317		177,203		136,930
Total	$	1,289,515

JPMorgan Facility

On March 31, 2017, the Company, through two indirect wholly owned subsidiaries, amended and restated the JPMorgan Facility, which currently provides for maximum total borrowings of $1,118,000, comprised of the $975,000 repurchase facility and a $143,000 asset specific financing, and a term expiring in March 2019 plus a one-year extension option available at the Company's option, subject to certain conditions. Amounts borrowed under the JPMorgan Facility bear interest at spreads ranging from 2.25% to 3.50% over one-month LIBOR. Margin calls may occur any time the aggregate repurchase price exceeds the agreed upon advance rate multiplied by the market value of the assets by more than $250. The Company has agreed to provide a limited guarantee of the obligations of its indirect wholly-owned subsidiaries under the JPMorgan Facility.

As of September 30, 2017, the Company had $840,360 of borrowings outstanding under the JPMorgan Facility secured by certain of the Company's commercial mortgage and subordinate loans.

DB Repurchase Facility

On September 29, 2016, the Company, through indirect wholly-owned subsidiaries, entered into the DB Repurchase Facility which provides for maximum total borrowings of $565,491 comprised of the $450,000 and £45,000 repurchase facility as well as a $55,200 asset specific financing in connection with financing first mortgage loans secured by real estate. The DB Repurchase Facility matures in March 2018 with twoone-year extension options available at the Company's option, subject to certain conditions. Amounts borrowed under the DB Repurchase Facility bear interest at spreads ranging from 2.10% to 3.00% over one-month LIBOR. Margin calls may occur any time at specified aggregate margin deficit thresholds. The Company has agreed to provide a guarantee of the obligations of its indirect wholly-owned subsidiaries under this facility.

As of September 30, 2017, the Company had $265,658 (inclusive of £45,000) borrowings outstanding under the DB Repurchase Facility secured by certain of the Company's commercial mortgage loans.

Goldman Loan

On January 26, 2015, the Company, through an indirect wholly-owned subsidiary, entered into the Goldman Loan. The Goldman Loan provides for a purchase price of $34,180 (as of September 30, 2017) and a repurchase date of the earliest of: (1) April 30, 2019, (2) an early repurchase date as a result of repayment or sale of the purchased loan, or (3) an accelerated repurchase date as a result of certain events of default. Subject to the terms and conditions thereof, the Goldman Loan provides for the purchase and sale of certain participation interests in a mortgage loan secured by single-family and condominium properties. Amounts borrowed under the Goldman Loan bear interest at a spread of 3.5% plus one-month LIBOR. In addition, the Goldman Loan provides that margin calls may occur during the continuance of certain credit events if the market value of the mortgaged properties drop below an agreed upon percentage. The Goldman Loan contains affirmative and negative covenants and provisions regarding events of default that are normal and customary for similar repurchase agreements.

As of September 30, 2017, the Company had $34,180 of borrowings outstanding under the Goldman Loan secured by one commercial mortgage loan held by the Company.

UBS Facility

In September 2013, the Company, through an indirect wholly-owned subsidiary, entered into the UBS Facility, which provided that the Company may borrow up to $133,899 in order to finance the acquisition of CMBS. The UBS Facility matured in September 2017 and the Company repaid the outstanding borrowings in full.

DB Facility

In April 2014, the Company, through an indirect wholly-owned subsidiary, entered into the DB Facility, which currently provides that the Company may borrow up to $300,000 in order to finance the acquisition of CMBS. The DB Facility matures in April 2018. Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 2.09% to 2.39% based on the rating of the collateral pledged.

The Company posts margin in cash based on the fair value of the underlying collateral. The margin posted is classified as restricted cash on the Company's condensed consolidated balance sheets.

Additionally, the undrawn amount is subject to a 1.8% non-use fee. The DB Facility contains customary terms and conditions for facilities of this type and financial covenants to be met by the Company, including minimum shareholder's equity of 50% of the gross capital proceeds of its initial public offering and any subsequent public or private offerings.

As of September 30, 2017, the Company had $149,317 of borrowings outstanding under the DB Facility secured by CMBS held by the Company.

The Company was in compliance with the financial covenants under each of its borrowing agreements at September 30, 2017 and December 31, 2016.

XML

Convertible Senior Notes

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Convertible Senior Notes

Convertible Senior Notes

On March 17, 2014, the Company issued $143,750 aggregate principal amount of 5.50% Convertible Senior Notes due 2019 (the "March 2019 Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company, of approximately $139,037. At September 30, 2017, the March 2019 Notes had a carrying value of $142,251 and an unamortized discount of $1,499.

On August 18, 2014, the Company issued an additional $111,000 aggregate principal amount of 5.50% Convertible Senior Notes due 2019 (the "August 2019 Notes" and together with the March 2019 Notes, the "2019 Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company, of approximately $109,615. At September 30, 2017, the August 2019 Notes had a carrying value of $109,187 and an unamortized discount of $1,813.

On August 21, 2017, the Company issued $230,000 aggregate principal amount of 4.75% Convertible Senior Notes due 2022 (the "August 2022 Notes" and together with the 2019 Notes, the "Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company, of approximately $224,825. At September 30, 2017, the August 2022 Notes had a carrying value of $220,473 and an unamortized discount of $9,527.

The following table summarizes the terms of the Notes.

	Principal Amount	Coupon Rate	Effective Rate (1)	Conversion Rate (2)	Maturity Date	Remaining Period of Amortization
March 2019 Notes	$143,750	5.50%	6.25%	57.3034	3/15/2019	1.46 years
August 2019 Notes	$111,000	5.50%	6.50%	57.3034	3/15/2019	1.46 years
August 2022 Notes	$230,000	4.75%	5.72%	50.2260	8/23/2022	4.90 years

———————

(1) Effective rate includes the effect of the adjustment for the conversion option (see footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.

(2) The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof.  The conversion rate represents the number of shares of common stock issuable per $1,000 principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by the Company to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.

The Company may not redeem the Notes prior to maturity. The closing price of the Company's common stock on September 29, 2017 of $18.11 was greater than the per share conversion price of the 2019 Notes and less than the per share conversion price of the August 2022 Notes. The Company has the intent and ability to settle the Notes in cash and, as a result, the Notes did not have any impact on the Company's diluted earnings per share.

In accordance with ASC 470 the liability and equity components of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) is to be separately accounted for in a manner that reflects the issuer’s nonconvertible debt borrowing rate. GAAP requires that the initial proceeds from the sale of the Notes be allocated between a liability component and an equity component in a manner that reflects interest expense at the interest rate of similar nonconvertible debt that could have been issued by the Company at such time. The Company measured the fair value of the debt components of the Notes as of their issuance date based on effective interest rates.  As a result, the Company attributed approximately $18,859 of the proceeds to the equity component of the Notes ($11,445 to the 2019 Notes and $7,414 to the August 2022 Notes), which represents the excess proceeds received over the fair value of the liability component of the Notes at the date of issuance. The equity component of the Notes has been reflected within additional paid-in capital in the condensed consolidated balance sheet as of September 30, 2017. The resulting debt discount is being amortized over the period during which the Notes are expected to be outstanding (the maturity date) as additional non-cash interest expense. The additional non-cash interest expense attributable to each of the Notes will increase in subsequent reporting periods through the maturity date as the Notes accrete to their par value over the same period.

The aggregate contractual interest expense was approximately $4,717 and $11,722 for the three and nine months ended September 30, 2017, respectively. The aggregate contractual interest expense was approximately $3,503 and $10,508 for the three and nine months ended September 30, 2016, respectively. With respect to the amortization of the discount on the liability component of the Notes as well as the amortization of deferred financing costs, the Company reported additional non-cash interest expense of approximately $1,213 and $3,025 for the three and nine months ended September 30, 2017, respectively. With respect to the amortization of the discount on the liability component of the Notes as well as the amortization of deferred financing costs, the Company reported additional non-cash interest expense of approximately $895 and $2,654 for the three and nine months ended September 30, 2016, respectively.

XML

Participations Sold

9 Months Ended

Sep. 30, 2017

Mortgage Loans on Real Estate [Line Items]

Participations Sold

Loans, Held for Investment

The Company’s loans receivable are comprised of the following:

Loan Type	September 30, 2017		December 31, 2016
Commercial mortgage loans, held for investment, net	$	2,218,222	$	1,641,856
Subordinate loans, held for investment, net	1,340,378		1,051,236
Total loans, held for investment, net	$	3,558,600	$	2,693,092

Activity relating to our loans, held for investment portfolio was as follows:

	Principal Balance		Deferred Fees/Other Items (1)		Provision for Loan Loss (2)		Carrying Value
December 31, 2016	2,720,344		(12,252	)	(15,000	)	2,693,092
Loan fundings	1,057,070		—		—		1,057,070
Loan repayments	(238,541	)	—		—		(238,541	)
Unrealized gain on foreign currency translation	20,974		—		—		20,974
Provision for loan loss (2)	—		—		(1,981	)	(1,981	)
Deferred fees and other items (1)	—		(13,047	)	—		(13,047	)
PIK interest, amortization of fees and other items (1)	19,321		21,712		—		41,033
September 30, 2017	3,579,168		(3,587	)	(16,981	)	3,558,600

———————

(1) Other items primarily consist of purchase discounts or premiums, exit fees, and deferred origination expenses.

(2) In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 against a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet.

The following table details overall statistics for our loan portfolio:

	September 30, 2017			December 31, 2016
Number of loans	56			45
Principal balance	$	3,579,168		$	2,720,344
Carrying value	$	3,558,600		$	2,693,092
Unfunded loan commitments (1)	$	80,164		$	170,365
Weighted-average cash coupon (2)	8.5		%	8.88		%

———————

(1) Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2) For floating rate loans, assumes one-month LIBOR of 1.23%and 0.77%, as of September 30, 2017 and December 31, 2016, respectively.

The tables below detail the property type and geographic distribution of the properties securing the loans in our portfolio:

	September 30, 2017			December 31, 2016
Property Type	Carrying Value	% of Portfolio		Carrying Value	% of Portfolio
Residential - for sale	735,551	20.7	%	469,997	17.5	%
Hotel	652,745	18.3	%	408,428	15.2	%
Urban Retail Predevelopment	644,283	18.1	%	491,187	18.2	%
Mixed Use	352,094	9.9	%	134,797	5.0	%
Office	293,093	8.2	%	255,031	9.5	%
Residential Rental	278,117	7.8	%	309,243	11.5	%
Retail Center	197,120	5.5	%	209,401	7.8	%
Healthcare	174,244	4.9	%	170,549	6.3	%
Other	154,017	4.3	%	87,650	3.3	%
Industrial	77,336	2.3	%	156,809	5.7	%
	3,558,600	100.0	%	2,693,092	100.0	%

	September 30, 2017		December 31, 2016
Geographic Location	Carrying Value	% of Portfolio	Carrying Value	% of Portfolio
Manhattan, NY	$1,246,235	35.0%	$870,914	32.3%
Brooklyn, NY	244,501	6.9%	163,389	6.1%
Northeast	133,979	3.8%	137,770	5.1%
Southeast	530,881	14.9%	332,276	12.3%
Midwest	524,984	14.7%	405,992	15.1%
Mid Atlantic	248,786	7.0%	263,717	9.8%
West	205,274	5.8%	219,664	8.2%
Southwest	33,824	1.0%	54,614	2.0%
United Kingdom	312,159	8.7%	244,756	9.1%
Other International	77,977	2.2%	—	—%
Total	$3,558,600	100%	$2,693,092	100%

The Company evaluates its loans for possible impairment on a quarterly basis. The Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations are sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the property’s liquidation value. The Company also evaluates the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, the Company considers the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such loan loss analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants. An allowance for loan loss is established when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan.

During the second quarter of 2017, the Company recorded a loan loss provision of $1,981 on a commercial mortgage loan secured by fully-built, for-sale residential condominium units located in Bethesda, MD. In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 on a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet. The loan loss provision and impairment were based on the difference between fair value of the underlying collateral, and the carrying value of the loan (prior to the loan loss provision and related impairment). Fair value of the collateral was determined using a discounted cash flow analysis. The significant unobservable inputs used in determining the collateral value were sales price per square foot and discount rate which were an average of $678 dollars per square foot across properties and 15%, respectively. Effective April 1, 2017, the Company ceased accruing all interest associated with the loan and accounts for the loan on a cost-recovery basis (all proceeds are applied towards the loan balance).

During 2016, the Company recorded a loan loss provision of $10,000 on a multifamily commercial mortgage loan and $5,000 on a multifamily subordinate loan secured by a multifamily property located in Williston, ND. The loan loss provision was based on the difference between fair value of the underlying collateral, and the carrying value of the loan (prior to the loan loss provision). Fair value of the collateral was determined using a discounted cash flow analysis. The significant unobservable inputs used in determining the collateral value were terminal capitalization rate and discount rate which were 11% and 10%, respectively. The Company ceased accruing payment in kind ("PIK") interest associated with the loan and recognizing interest income upon receipt of cash.

As of September 30, 2017, the aggregate loan loss provision was $11,981 and $5,000 for commercial mortgage loans and subordinate loans, respectively. As of December 31, 2016, the aggregate loan loss provision was $10,000 and $5,000 for commercial mortgage loans and subordinate loans, respectively.

For the three and nine months ended September 30, 2017, the Company received pre-payment penalties of $3,590 and $3,998, respectively. For the three and nine months ended September 30, 2016, the Company received pre-payment penalties of $4,000 and $5,225, respectively. The Company records pre-payment penalty income under interest income.

For the three and nine months ended September 30, 2017, the Company recognized PIK interest of $5,309 and $19,323, respectively. For the three and nine months ended September 30, 2016, the Company recognized PIK interest of $5,808 and $15,902, respectively.

Participating Mortgages [Member]

Mortgage Loans on Real Estate [Line Items]

Participations Sold

Participations Sold

Participations sold represent the interests in loans the Company originated and subsequently partially sold. The Company presents the participations sold as both assets and non-recourse liabilities because the participation does not qualify as a sale according to ASC 860, Transfers and Servicing. The income earned on the participation sold is recorded as interest income and an identical amount is recorded as interest expense on the Company's condensed consolidated statements of operations.

During January 2015, the Company closed a £34,519 (or $51,996) floating-rate mezzanine loan secured by a portfolio of 44 senior housing facilities located throughout the United Kingdom. During February 2015, the Company closed an additional £20,000 (or $30,672) and participated that balance to an investment fund affiliated with Apollo. During December 2016, the Company qualified for sale accounting with respect to the previous participation sold that was converted to a discrete financial instrument, and therefore deconsolidated the participation sold.

During May 2014, the Company closed a $155,000 floating-rate whole loan secured by the first mortgage and equity interests in an entity that owns a resort hotel in Aruba. During June 2014, the Company syndicated a $90,000 senior participation in the loan and retained a $65,000 junior participation in the loan. During August 2014, both the $90,000 senior participation and the Company's $65,000 junior participation were contributed to a CMBS securitization. In exchange for contributing its $65,000 junior participation, the Company received a CMBS secured solely by the $65,000 junior participation and classified it as CMBS (Held-to-Maturity) on its condensed consolidated financial statements. During May 2017, the loan and associated CMBS (Held-to-Maturity) were fully repaid and the related Securities, held-to-maturity and participation sold line items were removed from the Company's condensed consolidated balance sheet.

XML

Derivative Instruments

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative Instruments

The Company uses forward currency contracts to economically hedge interest and principal payments due under its loans denominated in currencies other than U.S. dollars.

The Company has entered into a series of forward contracts to sell an amount of foreign currency (British pound ("GBP")) for an agreed upon amount of U.S. dollars at various dates through April 2018. These forward contracts were executed to economically fix the U.S. dollar amounts of foreign denominated cash flows expected to be received by the Company related to foreign denominated loan investments.

The following table summarizes the Company's non-designated foreign exchange (“Fx”) forwards as of September 30, 2017:

Type of Derivative	September 30, 2017
	Number of Contracts	Aggregate Notional Amount	Notional Currency	Maturity
Fx Contracts - GBP	13	197,401	GBP	October 2017- April 2018

The following table summarizes the Company's non-designated Fx forwards as of December 31, 2016:

Type of Derivative	December 31, 2016
	Number of Contracts	Aggregate Notional Amount	Notional Currency	Maturity
Fx Contracts - GBP	11	148,310	GBP	January 2017- December 2017

The Company has not designated any of its derivative instruments as hedges as defined in ASC 815, Derivatives and Hedging and, therefore, changes in the fair value of the Company's derivative instruments are recorded directly in earnings. The following table summarizes the amounts recognized on the condensed consolidated statements of operations related to the Company’s derivative instruments for the three and nine months ended September 30, 2017 and 2016.

		Three months ended September 30,						Nine months ended September 30,
	Location of Loss Recognized in Income	2017			2016			2017			2016
Forward currency contract	Gain (loss) on derivative instruments - unrealized	$	(7,308	)	$	(10,304	)	$	(17,629	)	$	1,812
Forward currency contract	Gain (loss) on derivative instruments - realized	(179		)	15,112			(290		)	21,100
Interest rate caps (1)	Gain (loss) on derivative instruments - unrealized	6			7			3			(81		)
Sub-total		$	(7,481	)	$	4,815		$	(17,916	)	$	22,831
Forward currency contract	Income (loss) from unconsolidated joint venture	—			—			(587		)	—
Total		$	(7,481	)	$	4,815		$	(18,503	)	$	22,831

———————

(1) With a notional amount of $41,507 and $46,798 at September 30, 2017 and 2016, respectively.

The following table summarizes the gross asset and liability amounts related to the Company's derivative instruments at September 30, 2017 and December 31, 2016.

	September 30, 2017								December 31, 2016
	Gross Amount of Recognized Liabilities			Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet			Gross Amount of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheet		Net Amounts of Assets Presented in the Consolidated Balance Sheet
Interest rate caps	$	—		$	1	$	1		$	23	$	—	$	23
Forward currency contract	(11,747		)	—		(11,747		)	5,883		—		5,883
Total derivative instruments	$	(11,747	)	$	1	$	(11,746	)	$	5,906	$	—	$	5,906

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2017

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

AMTG Merger

As fully described in "Note 17- Business Combination", in August 2016, the Company acquired AMTG, an entity managed by an affiliate of Apollo.

Management Agreement

In connection with the Company’s initial public offering in September 2009, the Company entered into a management agreement (the “Management Agreement”) with the Manager, which describes the services to be provided by the Manager and its compensation for those services. The Manager is responsible for managing the Company’s day-to-day operations, subject to the direction and oversight of the Company’s board of directors.

Pursuant to the terms of the Management Agreement, the Manager is paid a base management fee equal to 1.5% per annum of the Company’s stockholders’ equity (as defined in the Management Agreement), calculated and payable (in cash) quarterly in arrears.

The current term of the Management Agreement expires on September 29, 2018 and is automatically renewed for successive one-year terms on each anniversary thereafter. The Management Agreement may be terminated upon expiration of the one-year extension term only upon the affirmative vote of at least two-thirds of the Company’s independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to the Company or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of the Company’s independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Following a meeting by the Company’s independent directors in February 2017, which included a discussion of the Manager’s performance and the level of the management fees thereunder, the Company determined not to seek termination of the Management Agreement.

For the three and nine months ended September 30, 2017, the Company incurred approximately $8,309 and $23,484, respectively, in base management fees under the Management Agreement. For the three and nine months ended September 30, 2016, the Company incurred approximately $5,903 and $16,374, respectively, in base management fees under the Management Agreement. In addition to the base management fee, the Company is also responsible for reimbursing the Manager for certain expenses paid by the Manager on behalf of the Company or for certain services provided by the Manager to the Company. For the three and nine months ended September 30, 2017, the Company paid expenses totaling $37 and $231 respectively, related to reimbursements for certain expenses paid by the Manager on behalf of the Company under the Management Agreement. For the three and nine months ended September 30, 2016, the Company paid expenses totaling $517 and $1,359, respectively, related to reimbursements for certain expenses paid by the Manager on behalf of the Company under the Management Agreement. Expenses incurred by the Manager and reimbursed by the Company are reflected in the respective condensed consolidated statement of operations expense category or the condensed consolidated balance sheet based on the nature of the item.

Included in payable to related party on the condensed consolidated balance sheet at September 30, 2017 and December 31, 2016 are approximately $8,309 and $7,015, respectively, for base management fees incurred but not yet paid under the Management Agreement.

Unconsolidated Joint Venture

In September 2014, the Company, through a wholly owned subsidiary, acquired a 59% ownership interest in Champ LP following which a wholly-owned subsidiary of Champ LP then acquired a 35% ownership interest in BKB. The Company acquired its ownership interest in Champ LP for an initial purchase price paid at closing of approximately €30,724 (or $39,477). The Company committed to invest up to approximately €38,000 (or $50,000).

In January 2015, the Company funded an additional investment of €3,331 (or $3,929) related to its investment in Champ LP. In February 2015, the Company sold approximately 48% of its ownership interest in Champ LP at cost to an account managed by Apollo for approximately €16,314 (or $20,794). In June 2016, the Company transferred €427 of its unfunded commitment to Apollo, reducing its unfunded commitment to Champ LP to €2,802 (or $2,985). 

In May 2017, the Company sold its remaining ownership interest in Champ LP, to unaffiliated third parties for €21,792 or $24,498, resulting in a loss of $3,305. As of September 30, 2017, the Company had no interest in Champ LP.

Loans receivable

In June, 2017, the Company increased its outstanding loan commitment through the acquisition of an additional $25,000 of interests in an existing pre-development mezzanine loan from a fund managed by an affiliate of the Manager, increasing the Company's total outstanding loan commitment to $100,000. Furthermore, in September 2017 the Company funded an additional $25,000 to acquire a portion of the same pre-development mezzanine loan from a fund managed by an affiliate of the Manager, increasing the Company's total outstanding loan commitment to $125,000. The pre-development mezzanine loan is for the construction of a residential condominium building in New York, New York and is part of a $300,000 mezzanine loan.

XML

Share-Based Payments

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Payments

Share-Based Payments

On September 23, 2009, the Company’s board of directors approved the Apollo Commercial Real Estate Finance, Inc., 2009 Equity Incentive Plan (as amended from time to time, the “LTIP”). The LTIP provides for grants of restricted common stock, restricted stock units ("RSUs") and other equity-based awards up to an aggregate of 7.5% of the issued and outstanding shares of the Company’s common stock (on a fully diluted basis). The LTIP is administered by the compensation committee of the Company’s board of directors (the “Compensation Committee”) and all grants under the LTIP must be approved by the Compensation Committee.

The Company recognized stock-based compensation expense of $2,635 and $9,887, respectively, for the three and nine months ended September 30, 2017, related to restricted stock and RSU vesting. The Company recognized stock-based compensation expense of $1,828 and $5,434, respectively, for the three and nine months ended September 30, 2016, related to restricted common stock and RSU vesting. The following table summarizes the activity related to restricted common stock and RSUs during the nine months ended September 30, 2017:

	Type	Date	Restricted Stock		RSUs		Estimated Fair Value on Grant Date		Initial Vesting	Final Vesting
Outstanding at December 31, 2016			150,110		1,703,775
	Canceled upon delivery	January 2017	—		(332,349	)	n/a		n/a	n/a
	Vested	January 2017	(5,161	)	—		n/a		n/a	n/a
	Forfeiture	March 2017	—		(1,971	)	n/a		n/a	n/a
	Vested	April 2017	(5,164	)			n/a		n/a	n/a
	Grant	April 2017	14,674		—		$	275	April 2018	April 2020
	Canceled upon delivery	May 2017	—		(1,971	)	n/a		n/a	n/a
	Vested	July 2017	(4,004	)			n/a		n/a	n/a
	Canceled upon delivery	July 2017			(544	)	n/a		n/a	n/a
	Grant	August 2017	13,026				$	233	August 2018	August 2018
	Grant	August 2017			790		$	14	August 2018	August 2021
	Forfeiture	September 2017			(8,273	)	n/a		n/a	n/a
Outstanding at September 30, 2017			163,481		1,359,457

Below is a summary of restricted stock and RSU vesting dates as of September 30, 2017.

Vesting Date	Restricted Stock Vesting	RSU Vesting	Total Awards
October 2017	3,997	—	3,997
December 2017	53,923	603,677	657,600
January 2018	2,749	—	2,749
April 2018	7,645	—	7,645
June 2018	—	544	544
July 2018	1,420	—	1,420
October 2018	1,424	—	1,424
December 2018	41,670	477,173	518,843
January 2019	1,419	—	1,419
April 2019	6,314	—	6,314
December 2019	25,000	277,273	302,273
April 2020	4,894	—	4,894
August 2020	—	264	264
Total	163,481	1,359,457	1,522,939

At September 30, 2017, the Company had unrecognized compensation expense of approximately $1,932 and $16,629, respectively, related to the vesting of restricted stock awards and RSUs noted in the table above.

RSU Deliveries

During the nine months ended September 30, 2017, the Company delivered 200,859 shares of common stock for 334,864 vested RSUs. The Company allows RSU participants to settle their tax liabilities with a reduction of their share delivery from the originally granted and vested RSUs. The amount, when agreed to by the participant, results in a cash payment to the Manager related to this tax liability and a corresponding adjustment to additional paid-in-capital on the condensed consolidated statement of changes in stockholders' equity. The adjustment was $2,336 for the nine months ended September 30, 2017, and is included as a reduction of capital increase related to the Company's equity incentive plan in the condensed consolidated statement of changes in stockholders’ equity.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

The Company's authorized capital stock consists of 450,000,000 shares of common stock, $0.01 par value per share and 50,000,000 shares of preferred stock, $0.01 par value per share. As of September 30, 2017, 105,451,235 shares of common stock were issued and outstanding and there were 8,000,000 shares of 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") issued and outstanding and 6,900,000 shares of 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock ("Series C Preferred Stock") issued and

outstanding.

On August 2, 2017, the Company redeemed all 3,450,000 shares of 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") at $25.00 plus accumulated but unpaid dividends of $0.1079 per share.

Dividends. During 2017, the Company declared the following dividends on its common stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.4600
June 15, 2017	June 30, 2017	July 17, 2017	$0.4600
September 14, 2017	September 29, 2017	October 16, 2017	$0.4600

During 2017, the Company declared the following dividends on its Series A Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.5391
June 15, 2017	June 30, 2017	July 17, 2017	$0.5391
July 3, 2017	August 2, 2017	August 2, 2017	$0.1079

During 2017, the Company declared the following dividends on its Series B Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.5000
June 15, 2017	June 30, 2017	July 17, 2017	$0.5000
September 14, 2017	September 29, 2017	October 16, 2017	$0.5000

During 2017, the Company declared the following dividends on its Series C Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 28, 2017	$0.5000
June 15, 2017	June 30, 2017	July 31, 2017	$0.5000
September 14, 2017	September 29, 2017	October 31, 2017	$0.5000

Common Stock Offerings. During the second quarter of 2017, the Company completed a follow-on public offering of 13,800,000 shares of its common stock, at a price of $18.05 per share. The aggregate net proceeds from the offering, including proceeds from the sale of the additional shares, were approximately $248,900 after deducting estimated offering expenses.

During the fourth quarter of 2016, the Company completed a follow-on public offering of 10,500,000 shares of its common stock, at a price of $16.97 per share. The aggregate net proceeds from the offering, including proceeds from the sale of the additional shares, were approximately $177,796 after deducting estimated offering expenses.

AMTG Merger. In addition, in 2016 the Company issued common and preferred equity in connection with the AMTG Merger as described in "Note 17 - Business Combination."

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Proceedings. From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of business.

After the announcement of the execution of the AMTG Merger Agreement, two putative class action lawsuits challenging the proposed First Merger (as defined in the AMTG Merger Agreement), captioned Aivasian v. Apollo Residential Mortgage, Inc., et al., No. 24-C-16-001532 and Wiener v. Apollo Residential Mortgage, Inc., et al., No. 24-C-16-001837, were filed in the Circuit Court for Baltimore City, (the “Court”). A putative class and derivative lawsuit was later filed in the Court captioned Crago v. Apollo Residential Mortgage, Inc., No. 24-C-16-002610. Following a hearing on May 6, 2016, the Court entered orders among other things, consolidating the three actions under the caption In Re Apollo Residential Mortgage, Inc. Shareholder Litigation, Case No.: 24-C-16-002610. The plaintiffs have designated the Crago complaint as the operative complaint. The operative complaint includes both direct and derivative claims, names as defendants AMTG, the board of directors of AMTG (the “AMTG Board”), ARI, Arrow Merger Sub Inc., Apollo and Athene Holding Ltd. and alleges, among other things, that the members of the AMTG Board breached their fiduciary duties to the AMTG stockholders and that the other corporate defendants aided and abetted such fiduciary breaches. The operative complaint further alleges, among other things, that the proposed First Merger involves inadequate consideration, was the result of an inadequate and conflicted sales process, and includes unreasonable deal protection devices that purportedly preclude competing offers. It also alleges that the transactions with Athene Holding Ltd. are unfair and that the registration statement on Form S-4 filed with the SEC on April 6, 2016 contains materially misleading disclosures and omits certain material information. The operative complaint seeks, among other things, certification of the proposed class, declaratory relief, preliminary and permanent injunctive relief, including enjoining or rescinding the First Merger, unspecified damages, and an award of other unspecified attorneys’ and other fees and costs. On May 6, 2016, counsel for the plaintiffs filed with the Court a stipulation seeking the appointment of interim co-lead counsel, which stipulation was approved by the Court on June 9, 2016. Defendants’ motions to dismiss have been fully briefed, and oral argument was held on December 8, 2016. On August 14, 2017, the Court issued an opinion dismissing the operative complaint in its entirety with prejudice. The time to appeal the order dismissing the lawsuit has expired, and no appeals have been filed.

On January 4, 2017, the United States Department of Justice served a Request for Information and Documents (the “Request”) on the Company, in connection with a preliminary investigation into certain aspects of the Company's former residential real estate portfolio, which the Company acquired in connection with the AMTG Merger and subsequently sold in 2016. The Request seeks a range of information in connection with the residential real estate portfolio, including, among other things, information concerning policies, procedures, and practices related to advertising, marketing, identifying, or acquiring residential properties for sale or rent, and various data for all rental and sales contracts executed since January 1, 2012. The Company is cooperating with the Department of Justice and fully complying with the Request.

Loan Commitments. As described in "Note 5 - Loans, Held for Investment", at September 30, 2017, the Company had $80,164 of unfunded commitments related to its commercial mortgage loan portfolio and subordinate loan portfolio.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The following table presents the carrying value and estimated fair value of the Company’s financial instruments not carried at fair value on the condensed consolidated balance sheet at September 30, 2017 and December 31, 2016:

	September 30, 2017						December 31, 2016
	Carrying Value			Estimated Fair Value			Carrying Value			Estimated Fair Value
Cash and cash equivalents	$	140,229		$	140,229		$	200,996		$	200,996
Restricted cash	76			76			62,457			62,457
Securities, held-to-maturity	—			—			146,352			146,352
Commercial mortgage loans	2,218,222			2,235,084			1,641,856			1,648,896
Subordinate loans	1,340,378			1,323,249			1,051,236			1,060,882
Borrowings under repurchase agreements	(1,289,515		)	(1,288,982		)	(1,146,566		)	(1,146,807		)
2019 Notes	(251,438		)	(277,041		)	(249,994		)	(268,124		)
August 2022 Notes	(220,473		)	(234,025		)	—			—
Participations sold	—			—			(84,979		)	(85,072		)

To determine estimated fair values of the financial instruments listed above, market rates of interest, which include credit assumptions, are used to discount contractual cash flows. The estimated fair values are not necessarily indicative of the amount the Company could realize on disposition of the financial instruments. The use of different market assumptions or estimation methodologies could have a material effect on the estimated fair value amounts. Estimates of fair value for cash and cash equivalents, restricted cash and convertible senior notes, net are measured using observable Level I inputs as defined in "Note 3 - Fair Value Disclosure." Estimates of fair value for all other financial instruments in the table above are measured using significant estimates, or unobservable Level III inputs as defined in "Note 3 - Fair Value Disclosure."

XML

Net Income per Share

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Net Income per Share

Net Income per Share

ASC 260, Earnings per share, requires the use of the two-class method of computing earnings per share for all periods presented for each class of common stock and participating security as if all earnings for the period had been distributed. Under the two-class method, during periods of net income, the net income is first reduced for dividends declared on all classes of securities to arrive at undistributed earnings. During periods of net losses, the net loss is reduced for dividends declared on participating securities only if the security has the right to participate in the earnings of the entity and an objectively determinable contractual obligation to share in net losses of the entity.

The remaining earnings are allocated to common stockholders and participating securities to the extent that each security shares in earnings as if all of the earnings for the period had been distributed. Each total is then divided by the applicable number of shares to arrive at basic earnings per share. For the diluted earnings, the denominator includes all outstanding shares of common stock and all potential shares of common stock assumed issued if they are dilutive. The numerator is adjusted for any changes in income or loss that would result from the assumed conversion of these potential shares of common stock.

The table below presents basic and diluted net (loss) income per share of common stock using the two-class method for the three and nine months ended September 30, 2017 and September 30, 2016:

	For the three     months ended   September 30,						For the nine   months ended   September 30,
	2017			2016			2017			2016
Numerator:
Net income	$	68,356		$	69,893		$	151,714		$	98,849
Preferred dividends	(11,148		)	(9,310		)	(29,768		)	(20,985		)
Net income available to common stockholders	57,208			60,583			121,946			77,864
Dividends declared on common stock	(48,507		)	(37,180		)	(139,155		)	(99,182		)
Dividends on participating securities	(625		)	(413		)	(1,884		)	(1,298		)
Net income (loss) attributable to common stockholders	$	8,076		$	22,990		$	(19,093	)	$	(22,616	)
Denominator:
Basic weighted average shares of common stock outstanding	105,446,704			71,919,549			97,546,437			68,913,362
Diluted weighted average shares of common stock outstanding	106,812,721			72,861,611			98,919,689			69,865,603
Basic and diluted net income per weighted average share of common stock
Distributable Earnings	$	0.46		$	0.52		$	1.43		$	1.44
Undistributed income (loss)	$	0.08		$	0.31		$	(0.20	)	$	(0.33	)
Basic and diluted net income per share of common stock	$	0.54		$	0.83		$	1.23		$	1.11

For the three and nine months ended September 30, 2017, 1,366,016 and 1,373,252 unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. For the three and nine months ended September 30, 2016, 942,062 and 952,241 unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive.

XML

Business Combination

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Business Combination

Business Combination

On August 31, 2016, the Company, pursuant to the terms and conditions of the AMTG Merger Agreement, acquired AMTG for consideration of common stock and preferred stock, as applicable and cash. AMTG merged with and into the Company with the Company continuing as the surviving entity. As a result, all operations of AMTG and its former subsidiaries are consolidated with the operations of the Company. In connection with financing the AMTG Merger, on August 31, 2016, the Company entered into a Loan Agreement (the “Athene Loan Agreement”) with Athene USA Corporation, a subsidiary of Athene Holding Ltd., as lender (“Athene USA”), pursuant to which the Company borrowed $175,000 in order to fund a portion of the Company’s obligations under the AMTG Merger Agreement. The Athene Loan Agreement was repaid in full and terminated on September 1, 2016. On August 31, 2016, pursuant to an Asset Purchase and Sale Agreement, dated February 26, 2016 (as amended, the “Asset Purchase Agreement”) by and among Athene Annuity & Life Assurance Company and Athene Annuity and Life Company (collectively, “Athene Annuity”) and the Company, the Company sold primarily non-agency residential mortgage backed securities previously held by AMTG to Athene Annuity for cash consideration of approximately $1,100,000. Proceeds from the sale were used to repay approximately $804,000 in associated financing, $175,000 to satisfy the Athene Loan Agreement and for general corporate purposes. All of the assets acquired from AMTG were sold during 2016.

The AMTG Merger was accounted for as a business combination in accordance with ASC 805, Business Combinations.  The transactions pursuant to the Athene Loan Agreement and the Asset Purchase Agreement were contemporaneous with and contingent on the AMTG Merger, therefore the Company recorded the transaction net. The Company was designated as the accounting acquirer. The total purchase price has been allocated based upon management’s estimates of fair value. The difference between the fair value of net assets of AMTG and the consideration was recorded as a bargain purchase gain.

The bargain purchase gain was computed as follows:

Consideration Paid:		$ (in thousands)
	Cash	$	220,159
	Common stock issued	218,397
	Preferred stock assumed	172,500
	Total consideration paid	$	611,056
Assets acquired:
	Cash and cash equivalents	399,402
	Restricted cash	10,552
	Investments	1,491,484
	Other assets	34,822
Liabilities assumed:
	Borrowings under repurchase agreements	(1,254,518		)
	Other liabilities	(30,665		)
	Net assets acquired	651,077
	Bargain purchase gain	$	40,021

The Company incurred $11,350 of transaction-related expenses related to the AMTG Merger during 2016. Transaction-related expenses are comprised primarily of transaction fees and AMTG Merger costs, including legal, finance, consulting, professional fees and other third-party costs.

The following table provides the pro forma consolidated operational data as if the AMTG Merger had occurred on January 1, 2016:

	Three Months Ended		Nine Months Ended
(in thousands, except per share data)	September 30, 2016		September 30, 2016
Total revenue	$	89,665	$	280,230
Net income attributable to common shareholders	15,615		40,161
Common shares outstanding at September 30, 2016	80,826,566		80,826,566
Net income per common share, basic and diluted	$	0.19	$	0.50

The pro forma consolidated operational data is based on assumptions and estimates considered appropriate by our management; however, these pro forma results are not necessarily indicative of the results of operations that would have been obtained had the AMTG Merger occurred at the beginning of the period presented, nor do they purport to represent the consolidated results of operations for future periods. The pro forma consolidated operational data does not include the impact of any synergies that may be achieved from the AMTG Merger or any strategies that management may consider in order to continue to efficiently manage operations.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

In October 2017, the Company received approximately $48,357 in proceeds from sales and principal pay downs from four CMBS.

Subsequent to the end of the third quarter, the Company committed capital to $294,134 of first mortgage loans, all of which were funded.

The Company funded approximately $2,475 of previously closed loans.

The Company received approximately $166,240 from loan repayments, including $35,530 of first mortgage loans and $130,710 from subordinate loans.

In October 2017, the Company concurrently entered into a common stock purchase agreement and a preferred stock repurchase agreement with QH RE Asset Company, LLC (“QHREAC”). Pursuant to the agreements, (i) QHREAC purchased 1,670,000 shares of the Company’s common stock, par value $0.01 per share, for cash at an aggregate purchase price of $30,795 ($18.44 per share), and (ii) the Company repurchased from QHREAC 1,229,607 shares of the Company’s Series B Preferred Stock, par value $0.01 per share, for an aggregate purchase price of $30,795 ( approximately $25.04 per share, made up of $25 liquidation value per share, plus $0.04 per share of accumulated and unpaid dividends through, but not including, the closing date of the transaction).

In October 2017, the Company upsized its JPMorgan Facility increasing the maximum borrowing capacity amount to $1,393,000, comprised of a $1,250,000 repurchase facility and a $143,000 asset specific financing.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements include the Company’s accounts and those of its consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company’s most significant estimates include the fair value of financial instruments, loan loss reserves and impairment. Actual results could differ from those estimates.

These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the Company’s financial position, results of operations and cash flows have been included. The Company's results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year or any other future period.

On August 31, 2016, the Company, pursuant to the terms and conditions of the Agreement and Plan of Merger, dated February 26, 2016 (as amended, the “AMTG Merger Agreement”) acquired Apollo Residential Mortgage, Inc. (“AMTG”). AMTG merged with and into the Company (the “AMTG Merger”) with the Company continuing as the surviving entity. As a result, all operations of AMTG and its former subsidiaries are consolidated with the operations of the Company. As of December 31, 2016 all assets acquired from AMTG were sold.

Under Financial Accounting Standards Board (the “FASB”) ASC Topic 805, “Business Combinations”, or ASC 805, the acquirer in a business combination must recognize, with certain exceptions, the fair values of assets acquired, liabilities assumed, and non-controlling interests when the acquisition constitutes a change in control of the acquired entity. We applied the provisions of ASC 805 in accounting for the Company's acquisition of AMTG. In doing so, we recorded provisional amounts for certain items as of the date of the acquisition, including the fair value of certain assets and liabilities. During the measurement period, a period which shall not exceed one year, the Company retrospectively adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of such date that, if known, would have affected the measurement of the amounts recognized. See further discussion in "Note 17 - Business Combination."

The Company currently operates in one business segment.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In May 2014, the FASB issued guidance which broadly amends the accounting guidance for revenue recognition. The guidance is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2017. The Company does not anticipate that the adoption of this guidance will have a material impact on the Company's condensed consolidated financial statements.

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” or ASU 2014-15. ASU 2014-15 introduces an explicit requirement for management to assess and provide certain disclosures if there is substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 is effective for the annual period ending after December 15, 2016. The Company adopted this guidance and determined that there was no material impact on the Company's condensed consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting (Topic 718),” or ASU 2016-09. ASU 2016-09 requires all income tax effects of share-based payment awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares for tax withholding purposes than is permitted under current guidance without triggering liability accounting. Finally, the guidance allows a policy election to account for employee forfeitures as they occur. The guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted this guidance and determined there was no material impact on the Company's condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments (Topic 326),” or ASU 2016-13. ASU 2016-13 significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income.  The guidance will replace the “incurred loss” approach under existing guidance with an “expected loss” model for instruments measured at amortized cost, and require entities to record allowances for available-for-sale debt securities rather than reduce the carrying amount, as they do today under the other-than-temporary impairment model. It also simplifies the accounting model for purchased credit-impaired debt securities and loans. The guidance is effective for fiscal years beginning after December 15, 2019 and is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company is currently assessing the impact, if any, the guidance will have on the Company's condensed consolidated financial statements when adopted.

In August 2016, the FASB issued ASU 2016-15 “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” or ASU 2016-15. ASU 2016-15 is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance addresses the classification of various transactions including debt prepayment or debt extinguishment costs, settlement of zero-coupon debt instruments, contingent consideration payments made after a business combination, distributions received from equity method investments, beneficial interests in securitization transactions, and others. The Company adopted this guidance in the third quarter of 2016 and determined that there was no material impact on the Company's condensed consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18 “Statement of Cash Flows (Topic 230): Restricted Cash,” or ASU 2016-18. ASU 2016-18 is intended to clarify how entities present restricted cash in the statement of cash flows. The guidance requires entities to show the changes in the total of cash and cash equivalents and restricted cash in the statement of cash flows. As a result, entities will no longer present transfers between cash and cash equivalents and restricted cash in the statement of cash flows. When cash and cash equivalents and restricted cash are presented in more than one line item on the balance sheet, the new guidance requires a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet. This reconciliation can be presented either on the face of the statement of cash flows or in the notes to the financial statements. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017 and is to be applied retrospectively. The Company early adopted ASU 2016-18 on June 30, 2017, which changed the Company's condensed consolidated statement of cash flows and related disclosures for all periods presented. The following is a reconciliation of the Company's cash, cash equivalents, and restricted cash to the total presented in the Company's condensed consolidated statement of cash flows for the nine months ended September 30, 2017 and September 30, 2016, respectively:

	Nine months ended September 30,
	2017		2016
Cash and cash equivalents	$	140,229	$	254,643
Restricted cash	76		62,324
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	140,305	$	316,967

In August 2017, the FASB issued ASU 2017-12 "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” or ASU 2017-12. The intention of ASU 2017-12 is to align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness previously recognized on existing cash flow and net investment hedges will be adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income (loss). The Company is currently assessing the impact, if any, the guidance will have on the Company's condensed consolidated financial statements when adopted. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018 and is applied retroactively.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Summary of Cash, Cash Equivalents and Restricted Cash

The following is a reconciliation of the Company's cash, cash equivalents, and restricted cash to the total presented in the Company's condensed consolidated statement of cash flows for the nine months ended September 30, 2017 and September 30, 2016, respectively:

	Nine months ended September 30,
	2017		2016
Cash and cash equivalents	$	140,229	$	254,643
Restricted cash	76		62,324
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	140,305	$	316,967

Summary of Cash, Cash Equivalents and Restricted Cash

The following is a reconciliation of the Company's cash, cash equivalents, and restricted cash to the total presented in the Company's condensed consolidated statement of cash flows for the nine months ended September 30, 2017 and September 30, 2016, respectively:

	Nine months ended September 30,
	2017		2016
Cash and cash equivalents	$	140,229	$	254,643
Restricted cash	76		62,324
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	140,305	$	316,967

XML

Fair Value Disclosure (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Summary of the Levels in Fair Value Hierarchy of Financial Instruments

The following table summarizes the levels in the fair value hierarchy into which the Company’s financial instruments were categorized as of September 30, 2017 and December 31, 2016:

	Fair Value as of September 30, 2017										Fair Value as of December 31, 2016
	Level I		Level II			Level III		Total			Level I		Level II		Level III		Total
CMBS (Fair Value Option)	$	—	$	—		$	191,902	$	191,902		$	—	$	331,076	$	—	$	331,076
Derivative instruments, net	—		(11,746		)	—		(11,746		)	—		5,906		—		5,906
Total	$	—	$	(11,746	)	$	191,902	$	180,156		$	—	$	336,982	$	—	$	336,982

Reconciliation of Investments for which Level 3 Inputs were used in Determining Fair Value

The following is a reconciliation of investments for which Level III inputs were used in determining fair value:

	CMBS
Fair value at December 31, 2016	$	—
Transfers into Level III (1)	254,484
Net realized loss on investments	(4,076		)
Net increase in unrealized gain on investments	13,488
Sales and repayments of investments	(71,073		)
Amortization of purchase discount, net	(921		)
Fair value at September 30, 2017	$	191,902

———————

(1) Transfers into Level III of the fair value hierarchy represent investments that experienced an insignificant level of market activity during the period and were thus valued in the absence of observable inputs. Transfers into Level III of the fair value hierarchy are recorded at the end of the reporting period. In June 2017, the Manager determined that, based on illiquidity in the market for these securities, broker quotes, which are the primary valuation technique used to mark these investments at fair value, lack observable inputs and thus a transfer into Level III was necessary. Based on this determination, as of June 30, 2017, we have applied Level III classification to these securities.

Quantitative Information About Significant Unobservable Inputs Used in the Fair Value Measurement of Level III Investments

The following table summarizes information about significant unobservable inputs used in the fair value measurement of Level III investments as of September 30, 2017. There were no Level III investments as of December 31, 2016:

			Unobservable Input
Asset Category	Fair Value	Primary Valuation Technique	Input	Range
CMBS	191,902	Broker quotes	Price (1)	63 - 101

———————

(1) A significant increase (decrease) in the unobservable input in isolation would result in significantly higher (lower) fair value measurement.

XML

Securities (Tables)

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Amortized Cost and Estimated Fair Value of Debt Securities

The amortized cost and estimated fair value of the Company’s debt securities at September 30, 2017 are summarized as follows:

Security Description	Face Amount		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
CMBS (Fair Value Option)	$	222,522	$	217,242	$	247	$	(25,587	)	$	191,902

The amortized cost and estimated fair value of the Company’s debt securities at December 31, 2016 are summarized as follows:

Security Description	Face Amount		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
CMBS (Fair Value Option)	$	375,861	$	368,247	$	292	$	(37,463	)	$	331,076
CMBS (Held-to-Maturity)	146,530		146,352		—		—			146,352
Total	$	522,391	$	514,599	$	292	$	(37,463	)	$	477,428

Overall Statistics for Company's AAA-Rated CMBS Investments Calculated on Weighted Average Basis

The overall statistics for the Company’s CMBS (Fair Value Option) calculated on a weighted average basis as of September 30, 2017 and December 31, 2016 are as follows:

	September 30, 2017		December 31, 2016
Credit Ratings *	BB-D		B+-NR
Coupon	5.9	%	5.9	%
Yield	4.2	%	6.0	%
Weighted Average Life	2.0 years		2.5 years

-————————

* Ratings per Fitch Ratings, Moody’s Investors Service or Standard & Poor's.

Percentage Vintage, Property Type, and Location of Collateral Securing Company's AAA-Rated CMBS Investments Calculated on Weighted Average Basis

The percentage vintage, property type and location of the collateral securing the Company's CMBS (Fair Value Option) calculated on a weighted average basis as of September 30, 2017 and December 31, 2016 are as follows:

Vintage	September 30, 2017		December 31, 2016
2005	—	%	2.0	%
2006	21.2		12.1
2007	57.0		73.5
2008	21.8		12.4
Total	100.0	%	100.0	%

Property Type	September 30, 2017		December 31, 2016
Office	37.8	%	34.6	%
Retail	25.8		29.0
Multifamily	13.6		12.4
Other (1)	22.8		24.0
Total	100.0	%	100.0	%

———————

(1) No other individual category comprises more than 10% of the total.

Location	September 30, 2017		December 31, 2016
South Atlantic	28.3	%	23.8	%
Middle Atlantic	11.9		16.7
Pacific	5.8		15.3
East North Central	16.7		10.8
Other (1)	37.3		33.4
Total	100.0	%	100.0	%

———————

 (1) No other individual category comprises more than 10% of the total.

XML

Loans, Held for Investment (Tables)

9 Months Ended

Sep. 30, 2017

Mortgage Loans on Real Estate [Abstract]

Schedule of Mortgage Loans Receivable

The Company’s loans receivable are comprised of the following:

Loan Type	September 30, 2017		December 31, 2016
Commercial mortgage loans, held for investment, net	$	2,218,222	$	1,641,856
Subordinate loans, held for investment, net	1,340,378		1,051,236
Total loans, held for investment, net	$	3,558,600	$	2,693,092

Schedule of Mortgage Loans on Real Estate Activity

Activity relating to our loans, held for investment portfolio was as follows:

	Principal Balance		Deferred Fees/Other Items (1)		Provision for Loan Loss (2)		Carrying Value
December 31, 2016	2,720,344		(12,252	)	(15,000	)	2,693,092
Loan fundings	1,057,070		—		—		1,057,070
Loan repayments	(238,541	)	—		—		(238,541	)
Unrealized gain on foreign currency translation	20,974		—		—		20,974
Provision for loan loss (2)	—		—		(1,981	)	(1,981	)
Deferred fees and other items (1)	—		(13,047	)	—		(13,047	)
PIK interest, amortization of fees and other items (1)	19,321		21,712		—		41,033
September 30, 2017	3,579,168		(3,587	)	(16,981	)	3,558,600

———————

(1) Other items primarily consist of purchase discounts or premiums, exit fees, and deferred origination expenses.

(2) In addition to the $1,981 provision for loan loss, the Company recorded an impairment of $3,019 against a related investment previously recorded under other assets on the Company's condensed consolidated balance sheet.

Schedule of Loans Receivable Statistics

The following table details overall statistics for our loan portfolio:

	September 30, 2017			December 31, 2016
Number of loans	56			45
Principal balance	$	3,579,168		$	2,720,344
Carrying value	$	3,558,600		$	2,693,092
Unfunded loan commitments (1)	$	80,164		$	170,365
Weighted-average cash coupon (2)	8.5		%	8.88		%

———————

(1) Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2) For floating rate loans, assumes one-month LIBOR of 1.23%and 0.77%, as of September 30, 2017 and December 31, 2016, respectively.

Schedule of Mortgage Loans by Property type and Geographic Distribution

The tables below detail the property type and geographic distribution of the properties securing the loans in our portfolio:

	September 30, 2017			December 31, 2016
Property Type	Carrying Value	% of Portfolio		Carrying Value	% of Portfolio
Residential - for sale	735,551	20.7	%	469,997	17.5	%
Hotel	652,745	18.3	%	408,428	15.2	%
Urban Retail Predevelopment	644,283	18.1	%	491,187	18.2	%
Mixed Use	352,094	9.9	%	134,797	5.0	%
Office	293,093	8.2	%	255,031	9.5	%
Residential Rental	278,117	7.8	%	309,243	11.5	%
Retail Center	197,120	5.5	%	209,401	7.8	%
Healthcare	174,244	4.9	%	170,549	6.3	%
Other	154,017	4.3	%	87,650	3.3	%
Industrial	77,336	2.3	%	156,809	5.7	%
	3,558,600	100.0	%	2,693,092	100.0	%

	September 30, 2017		December 31, 2016
Geographic Location	Carrying Value	% of Portfolio	Carrying Value	% of Portfolio
Manhattan, NY	$1,246,235	35.0%	$870,914	32.3%
Brooklyn, NY	244,501	6.9%	163,389	6.1%
Northeast	133,979	3.8%	137,770	5.1%
Southeast	530,881	14.9%	332,276	12.3%
Midwest	524,984	14.7%	405,992	15.1%
Mid Atlantic	248,786	7.0%	263,717	9.8%
West	205,274	5.8%	219,664	8.2%
Southwest	33,824	1.0%	54,614	2.0%
United Kingdom	312,159	8.7%	244,756	9.1%
Other International	77,977	2.2%	—	—%
Total	$3,558,600	100%	$2,693,092	100%

XML

Borrowings Under Repurchase Agreements (Tables)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Weighted Average Maturities and Interest Rates of Borrowings

At September 30, 2017 and December 31, 2016, the Company’s borrowings had the following outstanding balances, maturities and weighted average interest rates:

	September 30, 2017								December 31, 2016
Lender	Maximum Amount of Borrowings		Borrowings Outstanding			Maturity (1)	Weighted Average Rate (2)		Maximum Amount of Borrowings		Borrowings Outstanding			Maturity (1)	Weighted Average Rate (2)
JPMorgan Facility (3)	$	1,118,000	$	840,360		March 2020	L+2.27%		$	943,000	$	657,452		January 2019	L+2.25%
DB Repurchase Facility (4)	565,491		265,658			March 2020	L+2.35%		300,000		137,355			September 2019	L+2.66%
Goldman Loan	34,180		34,180			April 2019	L+3.50%		N/A		40,657			April 2019	L+3.50%
Sub-total	1,717,671		1,140,198				L+2.32%				835,464				L+2.38%
UBS Facility	N/A		N/A			N/A	N/A		N/A		133,899			September 2018	2.79	%
DB Facility (5)	300,000		149,317			April 2018	3.48	%	N/A		177,203			April 2018	3.63	%
Sub-total	300,000		149,317				3.48	%			311,102				3.27	%
Less: deferred financing costs	N/A		(10,884		)		N/A		N/A		(6,763		)		N/A
Total / Weighted Average	$	2,017,671	$	1,278,631			3.55	%			$	1,139,803			3.18	%

———————

(1) Maturity date assumes all extensions are exercised.

(2) Assumes one-month LIBOR was 1.23% and 0.77% as of September 30, 2017 and December 31, 2016, respectively.

(3) As of September 30, 2017, the Company's master repurchase agreement with JPMorgan Chase Bank, National Association

(the "JPMorgan Facility") provided for maximum total borrowings comprised of the $975,000 repurchase facility and a $143,000 asset specific financing.

(4) As of September 30, 2017, the Company's master repurchase agreement with Deutsche Bank AG, Cayman Islands Branch (the "DB Repurchase Facility") provided for maximum total borrowings comprised of the $450,000 and £45,000 repurchase facility and a $55,200 asset specific financing.

(5) Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 2.09% to 2.39% based on the rating of the collateral pledged.

Remaining Maturities of Borrowings

At September 30, 2017, the Company’s borrowings had the following remaining maturities:

	Less than 1 year (1)		1 to 3 years (1)		3 to 5 years		More than 5 years		Total
JPMorgan Facility	$	166,273	$	674,087	$	—	$	—	$	840,360
DB Repurchase Facility	—		265,658		—		—		265,658
Goldman Loan	—		34,180		—		—		34,180
DB Facility	149,317		—		—		—		149,317
Total	$	315,590	$	973,925	$	—	$	—	$	1,289,515

———————

(1) Assumes underlying assets are financed through the fully extended maturity date of the facility.

Schedule of Outstanding, Maximum and Average Balances of Debt

The table below summarizes the outstanding balances at September 30, 2017, as well as the maximum and average month-end balances for the nine months ended September 30, 2017 for the Company's borrowings under repurchase agreements.

			For the nine months ended September 30, 2017
	Balance at September 30, 2017		Maximum Month-End Balance		Average Month-End Balance
JPMorgan Facility borrowings	$	840,360	$	986,611	$	849,355
DB Repurchase Facility borrowings	265,658		367,010		286,326
Goldman Loan borrowings	34,180		39,590		37,554
DB Facility borrowings	149,317		177,203		136,930
Total	$	1,289,515

XML

Convertible Senior Notes (Tables)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Schedule of Convertible Senior Notes

The following table summarizes the terms of the Notes.

	Principal Amount	Coupon Rate	Effective Rate (1)	Conversion Rate (2)	Maturity Date	Remaining Period of Amortization
March 2019 Notes	$143,750	5.50%	6.25%	57.3034	3/15/2019	1.46 years
August 2019 Notes	$111,000	5.50%	6.50%	57.3034	3/15/2019	1.46 years
August 2022 Notes	$230,000	4.75%	5.72%	50.2260	8/23/2022	4.90 years

———————

(1) Effective rate includes the effect of the adjustment for the conversion option (see footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.

(2) The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof.  The conversion rate represents the number of shares of common stock issuable per $1,000 principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by the Company to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.

XML

Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Non-Designated Foreign Exchange Forwards

The following table summarizes the Company's non-designated foreign exchange (“Fx”) forwards as of September 30, 2017:

Type of Derivative	September 30, 2017
	Number of Contracts	Aggregate Notional Amount	Notional Currency	Maturity
Fx Contracts - GBP	13	197,401	GBP	October 2017- April 2018

The following table summarizes the Company's non-designated Fx forwards as of December 31, 2016:

Type of Derivative	December 31, 2016
	Number of Contracts	Aggregate Notional Amount	Notional Currency	Maturity
Fx Contracts - GBP	11	148,310	GBP	January 2017- December 2017

Summary of Amounts Recognized on Consolidated Statements of Operations Related to Company's Derivatives

The following table summarizes the amounts recognized on the condensed consolidated statements of operations related to the Company’s derivative instruments for the three and nine months ended September 30, 2017 and 2016.

		Three months ended September 30,						Nine months ended September 30,
	Location of Loss Recognized in Income	2017			2016			2017			2016
Forward currency contract	Gain (loss) on derivative instruments - unrealized	$	(7,308	)	$	(10,304	)	$	(17,629	)	$	1,812
Forward currency contract	Gain (loss) on derivative instruments - realized	(179		)	15,112			(290		)	21,100
Interest rate caps (1)	Gain (loss) on derivative instruments - unrealized	6			7			3			(81		)
Sub-total		$	(7,481	)	$	4,815		$	(17,916	)	$	22,831
Forward currency contract	Income (loss) from unconsolidated joint venture	—			—			(587		)	—
Total		$	(7,481	)	$	4,815		$	(18,503	)	$	22,831

———————

(1) With a notional amount of $41,507 and $46,798 at September 30, 2017 and 2016, respectively.

Summary of Gross Derivative Assets Related to Derivatives

The following table summarizes the gross asset and liability amounts related to the Company's derivative instruments at September 30, 2017 and December 31, 2016.

	September 30, 2017								December 31, 2016
	Gross Amount of Recognized Liabilities			Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet			Gross Amount of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheet		Net Amounts of Assets Presented in the Consolidated Balance Sheet
Interest rate caps	$	—		$	1	$	1		$	23	$	—	$	23
Forward currency contract	(11,747		)	—		(11,747		)	5,883		—		5,883
Total derivative instruments	$	(11,747	)	$	1	$	(11,746	)	$	5,906	$	—	$	5,906

XML

Share-Based Payments (Tables)

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

The following table summarizes the activity related to restricted common stock and RSUs during the nine months ended September 30, 2017:

	Type	Date	Restricted Stock		RSUs		Estimated Fair Value on Grant Date		Initial Vesting	Final Vesting
Outstanding at December 31, 2016			150,110		1,703,775
	Canceled upon delivery	January 2017	—		(332,349	)	n/a		n/a	n/a
	Vested	January 2017	(5,161	)	—		n/a		n/a	n/a
	Forfeiture	March 2017	—		(1,971	)	n/a		n/a	n/a
	Vested	April 2017	(5,164	)			n/a		n/a	n/a
	Grant	April 2017	14,674		—		$	275	April 2018	April 2020
	Canceled upon delivery	May 2017	—		(1,971	)	n/a		n/a	n/a
	Vested	July 2017	(4,004	)			n/a		n/a	n/a
	Canceled upon delivery	July 2017			(544	)	n/a		n/a	n/a
	Grant	August 2017	13,026				$	233	August 2018	August 2018
	Grant	August 2017			790		$	14	August 2018	August 2021
	Forfeiture	September 2017			(8,273	)	n/a		n/a	n/a
Outstanding at September 30, 2017			163,481		1,359,457

Summary of Grants, Exchanges and Forfeitures of Restricted Stock and RSUs

Below is a summary of restricted stock and RSU vesting dates as of September 30, 2017.

Vesting Date	Restricted Stock Vesting	RSU Vesting	Total Awards
October 2017	3,997	—	3,997
December 2017	53,923	603,677	657,600
January 2018	2,749	—	2,749
April 2018	7,645	—	7,645
June 2018	—	544	544
July 2018	1,420	—	1,420
October 2018	1,424	—	1,424
December 2018	41,670	477,173	518,843
January 2019	1,419	—	1,419
April 2019	6,314	—	6,314
December 2019	25,000	277,273	302,273
April 2020	4,894	—	4,894
August 2020	—	264	264
Total	163,481	1,359,457	1,522,939

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Dividends. During 2017, the Company declared the following dividends on its common stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.4600
June 15, 2017	June 30, 2017	July 17, 2017	$0.4600
September 14, 2017	September 29, 2017	October 16, 2017	$0.4600

During 2017, the Company declared the following dividends on its Series A Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.5391
June 15, 2017	June 30, 2017	July 17, 2017	$0.5391
July 3, 2017	August 2, 2017	August 2, 2017	$0.1079

During 2017, the Company declared the following dividends on its Series B Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 17, 2017	$0.5000
June 15, 2017	June 30, 2017	July 17, 2017	$0.5000
September 14, 2017	September 29, 2017	October 16, 2017	$0.5000

During 2017, the Company declared the following dividends on its Series C Preferred Stock:

Declaration Date	Record Date	Payment Date	Per Share
March 14, 2017	March 31, 2017	April 28, 2017	$0.5000
June 15, 2017	June 30, 2017	July 31, 2017	$0.5000
September 14, 2017	September 29, 2017	October 31, 2017	$0.5000

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Carrying Value and Estimated Fair Value of Company's Financial Instruments

The following table presents the carrying value and estimated fair value of the Company’s financial instruments not carried at fair value on the condensed consolidated balance sheet at September 30, 2017 and December 31, 2016:

	September 30, 2017						December 31, 2016
	Carrying Value			Estimated Fair Value			Carrying Value			Estimated Fair Value
Cash and cash equivalents	$	140,229		$	140,229		$	200,996		$	200,996
Restricted cash	76			76			62,457			62,457
Securities, held-to-maturity	—			—			146,352			146,352
Commercial mortgage loans	2,218,222			2,235,084			1,641,856			1,648,896
Subordinate loans	1,340,378			1,323,249			1,051,236			1,060,882
Borrowings under repurchase agreements	(1,289,515		)	(1,288,982		)	(1,146,566		)	(1,146,807		)
2019 Notes	(251,438		)	(277,041		)	(249,994		)	(268,124		)
August 2022 Notes	(220,473		)	(234,025		)	—			—
Participations sold	—			—			(84,979		)	(85,072		)

XML

Net Income per Share (Tables)

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Basic and Diluted Net Income per Share of Common Stock Using Two-Class Method

The table below presents basic and diluted net (loss) income per share of common stock using the two-class method for the three and nine months ended September 30, 2017 and September 30, 2016:

	For the three     months ended   September 30,						For the nine   months ended   September 30,
	2017			2016			2017			2016
Numerator:
Net income	$	68,356		$	69,893		$	151,714		$	98,849
Preferred dividends	(11,148		)	(9,310		)	(29,768		)	(20,985		)
Net income available to common stockholders	57,208			60,583			121,946			77,864
Dividends declared on common stock	(48,507		)	(37,180		)	(139,155		)	(99,182		)
Dividends on participating securities	(625		)	(413		)	(1,884		)	(1,298		)
Net income (loss) attributable to common stockholders	$	8,076		$	22,990		$	(19,093	)	$	(22,616	)
Denominator:
Basic weighted average shares of common stock outstanding	105,446,704			71,919,549			97,546,437			68,913,362
Diluted weighted average shares of common stock outstanding	106,812,721			72,861,611			98,919,689			69,865,603
Basic and diluted net income per weighted average share of common stock
Distributable Earnings	$	0.46		$	0.52		$	1.43		$	1.44
Undistributed income (loss)	$	0.08		$	0.31		$	(0.20	)	$	(0.33	)
Basic and diluted net income per share of common stock	$	0.54		$	0.83		$	1.23		$	1.11

XML

Business Combination (Tables)

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Schedule of Business Acquisitions

The following table provides the pro forma consolidated operational data as if the AMTG Merger had occurred on January 1, 2016:

	Three Months Ended		Nine Months Ended
(in thousands, except per share data)	September 30, 2016		September 30, 2016
Total revenue	$	89,665	$	280,230
Net income attributable to common shareholders	15,615		40,161
Common shares outstanding at September 30, 2016	80,826,566		80,826,566
Net income per common share, basic and diluted	$	0.19	$	0.50

The bargain purchase gain was computed as follows:

Consideration Paid:		$ (in thousands)
	Cash	$	220,159
	Common stock issued	218,397
	Preferred stock assumed	172,500
	Total consideration paid	$	611,056
Assets acquired:
	Cash and cash equivalents	399,402
	Restricted cash	10,552
	Investments	1,491,484
	Other assets	34,822
Liabilities assumed:
	Borrowings under repurchase agreements	(1,254,518		)
	Other liabilities	(30,665		)
	Net assets acquired	651,077
	Bargain purchase gain	$	40,021

XML

Summary of Significant Accounting Policies (Detail)	9 Months Ended
	Sep. 30, 2017 Segment
Accounting Policies [Abstract]
Number of business segments	1

XML

Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
Accounting Policies [Abstract]
Cash and cash equivalents	$ 140,229	$ 200,996	$ 254,643
Restricted cash	76	62,457	62,324
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$ 140,305	$ 263,453	$ 316,967	$ 97,542

XML

Fair Value Disclosure - Summary of Level 3 Financial Instruments (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 180,156	$ 336,982
Estimated Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, net	(11,746)	5,906
Estimated Fair Value [Member] | AAA Commercial Mortage Backed Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate purchase price of CMBS	191,902	331,076
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	0	0
Level 1 [Member] | Estimated Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, net	0	0
Level 1 [Member] | Estimated Fair Value [Member] | AAA Commercial Mortage Backed Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate purchase price of CMBS	0	0
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	(11,746)	336,982
Level 2 [Member] | Estimated Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, net	(11,746)	5,906
Level 2 [Member] | Estimated Fair Value [Member] | AAA Commercial Mortage Backed Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate purchase price of CMBS	0	331,076
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	191,902	0
Level 3 [Member] | Estimated Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, net	0	0
Level 3 [Member] | Estimated Fair Value [Member] | AAA Commercial Mortage Backed Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate purchase price of CMBS	$ 191,902	$ 0

XML

Fair Value Disclosure - Reconciliation of Level 3 Investments (Details) - CMBS [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2017 USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at December 31, 2016	$ 0
Transfers into Level III	254,484
Net realized loss on investments	(4,076)
Net increase in unrealized gain on investments	13,488
Sales and repayments of investments	(71,073)
Amortization of purchase discount, net	(921)
Fair value at September 30, 2017	$ 191,902

XML

Fair Value Disclosure - Quantitative Information About Significant Unobservable Inputs (Details) - CMBS [Member] - Broker quotes [Member] - Level 3 [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2017 USD ($)
Fair Value Inputs, Assets, Quantitative Information [Line Items]
CMBS, fair value	$ 191,902
Minimum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Price	63.00%
Maximum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Price	101.00%

XML

Securities - Additional Information (Detail)	1 Months Ended		3 Months Ended		9 Months Ended
	Aug. 31, 2016 USD ($)	May 31, 2014 USD ($) ft² casino room timeshare_unit	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Aug. 31, 2014 USD ($)	Jun. 30, 2014 USD ($)
Mortgage Loans on Real Estate [Line Items]
Realized loss on sale of securities			$ 4,076,000	$ 225,000	$ 5,118,000	$ 225,000
Hotel [Member] | Subordinate Mortgage Portfolio Segment [Member] | Hotel - Aruba [Member]
Mortgage Loans on Real Estate [Line Items]
Number of hotel rooms | room		442
Number of timeshare units in real estate property | timeshare_unit		114
Number of casinos in real estate property | casino		2
Property size, area (in square feet) | ft²		131,500
First Mortgage [Member] | Hotel [Member] | Subordinate Mortgage Portfolio Segment [Member] | Hotel - Aruba [Member]
Mortgage Loans on Real Estate [Line Items]
Mortgage loan, face amount		$ 155,000,000
Senior Participation [Member] | Hotel [Member] | Subordinate Mortgage Portfolio Segment [Member] | Hotel - Aruba [Member]
Mortgage Loans on Real Estate [Line Items]
Participation in loan, amount							$ 90,000,000	$ 90,000,000
Junior Participation [Member] | Hotel [Member] | Subordinate Mortgage Portfolio Segment [Member] | Hotel - Aruba [Member]
Mortgage Loans on Real Estate [Line Items]
Participation in loan, amount							$ 65,000,000	$ 65,000,000
Commercial Mortgage Backed Securities [Member]
Mortgage Loans on Real Estate [Line Items]
Realized loss on sale of securities	$ 225,000				$ 5,118,000
Amortized cost of fair value option	86,676,000
Gross realized gain	90,000
Gross realized loss	315,000
Proceeds from sale of securities, net of line of credit repayment	16,222,000
Wells Fargo [Member] | Line of Credit [Member]
Mortgage Loans on Real Estate [Line Items]
Repayment of line of credit	$ 70,229,000

XML

Securities - Amortized Cost and Estimated Fair Value (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016	Aug. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Total, Face Amount		$ 522,391
Total, Amortized Cost		514,599
Total, Gross Unrealized Gain		292
Total, Gross Unrealized Loss		(37,463)
Total, Carrying Value/Estimated Fair Value		477,428
Commercial Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair Value Option, Amortized Cost			$ 86,676
Held to Maturity, Face Amount		146,530
Held to Maturity, Amortized Cost		146,352
Held to Maturity, Gross Unrealized Gain		0
Held to Maturity, Gross Unrealized Loss		0
Held to Maturity, Carrying Value/Estimated Fair Value		146,352
Commercial Mortgage Backed Securities [Member] | Estimated Fair Value [Member] | Available-for-sale Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair Value Option, Face Amount	$ 222,522	375,861
Fair Value Option, Amortized Cost	217,242	368,247
Fair Value Option, Gross Unrealized Gain	247	292
Fair Value Option, Gross Unrealized Loss	(25,587)	(37,463)
Fair Value Option, Carrying Value/Estimated Fair Value	$ 191,902	$ 331,076

XML

Securities - Overall Statistics for Company's AAA-Rated CMBS Investments Calculated on Weighted Average Basis (Detail) - Commercial Mortgage Backed Securities [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Coupon	5.90%	5.90%
Yield	4.20%	6.00%
Weighted Average Life	2 years	2 years 6 months

XML

Securities - Percentage Vintage, Property Type, and Location of Collateral Securing Company's AAA-Rated CMBS Investments Calculated on Weighted Average Basis (Detail) - Available-for-sale Securities [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Vintage Concentration Risk [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	100.00%	100.00%
Vintage Concentration Risk [Member] | 2005 [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	0.00%	2.00%
Vintage Concentration Risk [Member] | 2006 [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	21.20%	12.10%
Vintage Concentration Risk [Member] | 2007 [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	57.00%	73.50%
Vintage Concentration Risk [Member] | 2008 [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	21.80%	12.40%
Product Concentration Risk [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	100.00%	100.00%
Product Concentration Risk [Member] | Office [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	37.80%	34.60%
Product Concentration Risk [Member] | Retail [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	25.80%	29.00%
Product Concentration Risk [Member] | Multifamily [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	13.60%	12.40%
Product Concentration Risk [Member] | Other [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	22.80%	24.00%
Geographic Concentration Risk [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	100.00%	100.00%
Geographic Concentration Risk [Member] | South Atlantic [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	28.30%	23.80%
Geographic Concentration Risk [Member] | Middle Atlantic [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	11.90%	16.70%
Geographic Concentration Risk [Member] | Pacific [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	5.80%	15.30%
Geographic Concentration Risk [Member] | East North Central [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	16.70%	10.80%
Geographic Concentration Risk [Member] | Other [Member]
Mortgage Loans on Real Estate [Line Items]
Percentage	37.30%	33.40%

XML

Loans, Held for Investment - Schedule of Mortgage Loans Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans, held for investment, net	$ 3,558,600	$ 2,693,092
Commercial Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans, held for investment, net	2,218,222	1,641,856
Subordinate Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans, held for investment, net	$ 1,340,378	$ 1,051,236

XML

Loans, Held for Investment - Schedule of Mortgage Loans on Real Estate Activity (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Principal Balance
Loan repayments				$ (17,062)	$ (118,120)
Provision for Loan Loss
Provision for loan loss	$ 0		$ 0	(5,000)	(15,000)
Carrying Value
Loan repayments				(17,062)	(118,120)
Provision for loan loss	0		0	(5,000)	(15,000)
Provision for loan loss	0		$ 0	5,000	$ 15,000
Commercial Mortgage and Subordinated Portfolio Segment [Member]
Principal Balance
Principal balance, beginning				2,720,344
Loan fundings				1,057,070
Loan repayments				(238,541)
Unrealized gain on foreign currency translation				20,974
Deferred fees and other items				0
PIK interest, amortization of fees and other items				19,321
Principal balance, ending	3,579,168			3,579,168
Deferred Fees/Other Items
Deferred fees/other items, beginning				(12,252)
Deferred fees and other items				(13,047)
PIK interest, amortization of fees and other items				21,712
Deferred fees/other items, ending	(3,587)			(3,587)
Provision for Loan Loss
Provision for loans, beginning				(15,000)
Provision for loan loss				(1,981)
Provision for loans, ending	(16,981)			(16,981)
Carrying Value
Carrying value, beginning				2,693,092
Loan fundings				1,057,070
Loan repayments				(238,541)
Unrealized gain on foreign currency translation				20,974
Provision for loan loss				(1,981)
Deferred fees and other items				(13,047)
PIK interest, amortization of fees and other items				41,033
Carrying value, ending	$ 3,558,600			3,558,600
Provision for loan loss				1,981
Other Assets [Member] | Commercial Mortgage and Subordinated Portfolio Segment [Member]
Carrying Value
Impairment of real estate loan		$ 3,019		$ 3,019

XML

Loans, Held for Investment - Schedule of Loan Receivable Statistics (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017 USD ($) loan	Dec. 31, 2016 USD ($) loan
Mortgage Loans on Real Estate [Abstract]
Number of loans | loan	56	45
Principal balance	$ 3,579,168	$ 2,720,344
Carrying Value	3,558,600	2,693,092
Unfunded loan commitments	$ 80,164	$ 170,365
Weighted-average cash coupon	8.50%	8.88%
London Interbank Offered Rate (LIBOR) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Basis spread on variable rate	1.23%	0.77%

XML

Loans, Held for Investment - Schedule of Mortgage Loans by Property Type and Geographic Distribution (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 3,558,600	$ 2,693,092
Percent of Portfolio	100.00%	100.00%
Residential - for sale [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 735,551	$ 469,997
Percent of Portfolio	20.70%	17.50%
Hotel [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 652,745	$ 408,428
Percent of Portfolio	18.30%	15.20%
Urban Retail Predevelopment [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 644,283	$ 491,187
Percent of Portfolio	18.10%	18.20%
Mixed Use [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 352,094	$ 134,797
Percent of Portfolio	9.90%	5.00%
Office [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 293,093	$ 255,031
Percent of Portfolio	8.20%	9.50%
Residential Rental [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 278,117	$ 309,243
Percent of Portfolio	7.80%	11.50%
Retail Center [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 197,120	$ 209,401
Percent of Portfolio	5.50%	7.80%
Healthcare [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 174,244	$ 170,549
Percent of Portfolio	4.90%	6.30%
Other [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 154,017	$ 87,650
Percent of Portfolio	4.30%	3.30%
Industrial [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 77,336	$ 156,809
Percent of Portfolio	2.30%	5.70%
Manhattan, New York [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 1,246,235	$ 870,914
Percent of Portfolio	35.00%	32.30%
Brooklyn, New York [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 244,501	$ 163,389
Percent of Portfolio	6.90%	6.10%
Northeast [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 133,979	$ 137,770
Percent of Portfolio	3.80%	5.10%
Southeast [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 530,881	$ 332,276
Percent of Portfolio	14.90%	12.30%
Midwest [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 524,984	$ 405,992
Percent of Portfolio	14.70%	15.10%
Mid Atlantic [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 248,786	$ 263,717
Percent of Portfolio	7.00%	9.80%
West [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 205,274	$ 219,664
Percent of Portfolio	5.80%	8.20%
Southwest [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 33,824	$ 54,614
Percent of Portfolio	1.00%	2.00%
United Kingdom [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 312,159	$ 244,756
Percent of Portfolio	8.70%	9.10%
Other International [Member]
Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 77,977	$ 0
Percent of Portfolio	2.20%	0.00%

XML

Loans, Held for Investment - Narrative (Details) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2017 USD ($)	Jun. 30, 2017 USD ($) $ / ft²	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment	$ 0		$ 0	$ 5,000	$ 15,000
Pre-payment penalties received	3,590		4,000	3,998	5,225
PIK interest	$ 5,309		$ 5,808	19,323	$ 15,902
Commercial Mortgage and Subordinated Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment				1,981
Commercial Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment				11,981		$ 10,000
Fair value inputs, terminal capitalization rate						11.00%
Fair value inputs, discount rate						10.00%
Subordinate Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment				5,000		$ 5,000
Residential Condominium - Bethesda, MD [Member] | Commercial Mortgage and Subordinated Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment		$ 1,981
Residential Condominium - Bethesda, MD [Member] | Commercial Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair value inputs, price per square foot | $ / ft²		678
Fair value inputs, discount rate		15.00%
Multifamily - Williston, ND [Member] | Commercial Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment						10,000
Multifamily - Williston, ND [Member] | Subordinate Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses and impairment						$ 5,000
Other Assets [Member] | Commercial Mortgage and Subordinated Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Impairment of real estate loan		$ 3,019		$ 3,019

XML

Unconsolidated Joint Venture - (Detail) € in Thousands, $ in Thousands	1 Months Ended							9 Months Ended
	May 31, 2017 USD ($)	May 31, 2017 EUR (€)	Jun. 30, 2016 EUR (€)	Feb. 28, 2015 USD ($)	Feb. 28, 2015 EUR (€)	Sep. 30, 2014 USD ($)	Sep. 30, 2014 EUR (€)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2016 EUR (€)	Jan. 31, 2015 USD ($)	Jan. 31, 2015 EUR (€)	Sep. 30, 2014 EUR (€)
Schedule of Equity Method Investments [Line Items]
Initial funding for equity method investment								$ 726	$ 362
KBCD Partnership [Member]
Schedule of Equity Method Investments [Line Items]
Initial funding for equity method investment						$ 39,477	€ 30,724
Commitment to Invest in KBCD [Member]
Schedule of Equity Method Investments [Line Items]
Commitment to invest						$ 50,000								€ 38,000
Unfunded Commitment, Champ L.P. [Member]
Schedule of Equity Method Investments [Line Items]
Commitment to invest										$ 2,985	€ 2,802
Commitment to invest transfer | €			€ 427
Wholly-owned Subsidiary [Member] | Champ Limited Partnership [Member]
Schedule of Equity Method Investments [Line Items]
Ownership interest						59.00%		0.00%						59.00%
Champ LP [Member] | KBC Bank Deutschland AG [Member]
Schedule of Equity Method Investments [Line Items]
Ownership interest						35.00%								35.00%
Company and affiliated investors ownership, percentage								100.00%
Champ LP [Member]
Schedule of Equity Method Investments [Line Items]
Sale of equity method investment, percentage				48.00%	48.00%
Proceeds from sale of equity method investments	$ 24,498	€ 21,792		$ 20,794	€ 16,314
Foreign exchange adjustments included in accumulated other comprehensive loss				$ 2,614
Loss on sale of equity method investment	$ 3,305
Champ LP [Member] | Additional Investment [Member]
Schedule of Equity Method Investments [Line Items]
Commitment to invest												$ 3,929	€ 3,331

XML

Borrowings Under Repurchase Agreements - Weighted Average Maturities and Interest Rates of Borrowings (Detail) £ in Thousands		9 Months Ended	12 Months Ended
	Jan. 26, 2015	Sep. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Sep. 30, 2017 GBP (£)	Mar. 31, 2017 USD ($)	Sep. 29, 2016 USD ($)	Sep. 29, 2016 GBP (£)
Debt Instrument [Line Items]
Borrowings Outstanding		$ 1,278,631,000	$ 1,139,803,000
Less: deferred financing costs		$ (10,884,000)	$ (6,763,000)
London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread on variable rate		1.23%	0.77%
Line of Credit [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 2,017,671,000
Borrowings Outstanding		$ 1,278,631,000	$ 1,139,803,000
Weighted Average Rate		3.55%	3.18%	3.55%
Less: deferred financing costs		$ (10,884,000)	$ (6,763,000)
Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		1.23%	0.77%
JP Morgan Chase DB Repurchase Facility, and Goldman Sachs [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 1,717,671,000
Borrowings Outstanding		$ 1,140,198,000	$ 835,464,000
JP Morgan Chase DB Repurchase Facility, and Goldman Sachs [Member] | Weighted Average [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		2.32%	2.38%
JPMorgan Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 1,118,000,000	$ 943,000,000
Borrowings Outstanding		840,360,000	$ 657,452,000
JPMorgan Facility [Member] | Line of Credit [Member] | General Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit		975,000,000
JPMorgan Facility [Member] | Line of Credit [Member] | Asset Specific Financing [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings					$ 143,000,000
Long-term line of credit		$ 143,000,000
JPMorgan Facility [Member] | Weighted Average [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		2.27%	2.25%
DB Repurchase Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 565,491,000	$ 300,000,000			$ 565,491,000
Borrowings Outstanding		265,658,000	$ 137,355,000
DB Repurchase Facility [Member] | Line of Credit [Member] | General Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit		450,000,000		£ 45,000		450,000,000	£ 45,000
DB Repurchase Facility [Member] | Line of Credit [Member] | Asset Specific Financing [Member]
Debt Instrument [Line Items]
Long-term line of credit		$ 55,200,000				$ 55,200,000
DB Repurchase Facility [Member] | Weighted Average [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		2.35%	2.66%
DB Repurchase Facility [Member] | Minimum [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		2.10%
DB Repurchase Facility [Member] | Maximum [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		3.00%
Goldman Loan [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Borrowings Outstanding		$ 34,180,000	$ 40,657,000
Goldman Loan [Member] | Line of Credit [Member] | Goldman Facility [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 34,180,000
Goldman Loan [Member] | Line of Credit [Member] | Goldman Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point	3.50%
Goldman Loan [Member] | Weighted Average [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		3.50%	3.50%
UBS and Deutsche Bank [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 300,000,000
Borrowings Outstanding		$ 149,317,000	$ 311,102,000
Weighted Average Rate		3.48%	3.27%	3.48%
UBS Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Borrowings Outstanding			$ 133,899,000
Weighted Average Rate			2.79%
DB Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Maximum Amount of Borrowings		$ 300,000,000
Borrowings Outstanding		$ 149,317,000	$ 177,203,000
Weighted Average Rate		3.48%	3.63%	3.48%
DB Facility [Member] | Minimum [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		2.09%
DB Facility [Member] | Maximum [Member] | Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis point		2.39%

XML

Borrowings Under Repurchase Agreements - Remaining Maturities of Borrowings (Detail) - Line of Credit [Member] $ in Thousands	Sep. 30, 2017 USD ($)
Line of Credit Facility [Line Items]
Less than 1 year	$ 315,590
1 to 3 years	973,925
3 to 5 years	0
More than 5 years	0
Total	1,289,515
JPMorgan Facility [Member]
Line of Credit Facility [Line Items]
Less than 1 year	166,273
1 to 3 years	674,087
3 to 5 years	0
More than 5 years	0
Total	840,360
DB Repurchase Facility [Member]
Line of Credit Facility [Line Items]
Less than 1 year	0
1 to 3 years	265,658
3 to 5 years	0
More than 5 years	0
Total	265,658
Goldman Loan [Member]
Line of Credit Facility [Line Items]
Less than 1 year	0
1 to 3 years	34,180
3 to 5 years	0
More than 5 years	0
Total	34,180
DB Facility [Member]
Line of Credit Facility [Line Items]
Less than 1 year	149,317
1 to 3 years	0
3 to 5 years	0
More than 5 years	0
Total	$ 149,317

XML

Borrowings Under Repurchase Agreements - Summary of Outstanding Balances, Maximum and Average Balances of Borrowings (Detail) - Line of Credit [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2017 USD ($)
Line of Credit Facility [Line Items]
Balance at September 30, 2017	$ 1,289,515
JPMorgan Facility [Member]
Line of Credit Facility [Line Items]
Balance at September 30, 2017	840,360
Maximum Month-End Balance	986,611
Average Month-End Balance	849,355
DB Repurchase Facility [Member]
Line of Credit Facility [Line Items]
Balance at September 30, 2017	265,658
Maximum Month-End Balance	367,010
Average Month-End Balance	286,326
Goldman Loan [Member]
Line of Credit Facility [Line Items]
Balance at September 30, 2017	34,180
Maximum Month-End Balance	39,590
Average Month-End Balance	37,554
DB Facility [Member]
Line of Credit Facility [Line Items]
Balance at September 30, 2017	149,317
Maximum Month-End Balance	177,203
Average Month-End Balance	$ 136,930

XML

Borrowings Under Repurchase Agreements - Additional Information (Detail) £ in Thousands				1 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2017 USD ($) subsidiary	Sep. 29, 2016 USD ($) extension	Jan. 26, 2015	Apr. 30, 2014 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Sep. 30, 2017 GBP (£)	Sep. 29, 2016 GBP (£)	Sep. 30, 2013 USD ($)
Debt Instrument [Line Items]
Borrowing outstanding					$ 1,278,631,000	$ 1,139,803,000
Line of Credit [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility					2,017,671,000
Borrowing outstanding					$ 1,278,631,000	$ 1,139,803,000
Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread					1.23%	0.77%
Line of Credit [Member] | JPMorgan Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility					$ 1,118,000,000	$ 943,000,000
Borrowing outstanding					840,360,000	657,452,000
Line of Credit [Member] | DB Repurchase Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility		$ 565,491,000			565,491,000	300,000,000
Borrowing outstanding					265,658,000	137,355,000
Number of extensions available | extension		2
Line of credit facility, potential extension period		1 year
Line of Credit [Member] | Goldman Loan [Member]
Debt Instrument [Line Items]
Borrowing outstanding					34,180,000	40,657,000
Line of Credit [Member] | UBS Facility [Member]
Debt Instrument [Line Items]
Borrowing outstanding						133,899,000
Line of Credit [Member] | DB Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility					300,000,000
Borrowing outstanding					$ 149,317,000	$ 177,203,000
Minimum [Member] | Line of Credit [Member] | DB Repurchase Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread					2.10%
Minimum [Member] | Line of Credit [Member] | DB Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread					2.09%
Maximum [Member] | Line of Credit [Member] | DB Repurchase Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread					3.00%
Maximum [Member] | Line of Credit [Member] | DB Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread					2.39%
JP Morgan Facility [Member] | Line of Credit [Member] | JPMorgan Facility [Member]
Debt Instrument [Line Items]
Number of indirect wholly owned subsidiaries | subsidiary	2
Amended and Restated JPMorgan Facility [Member] | Line of Credit [Member] | JPMorgan Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility	$ 1,118,000,000
Debt extension option	1 year
Threshold amount for margin calls (more than)	$ 250,000
Amended and Restated JPMorgan Facility [Member] | Minimum [Member] | Line of Credit [Member] | JPMorgan Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread	2.25%
Amended and Restated JPMorgan Facility [Member] | Maximum [Member] | Line of Credit [Member] | JPMorgan Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread	3.50%
Repurchase Facility [Member] | Line of Credit [Member] | JPMorgan Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility	$ 975,000,000
Asset Specific Financing [Member] | Line of Credit [Member] | JPMorgan Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility	$ 143,000,000
Long-term line of credit					$ 143,000,000
Asset Specific Financing [Member] | Line of Credit [Member] | DB Repurchase Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit		$ 55,200,000			55,200,000
General Facility [Member] | Line of Credit [Member] | JPMorgan Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit					975,000,000
General Facility [Member] | Line of Credit [Member] | DB Repurchase Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit		$ 450,000,000			450,000,000		£ 45,000	£ 45,000
Goldman Facility [Member] | Line of Credit [Member] | Goldman Loan [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility					$ 34,180,000
Goldman Facility [Member] | Line of Credit [Member] | Goldman Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread			3.50%
UBS Facility [Member] | Line of Credit [Member] | UBS Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility									$ 133,899
DB Facility [Member] | Line of Credit [Member] | DB Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing under facility				$ 300,000,000
Line of credit, covenant, minimum shareholder's equity of gross capital Proceeds				50.00%
DB Facility [Member] | Minimum [Member] | Line of Credit [Member] | DB Facility [Member] | Three Month LIBOR [Member]
Debt Instrument [Line Items]
Basis spread					2.09%
DB Facility [Member] | Maximum [Member] | Line of Credit [Member] | DB Facility [Member] | Three Month LIBOR [Member]
Debt Instrument [Line Items]
Basis spread					2.39%
Line of credit facility, non-use commitment fee percentage				1.80%

XML

Convertible Senior Notes - Narrative (Detail) - USD ($)				3 Months Ended		9 Months Ended
	Aug. 21, 2017	Aug. 18, 2014	Mar. 17, 2014	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Debt Instrument [Line Items]
Proceeds from issuance of convertible senior notes						$ 227,700,000	$ 0
Convertible senior notes, carrying value				$ 471,911,000		$ 471,911,000		$ 249,994,000
Company share price (in dollars per share)				$ 18.11		$ 18.11
Convertible Debt [Member] | 2019 and 2022 Notes [Member]
Debt Instrument [Line Items]
Equity component of the notes						$ 18,859,000
Convertible Debt [Member] | 2019 Notes [Member]
Debt Instrument [Line Items]
Equity component of the notes						11,445,000
Interest expense on debt				$ 4,717,000	$ 3,503,000	11,722,000	10,508,000
Additional non-cash interest expense				1,213,000	$ 895,000	3,025,000	$ 2,654,000
Convertible Debt [Member] | March 2019 Notes [Member]
Debt Instrument [Line Items]
Principal amount			$ 143,750,000	$ 143,750,000		$ 143,750,000
Coupon rate			5.50%	5.50%		5.50%
Proceeds from issuance of convertible senior notes			$ 139,037,000
Convertible senior notes, carrying value				$ 142,251,000		$ 142,251,000
Unamortized discount				1,499,000		1,499,000
Convertible Debt [Member] | August 2019 Notes [Member]
Debt Instrument [Line Items]
Principal amount		$ 111,000,000		$ 111,000,000		$ 111,000,000
Coupon rate		5.50%		5.50%		5.50%
Proceeds from issuance of convertible senior notes		$ 109,615,000
Convertible senior notes, carrying value				$ 109,187,000		$ 109,187,000
Unamortized discount				1,813,000		1,813,000
Convertible Debt [Member] | August 2022 Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 230,000,000			$ 230,000,000		$ 230,000,000
Coupon rate	4.75%			4.75%		4.75%
Proceeds from issuance of convertible senior notes	$ 224,825,000
Convertible senior notes, carrying value	220,473,000
Unamortized discount	$ 9,527,000
Equity component of the notes						$ 7,414,000

XML

Convertible Senior Notes - Summary of Notes (Detail) - Convertible Debt [Member]	9 Months Ended
	Sep. 30, 2017 USD ($)	Aug. 21, 2017 USD ($)	Aug. 18, 2014 USD ($)	Mar. 17, 2014 USD ($)
March 2019 Notes [Member]
Debt Instrument [Line Items]
Principal Amount	$ 143,750,000			$ 143,750,000
Coupon Rate	5.50%			5.50%
Effective rate	6.25%
Conversion rate	57.3034
Remaining Period of Amortization	1 year 5 months 16 days
August 2019 Notes [Member]
Debt Instrument [Line Items]
Principal Amount	$ 111,000,000		$ 111,000,000
Coupon Rate	5.50%		5.50%
Effective rate	6.50%
Conversion rate	57.3034
Remaining Period of Amortization	1 year 5 months 16 days
August 2022 Notes [Member]
Debt Instrument [Line Items]
Principal Amount	$ 230,000,000	$ 230,000,000
Coupon Rate	4.75%	4.75%
Effective rate	5.72%
Conversion rate	50.2260
Remaining Period of Amortization	4 years 10 months 24 days
2019 and 2022 Notes [Member]
Debt Instrument [Line Items]
Conversion rate basis, principal amount	$ 1,000,000

XML

Participations Sold (Detail)	1 Months Ended
	Jan. 31, 2015 USD ($) facility	Feb. 28, 2015 USD ($)	Feb. 28, 2015 GBP (£)	Jan. 31, 2015 GBP (£)	Aug. 31, 2014 USD ($)	Jun. 30, 2014 USD ($)	May 31, 2014 USD ($)
Commercial Mortgage Portfolio Segment [Member] | Mezzanine Loan, Acquired by Investment Funds [Member]
Mortgage Loans on Real Estate [Line Items]
Mortgage loan, face amount		$ 30,672,000	£ 20,000,000
Hotel [Member] | Hotel - Aruba [Member] | Subordinate Mortgage Portfolio Segment [Member] | First Mortgage [Member]
Mortgage Loans on Real Estate [Line Items]
Mortgage loan, face amount							$ 155,000,000
Senior Participation [Member] | Hotel [Member] | Hotel - Aruba [Member] | Subordinate Mortgage Portfolio Segment [Member]
Mortgage Loans on Real Estate [Line Items]
Participation in loan, amount					$ 90,000,000	$ 90,000,000
Junior Participation [Member] | Hotel [Member] | Hotel - Aruba [Member] | Subordinate Mortgage Portfolio Segment [Member]
Mortgage Loans on Real Estate [Line Items]
Participation in loan, amount					$ 65,000,000	$ 65,000,000
United Kingdom [Member] | Senior Housing Facility [Member] | Commercial Mortgage Portfolio Segment [Member] | Mezzanine Loan [Member]
Mortgage Loans on Real Estate [Line Items]
Mortgage loan, face amount	$ 51,996,000			£ 34,519,000
Number of properties | facility	44

XML

Derivative Instruments - Summary of Non-Designated Foreign Exchange Forwards (Details) - Not Designated as Hedging Instrument [Member] - Foreign Currency Contract [Member]	Sep. 30, 2017 GBP (£) contract	Dec. 31, 2016 GBP (£) contract
Derivative [Line Items]
Number of Contracts | contract	13	11
Aggregate Notional Amount | £	£ 197,401,000	£ 148,310,000

XML

Derivative Instruments - Summary of Derivatives (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - unrealized	$ (7,302,000)	$ (10,297,000)	$ (17,626,000)	$ 1,731,000
Gain (loss) on derivative instruments - realized			(289,000)	21,100,000
Sub-total	(7,481,000)	4,815,000	(17,916,000)	22,831,000
Total	(7,481,000)	4,815,000	(18,503,000)	22,831,000
Foreign Currency Contract [Member] | Gain (Loss) on Derivative Instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - unrealized	(7,308,000)	(10,304,000)	(17,629,000)	1,812,000
Gain (loss) on derivative instruments - realized	(179,000)	15,112,000	(290,000)	21,100,000
Foreign Currency Contract [Member] | Income (loss) From Unconsolidated Joint Venture [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - realized	0	0	(587,000)	0
Interest Rate Cap [Member] | Gain (Loss) on Derivative Instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - unrealized	6,000	7,000	3,000	(81,000)
Aggregate notional amount	$ 41,507,000	$ 46,798,000	$ 41,507,000	$ 46,798,000

XML

Derivative Instruments - Summary of Derivative Gross Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Derivative Liability [Abstract]
Gross Amount of Recognized Liabilities	$ (11,747)
Gross Amounts Offset in the Condensed Consolidated Balance Sheet	1
Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet	(11,746)	$ 0
Derivative Asset [Abstract]
Gross Amount of Recognized Assets		5,906
Gross Amounts Offset in the Consolidated Balance Sheet		0
Net Amounts of Assets Presented in the Consolidated Balance Sheet	0	5,906
Interest Rate Cap [Member]
Derivative Liability [Abstract]
Gross Amount of Recognized Liabilities	0
Gross Amounts Offset in the Condensed Consolidated Balance Sheet	1
Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet	1
Derivative Asset [Abstract]
Gross Amount of Recognized Assets		23
Gross Amounts Offset in the Consolidated Balance Sheet		0
Net Amounts of Assets Presented in the Consolidated Balance Sheet		23
Foreign Currency Contract [Member]
Derivative Liability [Abstract]
Gross Amount of Recognized Liabilities	(11,747)
Gross Amounts Offset in the Condensed Consolidated Balance Sheet	0
Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet	$ (11,747)
Derivative Asset [Abstract]
Gross Amount of Recognized Assets		5,883
Gross Amounts Offset in the Consolidated Balance Sheet		0
Net Amounts of Assets Presented in the Consolidated Balance Sheet		$ 5,883

XML

Related Party Transactions (Detail) € in Thousands	1 Months Ended							3 Months Ended		9 Months Ended
	May 31, 2017 USD ($)	May 31, 2017 EUR (€)	Jun. 30, 2016 EUR (€)	Feb. 28, 2015 USD ($)	Feb. 28, 2015 EUR (€)	Sep. 30, 2014 USD ($)	Sep. 30, 2014 EUR (€)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2016 EUR (€)	Jan. 31, 2015 USD ($)	Jan. 31, 2015 EUR (€)	Sep. 30, 2014 EUR (€)
Related Party Transaction [Line Items]
Related party expenses								$ 8,309,000	$ 5,903,000	$ 23,484,000	$ 16,374,000
Base management fees incurred but not yet paid								8,309,000		8,309,000			$ 7,015,000
Initial funding for equity method investment										$ 726,000	362,000
Limited Liability Company [Member]
Related Party Transaction [Line Items]
Rate of management fees										1.50%
Extension term										1 year
Voting requirement for termination of Management Agreement										66.66%
Period of termination										180 days
Termination vote threshold rate										300.00%
Period preceding termination which is used to calculate termination fee payment										24 months
Limited Liability Company [Member] | Management Fees [Member]
Related Party Transaction [Line Items]
Related party expenses								8,309,000	5,903,000	$ 23,484,000	16,374,000
Base management fees incurred but not yet paid								8,309,000		8,309,000			$ 7,015,000
Limited Liability Company [Member] | Reimbursements [Member]
Related Party Transaction [Line Items]
Related party expenses								$ 37,000	$ 517,000	$ 231,000	$ 1,359,000
KBCD Partnership [Member]
Related Party Transaction [Line Items]
Initial funding for equity method investment						$ 39,477,000	€ 30,724
Commitment to Invest in KBCD [Member]
Related Party Transaction [Line Items]
Commitment to invest						$ 50,000,000												€ 38,000
Unfunded Commitment, Champ L.P. [Member]
Related Party Transaction [Line Items]
Commitment to invest														$ 2,985,000	€ 2,802
Commitment to invest transfer | €			€ 427
Wholly-owned Subsidiary [Member] | Champ Limited Partnership [Member]
Related Party Transaction [Line Items]
Ownership interest						59.00%		0.00%		0.00%								59.00%
Champ LP [Member] | KBC Bank Deutschland AG [Member]
Related Party Transaction [Line Items]
Ownership interest						35.00%												35.00%
Champ LP [Member]
Related Party Transaction [Line Items]
Sale of equity method investment, percentage				48.00%	48.00%
Proceeds from sale of equity method investments	$ 24,498,000	€ 21,792		$ 20,794,000	€ 16,314
Loss on sale of equity method investment	$ 3,305,000
Champ LP [Member] | Additional Investment [Member]
Related Party Transaction [Line Items]
Commitment to invest																$ 3,929,000	€ 3,331
Pre-development Mezzanine Loan [Member] | Residential Condominium [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Mortgage loan, face amount								$ 300,000,000		$ 300,000,000
Commercial Mortgage Portfolio Segment [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Mortgage loan, face amount								125,000,000		125,000,000		$ 100,000,000
Commercial Mortgage Portfolio Segment [Member] | Pre-development Mezzanine Loan [Member] | Residential Condominium [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Mortgage loan, face amount								$ 25,000,000		$ 25,000,000		$ 25,000,000

XML

Share-Based Payments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Sep. 23, 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recognized stock-based compensation expense	$ 2,635	$ 1,828	$ 9,887	$ 5,434
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	1,932		1,932
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 16,629		$ 16,629
LTIP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of issued and outstanding shares of common stock provides for grants of restricted common stock, restricted stock units and other equity-based awards					7.50%
Common stock, shares delivered (in shares)			200,859
LTIP [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units vested (in shares)			334,864
Adjustment to additional paid in capital, tax liability			$ 2,336

XML

Share-Based Payments - Summary of Grants, Exchanges and Forfeitures of Restricted Stock and RSUs (Detail) - LTIP [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2017 USD ($) shares
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning of period (in shares)	150,110,000
Outstanding, end of period (in shares)	163,481,000
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning of period (in shares)	1,703,775,000
Vested (in shares)	(334,864)
Outstanding, end of period (in shares)	1,359,457,000
January 2017 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Vested (in shares)	(5,161,000)
January 2017 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Cancelled upon delivery (in shares)	(332,349,000)
March 2017 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Forfeiture (in shares)	(1,971,000)
April 2017 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Vested (in shares)	(5,164,000)
Grant (in shares)	14,674,000
Estimated fair value on grant date | $	$ 275
May 2017 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Cancelled upon delivery (in shares)	(1,971,000)
July 2017 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Vested (in shares)	(4,004,000)
July 2017 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Cancelled upon delivery (in shares)	(544,000)
August 2017 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Grant (in shares)	13,026,000
Estimated fair value on grant date | $	$ 233
August 2017 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Grant (in shares)	790,000
Estimated fair value on grant date | $	$ 14
September 2017 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Forfeiture (in shares)	(8,273,000)

XML

Share-Based Payments - Summary of Restricted Stock and RSU Vesting Dates (Detail) - LTIP [Member]	Sep. 30, 2017 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,522,939,000
October 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	3,997,000
December 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	657,600,000
January 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	2,749,000
April 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	7,645,000
June 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	544,000
July 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,420,000
October 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,424,000
December 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	518,843,000
January 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,419,000
April 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	6,314,000
December 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	302,273,000
April 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	4,894,000
August 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	264,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	163,481,000
Restricted Stock [Member] | October 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	3,997,000
Restricted Stock [Member] | December 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	53,923,000
Restricted Stock [Member] | January 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	2,749,000
Restricted Stock [Member] | April 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	7,645,000
Restricted Stock [Member] | June 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
Restricted Stock [Member] | July 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,420,000
Restricted Stock [Member] | October 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,424,000
Restricted Stock [Member] | December 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	41,670,000
Restricted Stock [Member] | January 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,419,000
Restricted Stock [Member] | April 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	6,314,000
Restricted Stock [Member] | December 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	25,000,000
Restricted Stock [Member] | April 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	4,894,000
Restricted Stock [Member] | August 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	1,359,457,000
RSU Vesting [Member] | October 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | December 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	603,677,000
RSU Vesting [Member] | January 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | April 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | June 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	544,000
RSU Vesting [Member] | July 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | October 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | December 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	477,173,000
RSU Vesting [Member] | January 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | April 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | December 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	277,273,000
RSU Vesting [Member] | April 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	0
RSU Vesting [Member] | August 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting	264,000

XML

Stockholders' Equity (Detail) - USD ($) $ / shares in Units, $ in Thousands						3 Months Ended				9 Months Ended
	Sep. 14, 2017	Aug. 02, 2017	Jul. 03, 2017	Jun. 15, 2017	Mar. 14, 2017	Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Class of Stock [Line Items]
Common stock, shares authorized (in shares)						450,000,000		450,000,000		450,000,000
Common stock, par value (in dollars per share)						$ 0.01		$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares)						50,000,000		50,000,000		50,000,000
Preferred stock, par value (in dollars per share)						$ 0.01		$ 0.01		$ 0.01
Common stock, shares issued (in shares)						105,451,235		91,422,676		105,451,235
Common stock, shares outstanding (in shares)						105,451,235		91,422,676		105,451,235
Dividend declared per share of common stock (in dollars per share)						$ 0.46			$ 0.46	$ 1.38	$ 1.38
Proceeds from issuance of common stock as a result of follow-on public offering							$ 248,900	$ 177,796
Common Stock [Member]
Class of Stock [Line Items]
Dividend declared per share of common stock (in dollars per share)	$ 0.46			$ 0.46	$ 0.46
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)		3,450,000,000				0		3,450,000		0
Preferred stock, shares outstanding (in shares)						0		3,450,000		0
Dividend rate, preferred stock		8.625%
Preferred stock, redemption price (in dollars per share)		$ 25
Unpaid dividends (in dollars per share)		$ 0.1079
Dividend declared per share of preferred stock (in dollars per share)			$ 0.1079	0.5391	0.5391
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)						8,000,000		8,000,000		8,000,000
Preferred stock, shares outstanding (in shares)						8,000,000		8,000,000		8,000,000
Dividend rate, preferred stock										8.00%
Dividend declared per share of preferred stock (in dollars per share)	0.5000			0.5000	0.5000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)						6,900,000		6,900,000		6,900,000
Preferred stock, shares outstanding (in shares)						6,900,000		6,900,000		6,900,000
Dividend rate, preferred stock										8.00%
Dividend declared per share of preferred stock (in dollars per share)	$ 0.5000			$ 0.5000	$ 0.5000
Common Stock [Member]
Class of Stock [Line Items]
New issuance of stock (shares)										13,800,000
Common Stock [Member] | Follow On Public Offering [Member]
Class of Stock [Line Items]
New issuance of stock (shares)							13,800,000	10,500,000
Price per share of newly issued stock (in dollars per share)							$ 18.05	$ 16.97

XML

Commitments and Contingencies - Additional Information (Detail) $ in Thousands	May 06, 2016 lawsuit	Sep. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Aug. 31, 2016 lawsuit
Schedule of Equity Method Investments [Line Items]
Number of class action lawsuits | lawsuit				2
Number of consolidated lawsuits | lawsuit	3
Unfunded loan commitments | $		$ 80,164	$ 170,365
Commercial Mortgage and Subordinated Portfolio Segment [Member]
Schedule of Equity Method Investments [Line Items]
Unfunded loan commitments | $		$ 80,164

XML

Fair Value of Financial Instruments (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Restricted cash	$ 76	$ 62,457	$ 62,324
Securities, held-to-maturity	0	146,352
Level 1 [Member] | Carrying Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash and cash equivalents	140,229	200,996
Restricted cash	76	62,457
Level 1 [Member] | Estimated Fair Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash and cash equivalents	140,229	200,996
Restricted cash	76	62,457
Level 3 [Member] | Carrying Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Securities, held-to-maturity	0	146,352
Borrowings under repurchase agreements	(1,289,515)	(1,146,566)
Level 3 [Member] | Carrying Value [Member] | Commercial Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Commercial mortgage and subordinate loans	2,218,222	1,641,856
Level 3 [Member] | Carrying Value [Member] | Subordinate Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Commercial mortgage and subordinate loans	1,340,378	1,051,236
Level 3 [Member] | Estimated Fair Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Securities, held-to-maturity	0	146,352
Borrowings under repurchase agreements	(1,288,982)	(1,146,807)
Level 3 [Member] | Estimated Fair Value [Member] | Commercial Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Commercial mortgage and subordinate loans	2,235,084	1,648,896
Level 3 [Member] | Estimated Fair Value [Member] | Subordinate Mortgage Portfolio Segment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Commercial mortgage and subordinate loans	1,323,249	1,060,882
Level 3 [Member] | Participating Mortgages [Member] | Carrying Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Participations sold	0	(84,979)
Level 3 [Member] | Participating Mortgages [Member] | Estimated Fair Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Participations sold	0	(85,072)
2019 Notes [Member] | Level 1 [Member] | Carrying Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
2019 Notes	(251,438)	(249,994)
2019 Notes [Member] | Level 1 [Member] | Estimated Fair Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
2019 Notes	(277,041)	(268,124)
2022 Notes [Member] | Level 1 [Member] | Carrying Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
2019 Notes	(220,473)	0
2022 Notes [Member] | Level 1 [Member] | Estimated Fair Value [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
2019 Notes	$ (234,025)	$ 0

XML

Net Income per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Numerator:
Net income	$ 68,356	$ 69,893	$ 151,714	$ 98,849
Preferred dividends	(11,148)	(9,310)	(29,768)	(20,985)
Net income available to common stockholders	57,208	60,583	121,946	77,864
Dividends declared on common stock	(48,507)	(37,180)	(139,155)	(99,182)
Dividends on participating securities	(625)	(413)	(1,884)	(1,298)
Net income (loss) attributable to common stockholders	$ 8,076	$ 22,990	$ (19,093)	$ (22,616)
Denominator:
Basic weighted average shares of common stock outstanding (shares)	105,446,704	71,919,549	97,546,437	68,913,362
Diluted weighted average shares of common stock outstanding (shares)	106,812,721	72,861,611	98,919,689	69,865,603
Basic and diluted net income per weighted average share of common stock
Distributable Earnings (in dollars per share)	$ 0.46	$ 0.52	$ 1.43	$ 1.44
Undistributed (loss) (in dollars per share)	0.08	0.31	(0.20)	(0.33)
Basic and diluted net income per share of common stock (in dollars per share)	$ 0.54	$ 0.83	$ 1.23	$ 1.11
RSUs [Member]
Basic and diluted net income per weighted average share of common stock
Unvested securities excluded from earnings per share calculation (shares)	1,366,016	942,062	1,373,252	952,241

XML

Business Combination - Narrative (Details) - USD ($)		12 Months Ended
	Aug. 31, 2016	Dec. 31, 2016
Business Acquisition [Line Items]
Proceeds from sale of mortgaged based securities	$ 1,100,000,000
Apollo Residential Mortgage, Inc. Merger [Member]
Business Acquisition [Line Items]
Transaction-related expenses		$ 11,350,000
Loans Payable [Member]
Business Acquisition [Line Items]
Repayments of debt	804,000,000
Loans Payable [Member] | Athene Loan Agreement [Member]
Business Acquisition [Line Items]
Principal amount	175,000,000
Repayments of debt	$ 175,000,000

XML

Business Combination - Fair Value of Net Assets and Consideration Paid (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Aug. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Liabilities assumed:
Bargain purchase gain		$ 0	$ 40,021	$ 0	$ 40,021
Apollo Residential Mortgage, Inc. Merger [Member]
Consideration Paid:
Cash	$ 220,159
Total consideration paid	611,056
Assets acquired:
Cash and cash equivalents	399,402
Restricted cash	10,552
Investments	1,491,484
Other assets	34,822
Liabilities assumed:
Borrowings under repurchase agreements	(1,254,518)
Other liabilities	(30,665)
Net assets acquired	651,077
Bargain purchase gain	40,021
Common Stock [Member] | Apollo Residential Mortgage, Inc. Merger [Member]
Consideration Paid:
Consideration transferred, equity interest issued and issuable	218,397
Preferred Stock [Member] | Apollo Residential Mortgage, Inc. Merger [Member]
Consideration Paid:
Consideration transferred, equity interest issued and issuable	$ 172,500

XML

Business Combination - Pro Forma Consolidated Operational Data (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2016	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Business Acquisition [Line Items]
Net income available to common stockholders	$ 57,208	$ 60,583			$ 121,946	$ 77,864
Common shares outstanding at September 30, 2016 (in shares)	105,451,235				105,451,235		91,422,676
Net income per common share, basic and diluted (in dollars per share)	$ 0.54	$ 0.83			$ 1.23	$ 1.11
Apollo Residential Mortgage, Inc. Merger [Member]
Business Acquisition [Line Items]
Total revenue			$ 89,665	$ 280,230
Net income available to common stockholders			$ 15,615	$ 40,161
Common shares outstanding at September 30, 2016 (in shares)			80,826,566	80,826,566
Net income per common share, basic and diluted (in dollars per share)			$ 0.19	$ 0.50

XML

Subsequent Events (Detail)		1 Months Ended	9 Months Ended
	Nov. 01, 2017 USD ($)	Oct. 31, 2017 USD ($) Security $ / shares shares	Sep. 30, 2017 USD ($) $ / shares	Sep. 30, 2016 USD ($)	Mar. 31, 2017 USD ($)	Dec. 31, 2016 USD ($) $ / shares
Subsequent Event [Line Items]
Payments received on commercial mortgage loans			$ 17,062,000	$ 118,120,000
Payments received on subordinate loans			$ 221,478,000	$ 81,524,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.01			$ 0.01
Share price (in dollars per share) | $ / shares			18.11
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.01			$ 0.01
Subsequent Event [Member]
Subsequent Event [Line Items]
Number of CMBS | Security		4
Loan fundings	$ 2,475,000
Proceeds from loan repayments	166,240,000
Payments received on commercial mortgage loans	35,530,000
Payments received on subordinate loans	130,710,000
Series B Preferred stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares repurchased | shares		1,229,607
Aggregate purchase price of shares repurchased		$ 30,795,000
Share price (in dollars per share) | $ / shares		$ 25.04
Preferred stock, par value (in dollars per share) | $ / shares		0.01
Liquidation value (in dollars per share) | $ / shares		25
Unpaid dividends (in dollars per share) | $ / shares		$ 0.04
CMBS [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from sale and principal pay downs		$ 48,357,000
Commercial Mortgage Portfolio Segment [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Total loans, held for investment, net	$ 294,134,000
QHREAC [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares repurchased | shares		1,670,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.01
Aggregate purchase price of shares repurchased		$ 30,795,000
Share price (in dollars per share) | $ / shares		$ 18.44
Line of Credit [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility			$ 2,017,671,000
JP Morgan Chase [Member] | Line of Credit [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility			$ 1,118,000,000			$ 943,000,000
Amended and Restated JPMorgan Facility [Member] | JP Morgan Chase [Member] | Line of Credit [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility					$ 1,118,000,000
Amended and Restated JPMorgan Facility [Member] | JP Morgan Chase [Member] | Line of Credit [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility		$ 1,393,000,000
Repurchase Facility [Member] | JP Morgan Chase [Member] | Line of Credit [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility					975,000,000
Repurchase Facility [Member] | JP Morgan Chase [Member] | Line of Credit [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility		1,250,000,000
Asset Specific Financing [Member] | JP Morgan Chase [Member] | Line of Credit [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility					$ 143,000,000
Asset Specific Financing [Member] | JP Morgan Chase [Member] | Line of Credit [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Maximum borrowing under facility		$ 143,000,000